{"parse":{"title":"Naltrexone","pageid":1195987,"revid":857016260,"text":{"*":"<div class=\"mw-parser-output\"><div role=\"note\" class=\"hatnote navigation-not-searchable\">Not to be confused with <a href=\"/wiki/Naloxone\" title=\"Naloxone\">Naloxone</a> or <a href=\"/wiki/Nalmexone\" title=\"Nalmexone\">Nalmexone</a>.</div>\n<table class=\"infobox\" style=\"width:22em;border-spacing:2px;\"><caption><span title=\"International nonproprietary name (INN): Naltrexone\">Naltrexone</span></caption><tbody><tr><td colspan=\"2\" style=\"text-align:center\">\n<a href=\"/wiki/File:Naltrexone_skeletal.svg\" class=\"image\"><img alt=\"Naltrexone skeletal.svg\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/4/4d/Naltrexone_skeletal.svg/200px-Naltrexone_skeletal.svg.png\" width=\"200\" height=\"194\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/4/4d/Naltrexone_skeletal.svg/300px-Naltrexone_skeletal.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/4/4d/Naltrexone_skeletal.svg/400px-Naltrexone_skeletal.svg.png 2x\" data-file-width=\"516\" data-file-height=\"500\" /></a></td></tr><tr><td colspan=\"2\" style=\"text-align:center\">\n<a href=\"/wiki/File:Naltrexone-3D-balls.png\" class=\"image\"><img alt=\"Naltrexone-3D-balls.png\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/b/b8/Naltrexone-3D-balls.png/250px-Naltrexone-3D-balls.png\" width=\"250\" height=\"164\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/b/b8/Naltrexone-3D-balls.png/375px-Naltrexone-3D-balls.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b8/Naltrexone-3D-balls.png/500px-Naltrexone-3D-balls.png 2x\" data-file-width=\"1100\" data-file-height=\"722\" /></a></td></tr><tr><th colspan=\"2\" style=\"text-align:center;background:#ddd\">Clinical data</th></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/Drug_nomenclature#Trade_names\" title=\"Drug nomenclature\">Trade names</a></th><td>\nReVia, Vivitrol, others</td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\">Synonyms</th><td>\nEN-1639A; UM-792; <i>N</i>-Cyclopropyl-methylnoroxymorphone; <i>N</i>-Cyclopropylmethyl-14-hydroxydihydro-morphinone; 17-(Cyclopropylmethyl)-4,5\u03b1-epoxy-3,14-dihydroxymorphinan-6-one</td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/American_Society_of_Health-System_Pharmacists\" title=\"American Society of Health-System Pharmacists\">AHFS</a>/<a href=\"/wiki/Drugs.com\" title=\"Drugs.com\">Drugs.com</a></th><td>\n<span title=\"www.drugs.com\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.drugs.com/monograph/naltrexone.html\">Monograph</a></span></td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/MedlinePlus\" title=\"MedlinePlus\">MedlinePlus</a></th><td>\n<span title=\"medlineplus.gov\"><a rel=\"nofollow\" class=\"external text\" href=\"https://medlineplus.gov/druginfo/meds/a685041.html\">a685041</a></span></td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/Pregnancy_category\" title=\"Pregnancy category\">Pregnancy<br />category</a></th><td>\n<div class=\"plainlist\">\n<ul><li><small><abbr class=\"country-name\" title=\"\">AU</abbr>:</small>&#x20;<a href=\"/wiki/Pregnancy_category#Australia\" title=\"Pregnancy category\">B3</a>&#x20;</li>\n<li><small><abbr class=\"country-name\" title=\"United States\">US</abbr>:</small>&#x20;<a href=\"/wiki/Pregnancy_category#United_States\" title=\"Pregnancy category\">C</a> (Risk not ruled out)&#x20;</li></ul>\n<ul><li class=\"mw-empty-elt\"></li></ul>\n</div></td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/Route_of_administration\" title=\"Route of administration\">Routes of<br />administration</a></th><td>\n<a href=\"/wiki/Oral_administration\" title=\"Oral administration\">By mouth</a>, <a href=\"/wiki/Intramuscular_injection\" title=\"Intramuscular injection\">intramuscular injection</a>, <a href=\"/wiki/Subcutaneous_implant\" title=\"Subcutaneous implant\">subcutaneous implant</a></td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/Anatomical_Therapeutic_Chemical_Classification_System\" title=\"Anatomical Therapeutic Chemical Classification System\">ATC code</a></th><td>\n<div class=\"plainlist\"><ul><li><a href=\"/wiki/ATC_code_N07\" title=\"ATC code N07\">N07BB04</a>&#x20;(<span title=\"www.whocc.no\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.whocc.no/atc_ddd_index/?code=N07BB04\">WHO</a></span>)&#x20;</li></ul></div></td></tr><tr><th colspan=\"2\" style=\"text-align:center;background:#ddd\">Legal status</th></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/Regulation_of_therapeutic_goods\" title=\"Regulation of therapeutic goods\">Legal status</a></th><td>\n<div class=\"plainlist\">\n<ul><li><small><abbr class=\"country-name\" title=\"Australia\">AU</abbr>:</small>&#x20;<a href=\"/wiki/Standard_for_the_Uniform_Scheduling_of_Drugs_and_Poisons#Schedule_4_Prescription_Only_Medicine\" class=\"mw-redirect\" title=\"Standard for the Uniform Scheduling of Drugs and Poisons\">S4</a> (Prescription only)&#x20;</li>\n<li><small><abbr class=\"country-name\" title=\"Canada\">CA</abbr></small>:&#x20;<a href=\"/wiki/Prescription_drug\" title=\"Prescription drug\"> \u211e-only</a>&#x20;</li>\n<li><small><abbr class=\"country-name\" title=\"United Kingdom\">UK</abbr>:</small>&#x20;<a href=\"/wiki/Prescription_drug\" title=\"Prescription drug\">POM</a> (Prescription only)&#x20;</li>\n<li><small><abbr class=\"country-name\" title=\"United States\">US</abbr>:</small>&#x20;<a href=\"/wiki/Prescription_drug\" title=\"Prescription drug\">\u211e-only</a>&#x20;</li>\n<li>In&#160;general: \u211e&#160;(Prescription only)</li></ul></div>\n</td></tr><tr><th colspan=\"2\" style=\"text-align:center;background:#ddd\"><a href=\"/wiki/Pharmacokinetics\" title=\"Pharmacokinetics\">Pharmacokinetic</a> data</th></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/Bioavailability\" title=\"Bioavailability\">Bioavailability</a></th><td>\n5\u201340%</td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/Plasma_protein_binding\" title=\"Plasma protein binding\">Protein binding</a></th><td>\n21%</td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/Drug_metabolism\" title=\"Drug metabolism\">Metabolism</a></th><td>\n<a href=\"/wiki/Liver\" title=\"Liver\">Liver</a></td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/Biological_half-life\" title=\"Biological half-life\">Elimination <span class=\"nowrap\">half-life</span></a></th><td>\nNaltrexone: 4 hours<br /><a href=\"/wiki/6%CE%B2-Naltrexol\" title=\"6\u03b2-Naltrexol\">6\u03b2-Naltrexol</a>: 13 hours</td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/Excretion\" title=\"Excretion\">Excretion</a></th><td>\n<a href=\"/wiki/Urine\" title=\"Urine\">Urine</a></td></tr><tr><th colspan=\"2\" style=\"text-align:center;background:#ddd\">Identifiers</th></tr><tr><td colspan=\"2\" style=\"text-align:center\">\n<div class=\"NavFrame collapsed\" style=\"border: none; padding: 0;\">\n<div class=\"NavHead\" style=\"font-size: 105%; background: transparent; text-align: left;\"><a href=\"/wiki/IUPAC_nomenclature_of_chemistry\" title=\"IUPAC nomenclature of chemistry\">IUPAC name</a></div>\n<ul class=\"NavContent\" style=\"list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;\"><li style=\"line-height: inherit; margin: 0\"><span style=\"font-size: 11px;\">(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1<i>H</i>-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one</span></li></ul>\n</div></td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/CAS_Registry_Number\" title=\"CAS Registry Number\">CAS Number</a></th><td>\n<div class=\"plainlist\"><ul><li><span title=\"www.commonchemistry.org\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.commonchemistry.org/ChemicalDetail.aspx?ref=16590-41-3\">16590-41-3</a></span><sup>&#160;<img alt=\"\u2611\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png\" width=\"7\" height=\"7\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x\" data-file-width=\"600\" data-file-height=\"600\" /><span style=\"display:none\">Y</span></sup></li></ul></div></td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/PubChem#CID\" title=\"PubChem\">PubChem</a> <span style=\"font-weight:normal\"><abbr title=\"Compound ID\">CID</abbr></span></th><td>\n<div class=\"plainlist\"><ul><li><span title=\"pubchem.ncbi.nlm.nih.gov\"><a rel=\"nofollow\" class=\"external text\" href=\"https://pubchem.ncbi.nlm.nih.gov/compound/5360515\">5360515</a></span></li></ul></div></td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/Guide_to_Pharmacology\" title=\"Guide to Pharmacology\">IUPHAR/BPS</a></th><td>\n<div class=\"plainlist\"><ul><li><span title=\"www.guidetopharmacology.org\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1639\">1639</a></span></li></ul></div></td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/DrugBank\" title=\"DrugBank\">DrugBank</a></th><td>\n<div class=\"plainlist\"><ul><li><span title=\"www.drugbank.ca\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.drugbank.ca/drugs/DB00704\">DB00704</a></span><sup>&#160;<img alt=\"\u2611\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png\" width=\"7\" height=\"7\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x\" data-file-width=\"600\" data-file-height=\"600\" /><span style=\"display:none\">Y</span></sup></li></ul></div></td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/ChemSpider\" title=\"ChemSpider\">ChemSpider</a></th><td>\n<div class=\"plainlist\"><ul><li><span title=\"www.chemspider.com\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.chemspider.com/Chemical-Structure.4514524.html\">4514524</a></span><sup>&#160;<img alt=\"\u2611\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png\" width=\"7\" height=\"7\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x\" data-file-width=\"600\" data-file-height=\"600\" /><span style=\"display:none\">Y</span></sup></li></ul></div></td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/Unique_Ingredient_Identifier\" title=\"Unique Ingredient Identifier\">UNII</a></th><td>\n<div class=\"plainlist\"><ul><li><span title=\"fdasis.nlm.nih.gov\"><a rel=\"nofollow\" class=\"external text\" href=\"https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=5S6W795CQM\">5S6W795CQM</a></span></li></ul></div></td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/KEGG\" title=\"KEGG\">KEGG</a></th><td>\n<div class=\"plainlist\"><ul><li><span title=\"www.kegg.jp\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.kegg.jp/entry/D05113\">D05113</a></span><sup>&#160;<img alt=\"\u2611\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png\" width=\"7\" height=\"7\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x\" data-file-width=\"600\" data-file-height=\"600\" /><span style=\"display:none\">Y</span></sup></li></ul></div></td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/ChEBI\" title=\"ChEBI\">ChEBI</a></th><td>\n<div class=\"plainlist\"><ul><li><span title=\"www.ebi.ac.uk\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:7465\">CHEBI:7465</a></span><sup>&#160;<img alt=\"\u2611\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png\" width=\"7\" height=\"7\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x\" data-file-width=\"600\" data-file-height=\"600\" /><span style=\"display:none\">Y</span></sup></li></ul></div></td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/ChEMBL\" title=\"ChEMBL\">ChEMBL</a></th><td>\n<div class=\"plainlist\"><ul><li><span title=\"www.ebi.ac.uk\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL19019\">CHEMBL19019</a></span><sup>&#160;<img alt=\"\u2612\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/7px-X_mark.svg.png\" width=\"7\" height=\"8\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/11px-X_mark.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/14px-X_mark.svg.png 2x\" data-file-width=\"525\" data-file-height=\"600\" /><span style=\"display:none\">N</span></sup></li></ul></div></td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/ECHA_InfoCard\" class=\"mw-redirect\" title=\"ECHA InfoCard\"><span title=\"echa.europa.eu\">ECHA InfoCard</span></a></th><td>\n<a rel=\"nofollow\" class=\"external text\" href=\"https://echa.europa.eu/substance-information/-/substanceinfo/100.036.939\">100.036.939</a> <a href=\"https://www.wikidata.org/wiki/Q409587#P2566\" title=\"Edit this at Wikidata\"><img alt=\"Edit this at Wikidata\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/7/73/Blue_pencil.svg/10px-Blue_pencil.svg.png\" width=\"10\" height=\"10\" style=\"vertical-align: text-top\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/7/73/Blue_pencil.svg/15px-Blue_pencil.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/73/Blue_pencil.svg/20px-Blue_pencil.svg.png 2x\" data-file-width=\"600\" data-file-height=\"600\" /></a></td></tr><tr><th colspan=\"2\" style=\"text-align:center;background:#ddd\">Chemical and physical data</th></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/Chemical_formula\" title=\"Chemical formula\">Formula</a></th><td>\n<span title=\"Carbon\">C</span><sub>20</sub><span title=\"Hydrogen\">H</span><sub>23</sub><span title=\"Nitrogen\">N</span><span title=\"Oxygen\">O</span><sub>4</sub></td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/Molar_mass\" title=\"Molar mass\">Molar mass</a></th><td>\n341.401 g/mol</td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\">3D model (<a href=\"/wiki/JSmol\" class=\"mw-redirect\" title=\"JSmol\">JSmol</a>)</th><td>\n<div class=\"plainlist\"><ul><li><span title=\"chemapps.stolaf.edu (3D interactive model)\"><a rel=\"nofollow\" class=\"external text\" href=\"https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC4%5BC%40%40H%5D5Oc1c2c%28ccc1O%29C%5BC%40H%5D3N%28CC%5BC%40%5D25%5BC%40%40%5D3%28O%29CC4%29CC6CC6\">Interactive image</a></span></li></ul></div></td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/Melting_point\" title=\"Melting point\">Melting point</a></th><td>\n169&#160;\u00b0C (336&#160;\u00b0F)</td></tr><tr><td colspan=\"2\" style=\"text-align:center\">\n<div class=\"NavFrame collapsed\" style=\"border: none; padding: 0;\">\n<div class=\"NavHead\" style=\"font-size: 105%; background: transparent; text-align: left;\"><a href=\"/wiki/Simplified_molecular-input_line-entry_system\" title=\"Simplified molecular-input line-entry system\">SMILES</a></div>\n<ul class=\"NavContent\" style=\"list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;\"><li style=\"line-height: inherit; margin: 0\"><div style=\"word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;\">O=C4[C@@H]5Oc1c2c(ccc1O)C[C@H]3N(CC[C@]25[C@@]3(O)CC4)CC6CC6</div></li></ul>\n</div></td></tr><tr><td colspan=\"2\" style=\"text-align:center\">\n<div class=\"NavFrame collapsed\" style=\"border: none; padding: 0;\">\n<div class=\"NavHead\" style=\"font-size: 105%; background: transparent; text-align: left;\"><a href=\"/wiki/International_Chemical_Identifier\" title=\"International Chemical Identifier\">InChI</a></div>\n<ul class=\"NavContent\" style=\"list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;\"><li style=\"line-height: inherit; margin: 0\"><div style=\"word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;\">InChI=1S/C20H23NO4/c22-13-4-3-12-9-15-20(24)6-5-14(23)18-19(20,16(12)17(13)25-18)7-8-21(15)10-11-1-2-11/h3-4,11,15,18,22,24H,1-2,5-10H2/t15-,18+,19+,20-/m1/s1<sup>&#160;<img alt=\"\u2611\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png\" width=\"7\" height=\"7\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x\" data-file-width=\"600\" data-file-height=\"600\" /><span style=\"display:none\">Y</span></sup></div></li><li style=\"line-height: inherit; margin: 0\"><div style=\"word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;\">Key:DQCKKXVULJGBQN-XFWGSAIBSA-N<sup>&#160;<img alt=\"\u2611\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png\" width=\"7\" height=\"7\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x\" data-file-width=\"600\" data-file-height=\"600\" /><span style=\"display:none\">Y</span></sup></div></li></ul>\n</div></td></tr><tr><th colspan=\"2\" style=\"text-align:center;background:#ddd\"><span style=\"font-weight:normal;\">&#160;<sup><img alt=\"\u2612\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/7px-X_mark.svg.png\" width=\"7\" height=\"8\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/11px-X_mark.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/14px-X_mark.svg.png 2x\" data-file-width=\"525\" data-file-height=\"600\" /><span style=\"display:none\">N</span><img alt=\"\u2611\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png\" width=\"7\" height=\"7\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x\" data-file-width=\"600\" data-file-height=\"600\" /><span style=\"display:none\">Y</span></sup>&#160;<a href=\"/wiki/Wikipedia:WikiProject_Chemicals/Chembox_validation\" title=\"Wikipedia:WikiProject Chemicals/Chembox validation\">(what is this?)</a></span><span style=\"font-weight:normal;\">&#160;&#160;<span class=\"reflink plainlinks nourlexpansion\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Special:ComparePages&amp;rev1=464372546&amp;page2=Naltrexone\">(verify)</a></span></span></th></tr></tbody></table>\n<p><b>Naltrexone</b>, sold under the brand names <b>ReVia</b> and <b>Vivitrol</b> among others, is a <a href=\"/wiki/Medication\" title=\"Medication\">medication</a> primarily used to manage <a href=\"/wiki/Alcohol_dependence\" title=\"Alcohol dependence\">alcohol</a> or <a href=\"/wiki/Opioid_dependence\" class=\"mw-redirect\" title=\"Opioid dependence\">opioid dependence</a>.<sup id=\"cite_ref-AHFS2017_1-0\" class=\"reference\"><a href=\"#cite_note-AHFS2017-1\">&#91;1&#93;</a></sup> An opioid-dependent person should not receive naltrexone before detoxification.<sup id=\"cite_ref-AHFS2017_1-1\" class=\"reference\"><a href=\"#cite_note-AHFS2017-1\">&#91;1&#93;</a></sup> It is taken by mouth or by <a href=\"/wiki/Intramuscular\" class=\"mw-redirect\" title=\"Intramuscular\">injection into a muscle</a>.<sup id=\"cite_ref-AHFS2017_1-2\" class=\"reference\"><a href=\"#cite_note-AHFS2017-1\">&#91;1&#93;</a></sup> Effects begin within 30 minutes.<sup id=\"cite_ref-AHFS2017_1-3\" class=\"reference\"><a href=\"#cite_note-AHFS2017-1\">&#91;1&#93;</a></sup> A decreased desire for opioids, though, may take a few weeks.<sup id=\"cite_ref-AHFS2017_1-4\" class=\"reference\"><a href=\"#cite_note-AHFS2017-1\">&#91;1&#93;</a></sup>\n</p><p>Side effects may include <a href=\"/wiki/Trouble_sleeping\" class=\"mw-redirect\" title=\"Trouble sleeping\">trouble sleeping</a>, <a href=\"/wiki/Anxiety\" title=\"Anxiety\">anxiety</a>, <a href=\"/wiki/Nausea\" title=\"Nausea\">nausea</a>, and <a href=\"/wiki/Headache\" title=\"Headache\">headaches</a>.<sup id=\"cite_ref-AHFS2017_1-5\" class=\"reference\"><a href=\"#cite_note-AHFS2017-1\">&#91;1&#93;</a></sup> In those still on opioids, <a href=\"/wiki/Opioid_withdrawal\" class=\"mw-redirect\" title=\"Opioid withdrawal\">opioid withdrawal</a> may occur.<sup id=\"cite_ref-AHFS2017_1-6\" class=\"reference\"><a href=\"#cite_note-AHFS2017-1\">&#91;1&#93;</a></sup> Use is not recommended in people with <a href=\"/wiki/Liver_failure\" title=\"Liver failure\">liver failure</a>.<sup id=\"cite_ref-AHFS2017_1-7\" class=\"reference\"><a href=\"#cite_note-AHFS2017-1\">&#91;1&#93;</a></sup> It is unclear if use is safe during <a href=\"/wiki/Pregnancy\" title=\"Pregnancy\">pregnancy</a>.<sup id=\"cite_ref-AHFS2017_1-8\" class=\"reference\"><a href=\"#cite_note-AHFS2017-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-2\" class=\"reference\"><a href=\"#cite_note-2\">&#91;2&#93;</a></sup> Naltrexone is an <a href=\"/wiki/Opioid_antagonist\" title=\"Opioid antagonist\">opioid antagonist</a> and works by blocking the effects of <a href=\"/wiki/Opioid\" title=\"Opioid\">opioids</a>, both those <a href=\"/wiki/Endorphin\" class=\"mw-redirect\" title=\"Endorphin\">from inside</a> and outside the body.<sup id=\"cite_ref-AHFS2017_1-9\" class=\"reference\"><a href=\"#cite_note-AHFS2017-1\">&#91;1&#93;</a></sup>\n</p><p>Naltrexone was first made in 1965 and was approved for medical use in the United States in 1984.<sup id=\"cite_ref-AHFS2017_1-10\" class=\"reference\"><a href=\"#cite_note-AHFS2017-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-Sad2012_3-0\" class=\"reference\"><a href=\"#cite_note-Sad2012-3\">&#91;3&#93;</a></sup> As of 2017, the wholesale cost of tablets is about US$0.74 <a href=\"/wiki/Defined_daily_dose\" title=\"Defined daily dose\">per day</a> in the US.<sup id=\"cite_ref-4\" class=\"reference\"><a href=\"#cite_note-4\">&#91;4&#93;</a></sup><sup id=\"cite_ref-Medi2017_5-0\" class=\"reference\"><a href=\"#cite_note-Medi2017-5\">&#91;5&#93;</a></sup> The extended-release injections cost about $1,267 per month ($41.20 per day).<sup id=\"cite_ref-Medi2017_5-1\" class=\"reference\"><a href=\"#cite_note-Medi2017-5\">&#91;5&#93;</a></sup> Naltrexone, as <a href=\"/wiki/Bupropion/naltrexone\" title=\"Bupropion/naltrexone\">bupropion/naltrexone</a>, is also used to treat <a href=\"/wiki/Obesity\" title=\"Obesity\">obesity</a>.<sup id=\"cite_ref-6\" class=\"reference\"><a href=\"#cite_note-6\">&#91;6&#93;</a></sup>\n</p>\n<div class=\"toclimit-3\"><div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Medical_uses\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Medical uses</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-2\"><a href=\"#Alcoholism\"><span class=\"tocnumber\">1.1</span> <span class=\"toctext\">Alcoholism</span></a></li>\n<li class=\"toclevel-2 tocsection-3\"><a href=\"#Opioid_use\"><span class=\"tocnumber\">1.2</span> <span class=\"toctext\">Opioid use</span></a></li>\n<li class=\"toclevel-2 tocsection-4\"><a href=\"#Others\"><span class=\"tocnumber\">1.3</span> <span class=\"toctext\">Others</span></a></li>\n<li class=\"toclevel-2 tocsection-5\"><a href=\"#Available_forms\"><span class=\"tocnumber\">1.4</span> <span class=\"toctext\">Available forms</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-6\"><a href=\"#Contraindications\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Contraindications</span></a></li>\n<li class=\"toclevel-1 tocsection-7\"><a href=\"#Side_effects\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Side effects</span></a></li>\n<li class=\"toclevel-1 tocsection-8\"><a href=\"#Pharmacology\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">Pharmacology</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-9\"><a href=\"#Pharmacodynamics\"><span class=\"tocnumber\">4.1</span> <span class=\"toctext\">Pharmacodynamics</span></a>\n<ul>\n<li class=\"toclevel-3 tocsection-10\"><a href=\"#Mechanism_of_action\"><span class=\"tocnumber\">4.1.1</span> <span class=\"toctext\">Mechanism of action</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-2 tocsection-11\"><a href=\"#Pharmacokinetics\"><span class=\"tocnumber\">4.2</span> <span class=\"toctext\">Pharmacokinetics</span></a></li>\n<li class=\"toclevel-2 tocsection-12\"><a href=\"#Pharmacogenetics\"><span class=\"tocnumber\">4.3</span> <span class=\"toctext\">Pharmacogenetics</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-13\"><a href=\"#Chemistry\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">Chemistry</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-14\"><a href=\"#Analogues\"><span class=\"tocnumber\">5.1</span> <span class=\"toctext\">Analogues</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-15\"><a href=\"#History\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">History</span></a></li>\n<li class=\"toclevel-1 tocsection-16\"><a href=\"#Society_and_culture\"><span class=\"tocnumber\">7</span> <span class=\"toctext\">Society and culture</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-17\"><a href=\"#Generic_names\"><span class=\"tocnumber\">7.1</span> <span class=\"toctext\">Generic names</span></a></li>\n<li class=\"toclevel-2 tocsection-18\"><a href=\"#Brand_names\"><span class=\"tocnumber\">7.2</span> <span class=\"toctext\">Brand names</span></a></li>\n<li class=\"toclevel-2 tocsection-19\"><a href=\"#Controversies\"><span class=\"tocnumber\">7.3</span> <span class=\"toctext\">Controversies</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-20\"><a href=\"#Research\"><span class=\"tocnumber\">8</span> <span class=\"toctext\">Research</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-21\"><a href=\"#Depersonalization\"><span class=\"tocnumber\">8.1</span> <span class=\"toctext\">Depersonalization</span></a></li>\n<li class=\"toclevel-2 tocsection-22\"><a href=\"#Low-dose\"><span class=\"tocnumber\">8.2</span> <span class=\"toctext\">Low-dose</span></a></li>\n<li class=\"toclevel-2 tocsection-23\"><a href=\"#Self-injury\"><span class=\"tocnumber\">8.3</span> <span class=\"toctext\">Self-injury</span></a></li>\n<li class=\"toclevel-2 tocsection-24\"><a href=\"#Behavioral_disorders\"><span class=\"tocnumber\">8.4</span> <span class=\"toctext\">Behavioral disorders</span></a></li>\n<li class=\"toclevel-2 tocsection-25\"><a href=\"#Interferon_alpha\"><span class=\"tocnumber\">8.5</span> <span class=\"toctext\">Interferon alpha</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-26\"><a href=\"#See_also\"><span class=\"tocnumber\">9</span> <span class=\"toctext\">See also</span></a></li>\n<li class=\"toclevel-1 tocsection-27\"><a href=\"#References\"><span class=\"tocnumber\">10</span> <span class=\"toctext\">References</span></a></li>\n</ul>\n</div>\n</div>\n<h2><span class=\"mw-headline\" id=\"Medical_uses\">Medical uses</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Naltrexone&amp;action=edit&amp;section=1\" title=\"Edit section: Medical uses\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<h3><span class=\"mw-headline\" id=\"Alcoholism\">Alcoholism</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Naltrexone&amp;action=edit&amp;section=2\" title=\"Edit section: Alcoholism\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Naltrexone has been best studied as a treatment for <a href=\"/wiki/Alcoholism\" title=\"Alcoholism\">alcoholism</a>.<sup id=\"cite_ref-7\" class=\"reference\"><a href=\"#cite_note-7\">&#91;7&#93;</a></sup> Naltrexone has been shown to decrease the amount and frequency of drinking.<sup id=\"cite_ref-Ros2010_8-0\" class=\"reference\"><a href=\"#cite_note-Ros2010-8\">&#91;8&#93;</a></sup> It does not appear to change the percentage of people drinking.<sup id=\"cite_ref-9\" class=\"reference\"><a href=\"#cite_note-9\">&#91;9&#93;</a></sup> Its overall benefit has been described as \"modest\".<sup id=\"cite_ref-10\" class=\"reference\"><a href=\"#cite_note-10\">&#91;10&#93;</a></sup>\n</p><p><a href=\"/wiki/Acamprosate\" title=\"Acamprosate\">Acamprosate</a> may work better than naltrexone for eliminating drinking, while naltrexone may decrease the desire for alcohol to a greater extent.<sup id=\"cite_ref-Mai2013_11-0\" class=\"reference\"><a href=\"#cite_note-Mai2013-11\">&#91;11&#93;</a></sup>\n</p><p>The <a href=\"/wiki/Sinclair_method\" class=\"mw-redirect\" title=\"Sinclair method\">Sinclair method</a> is a method of using opiate antagonists such as naltrexone to treat alcoholism. The person takes the medication about an hour (and only then) before drinking to avoid side effects that arise from chronic use.<sup id=\"cite_ref-12\" class=\"reference\"><a href=\"#cite_note-12\">&#91;12&#93;</a></sup><sup id=\"cite_ref-Sin2001_13-0\" class=\"reference\"><a href=\"#cite_note-Sin2001-13\">&#91;13&#93;</a></sup> The opioid antagonist blocks the positive-reinforcement effects of alcohol and allows the person to stop or reduce drinking.<sup id=\"cite_ref-Sin2001_13-1\" class=\"reference\"><a href=\"#cite_note-Sin2001-13\">&#91;13&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Opioid_use\">Opioid use</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Naltrexone&amp;action=edit&amp;section=3\" title=\"Edit section: Opioid use\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Long-acting injectable naltrexone decreases <a href=\"/wiki/Heroin\" title=\"Heroin\">heroin</a> use more than placebo.<sup id=\"cite_ref-Shar2017_14-0\" class=\"reference\"><a href=\"#cite_note-Shar2017-14\">&#91;14&#93;</a></sup> It has benefits over <a href=\"/wiki/Methadone\" title=\"Methadone\">methadone</a> and <a href=\"/wiki/Buprenorphine\" title=\"Buprenorphine\">buprenorphine</a> in that it is not a restricted medication.<sup id=\"cite_ref-Shar2017_14-1\" class=\"reference\"><a href=\"#cite_note-Shar2017-14\">&#91;14&#93;</a></sup> It may decrease cravings for opioids after a number of weeks, and decreases the risk of <a href=\"/wiki/Overdose\" class=\"mw-redirect\" title=\"Overdose\">overdose</a>.<sup id=\"cite_ref-AHFS2017_1-11\" class=\"reference\"><a href=\"#cite_note-AHFS2017-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-15\" class=\"reference\"><a href=\"#cite_note-15\">&#91;15&#93;</a></sup> It is given once per month and has better <a href=\"/wiki/Compliance_(medicine)\" class=\"mw-redirect\" title=\"Compliance (medicine)\">compliance</a> than the oral formulation.<sup id=\"cite_ref-ComerSullivan2006_16-0\" class=\"reference\"><a href=\"#cite_note-ComerSullivan2006-16\">&#91;16&#93;</a></sup>\n</p><p>A 2011 review found insufficient evidence to determine the effect of naltrexone taken by mouth in opioid dependence.<sup id=\"cite_ref-17\" class=\"reference\"><a href=\"#cite_note-17\">&#91;17&#93;</a></sup> While some do well with this formulation, it must be taken daily, and a person whose cravings become overwhelming can obtain opioid intoxication simply by skipping a dose. Due to this issue, the usefulness of oral naltrexone in <a href=\"/wiki/Opioid_use_disorder\" title=\"Opioid use disorder\">opioid use disorders</a> is limited by the low retention in treatment. Naltrexone by mouth remains an ideal treatment for a small number of people with opioid use, usually those with a stable social situation and motivation. With additional <a href=\"/wiki/Contingency_management\" title=\"Contingency management\">contingency management</a> support, naltrexone may be effective in a broader population.<sup id=\"cite_ref-18\" class=\"reference\"><a href=\"#cite_note-18\">&#91;18&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Others\">Others</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Naltrexone&amp;action=edit&amp;section=4\" title=\"Edit section: Others\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Naltrexone is not useful for <a href=\"/wiki/Smoking_cessation\" title=\"Smoking cessation\">quitting smoking</a>.<sup id=\"cite_ref-19\" class=\"reference\"><a href=\"#cite_note-19\">&#91;19&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Available_forms\">Available forms</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Naltrexone&amp;action=edit&amp;section=5\" title=\"Edit section: Available forms\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Naltrexone is available and most commonly used in the form of an <a href=\"/wiki/Oral_administration\" title=\"Oral administration\">oral</a> <a href=\"/wiki/Tablet_(pharmacy)\" title=\"Tablet (pharmacy)\">tablet</a> (50&#160;mg).<sup id=\"cite_ref-Milhorn2017_20-0\" class=\"reference\"><a href=\"#cite_note-Milhorn2017-20\">&#91;20&#93;</a></sup> Vivitrol, a naltrexone formulation for <a href=\"/wiki/Injection_(medicine)#Depot_injection\" title=\"Injection (medicine)\">depot injection</a> containing 380&#160;mg of the medication per vial, is also available.<sup id=\"cite_ref-Milhorn2017_20-1\" class=\"reference\"><a href=\"#cite_note-Milhorn2017-20\">&#91;20&#93;</a></sup><sup id=\"cite_ref-MedicalNewsToday2006_21-0\" class=\"reference\"><a href=\"#cite_note-MedicalNewsToday2006-21\">&#91;21&#93;</a></sup> Additionally, naltrexone <a href=\"/wiki/Subcutaneous_implant\" title=\"Subcutaneous implant\">subcutaneous implants</a> that are surgically implanted are available.<sup id=\"cite_ref-TGA_22-0\" class=\"reference\"><a href=\"#cite_note-TGA-22\">&#91;22&#93;</a></sup> While these are manufactured in Australia, they are not authorized for use within Australia, but only for export.<sup id=\"cite_ref-23\" class=\"reference\"><a href=\"#cite_note-23\">&#91;23&#93;</a></sup> By 2009, naltrexone implants showed encouraging results.<sup id=\"cite_ref-24\" class=\"reference\"><a href=\"#cite_note-24\">&#91;24&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Contraindications\">Contraindications</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Naltrexone&amp;action=edit&amp;section=6\" title=\"Edit section: Contraindications\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Naltrexone should not be used by persons with acute hepatitis or liver failure, or those with recent opioid use (typically 7\u201310 days).\n</p>\n<h2><span class=\"mw-headline\" id=\"Side_effects\">Side effects</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Naltrexone&amp;action=edit&amp;section=7\" title=\"Edit section: Side effects\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The most common side effects reported with naltrexone are <a href=\"/wiki/Gastrointestinal\" class=\"mw-redirect\" title=\"Gastrointestinal\">gastrointestinal</a> complaints such as <a href=\"/wiki/Diarrhea\" title=\"Diarrhea\">diarrhea</a> and abdominal cramping. These adverse effects are analogous to the symptoms of <a href=\"/wiki/Opioid_withdrawal\" class=\"mw-redirect\" title=\"Opioid withdrawal\">opioid withdrawal</a>, as the mu receptor blockade will increase GI motility.\n</p><p>Naltrexone has been reported to cause liver damage (when given at doses higher than recommended). It carries an FDA boxed warning for this rare side effect. Due to these reports, some physicians may check liver function tests prior to starting naltrexone, and periodically thereafter. Concerns for liver toxicity initially arose from a study of nonaddicted obese patients receiving 300&#160;mg of naltrexone.<sup id=\"cite_ref-25\" class=\"reference\"><a href=\"#cite_note-25\">&#91;25&#93;</a></sup> Subsequent studies have suggested limited toxicity in other patient populations.\n</p><p>Naltrexone should not be started until several (typically 7-10) days of abstinence from opioids have been achieved. This is due to the risk of acute opioid withdrawal if naltrexone is taken, as naltrexone will displace most opioids from their receptors. The time of abstinence may be shorter than 7 days, depending on the half-life of the specific opioid taken. Some physicians use a naloxone challenge to determine whether an individual has any opioids remaining. The challenge involves giving a test dose of naloxone and monitoring for opioid withdrawal. If withdrawal occurs, naltrexone should not be started.<sup id=\"cite_ref-galanter_26-0\" class=\"reference\"><a href=\"#cite_note-galanter-26\">&#91;26&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Pharmacology\">Pharmacology</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Naltrexone&amp;action=edit&amp;section=8\" title=\"Edit section: Pharmacology\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<h3><span class=\"mw-headline\" id=\"Pharmacodynamics\">Pharmacodynamics</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Naltrexone&amp;action=edit&amp;section=9\" title=\"Edit section: Pharmacodynamics\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<table class=\"wikitable floatright\" style=\"text-align: center;\">\n<caption>Naltrexone at opioid receptors\n</caption>\n<tbody><tr>\n<th colspan=\"3\"><a href=\"/wiki/Binding_affinity\" class=\"mw-redirect\" title=\"Binding affinity\">Affinities</a> (<a href=\"/wiki/Inhibitor_constant\" class=\"mw-redirect\" title=\"Inhibitor constant\"><abbr title=\"Inhibitor constant\">K<sub>i</sub></abbr></a>)</th>\n<th>Ratio</th>\n<th rowspan=\"2\">Ref\n</th></tr>\n<tr>\n<th><a href=\"/wiki/%CE%9C-Opioid_receptor\" class=\"mw-redirect\" title=\"\u039c-Opioid receptor\"><abbr title=\"\u03bc-Opioid receptor\">MOR</abbr></a></th>\n<th><a href=\"/wiki/%CE%94-Opioid_receptor\" class=\"mw-redirect\" title=\"\u0394-Opioid receptor\"><abbr title=\"\u03b4-Opioid receptor\">DOR</abbr></a></th>\n<th><a href=\"/wiki/%CE%9A-Opioid_receptor\" class=\"mw-redirect\" title=\"\u039a-Opioid receptor\"><abbr title=\"\u03ba-Opioid receptor\">KOR</abbr></a></th>\n<th>MOR:DOR:KOR\n</th></tr>\n<tr>\n<td>1.0 nM<br />0.0825 nM</td>\n<td>149 nM<br />8.02 nM</td>\n<td>3.9 nM<br />0.509 nM</td>\n<td>1:149:4<br />1:97:6</td>\n<td><sup id=\"cite_ref-pmid8114680_27-0\" class=\"reference\"><a href=\"#cite_note-pmid8114680-27\">&#91;27&#93;</a></sup><br /><sup id=\"cite_ref-pmid7562497_28-0\" class=\"reference\"><a href=\"#cite_note-pmid7562497-28\">&#91;28&#93;</a></sup>\n</td></tr></tbody></table>\n<p>Naltrexone and its <a href=\"/wiki/Active_metabolite\" title=\"Active metabolite\">active metabolite</a> <a href=\"/wiki/6%CE%B2-naltrexol\" class=\"mw-redirect\" title=\"6\u03b2-naltrexol\">6\u03b2-naltrexol</a> are <a href=\"/wiki/Competitive_antagonist\" class=\"mw-redirect\" title=\"Competitive antagonist\">competitive antagonists</a> at the <a href=\"/wiki/%CE%9C-opioid_receptor\" title=\"\u039c-opioid receptor\">\u03bc-opioid receptor</a> (MOR), the <a href=\"/wiki/%CE%9A-opioid_receptor\" title=\"\u039a-opioid receptor\">\u03ba-opioid receptor</a> (KOR) to a lesser extent, and, to a far lesser extent, at the <a href=\"/wiki/%CE%94-opioid_receptor\" title=\"\u0394-opioid receptor\">\u03b4-opioid receptor</a> (DOR).<sup id=\"cite_ref-29\" class=\"reference\"><a href=\"#cite_note-29\">&#91;29&#93;</a></sup>\n</p>\n<h4><span class=\"mw-headline\" id=\"Mechanism_of_action\">Mechanism of action</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Naltrexone&amp;action=edit&amp;section=10\" title=\"Edit section: Mechanism of action\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p>The blockade of <a href=\"/wiki/Opioid_receptor\" title=\"Opioid receptor\">opioid receptors</a> is the basis behind naltrexone's action in the management of opioid dependence&#8212;it reversibly blocks or attenuates the effects of opioids. Its mechanism of action in alcohol dependence is not fully understood, but as an opioid receptor antagonist is likely to be due to the modulation of the <a href=\"/wiki/Dopaminergic\" title=\"Dopaminergic\">dopaminergic</a> <a href=\"/wiki/Mesolimbic_pathway\" title=\"Mesolimbic pathway\">mesolimbic pathway</a> (one of the primary centers for risk-reward analysis in the brain, and a tertiary \"pleasure center\") which is hypothesized to be a major center of the reward associated with addiction that all major drugs of abuse are believed to activate.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (December 2009)\">citation needed</span></a></i>&#93;</sup> Mechanism of action may be antagonism to endogenous opioids such as <a href=\"/wiki/Tetrahydropapaveroline\" title=\"Tetrahydropapaveroline\">tetrahydropapaveroline</a>, whose production is augmented in the presence of alcohol.<sup id=\"cite_ref-HaberRoske1996_30-0\" class=\"reference\"><a href=\"#cite_note-HaberRoske1996-30\">&#91;30&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Pharmacokinetics\">Pharmacokinetics</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Naltrexone&amp;action=edit&amp;section=11\" title=\"Edit section: Pharmacokinetics\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Naltrexone is <a href=\"/wiki/Metabolism\" title=\"Metabolism\">metabolized</a> in the <a href=\"/wiki/Liver\" title=\"Liver\">liver</a> mainly to 6\u03b2-naltrexol by the <a href=\"/wiki/Enzyme\" title=\"Enzyme\">enzyme</a> <a href=\"/w/index.php?title=Dihydrodiol_dehydrogenase&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Dihydrodiol dehydrogenase (page does not exist)\">dihydrodiol dehydrogenase</a>. Other <a href=\"/wiki/Metabolite\" title=\"Metabolite\">metabolites</a> include 2-hydroxy-3-methoxy-6\u03b2-naltrexol and 2-hydroxy-3-methoxy-naltrexone. These are then further metabolized by <a href=\"/wiki/Conjugation_(biochemistry)\" class=\"mw-redirect\" title=\"Conjugation (biochemistry)\">conjugation</a> with <a href=\"/wiki/Glucuronide\" title=\"Glucuronide\">glucuronide</a>.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (June 2017)\">citation needed</span></a></i>&#93;</sup> The plasma <a href=\"/wiki/Biological_half-life\" title=\"Biological half-life\">half-life</a> of naltrexone and its metabolite 6\u03b2-naltrexol are about 4 hours and 13 hours, respectively.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (June 2017)\">citation needed</span></a></i>&#93;</sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Pharmacogenetics\">Pharmacogenetics</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Naltrexone&amp;action=edit&amp;section=12\" title=\"Edit section: Pharmacogenetics\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>A naltrexone treatment study by Anton et al., released by the <a href=\"/wiki/National_Institutes_of_Health\" title=\"National Institutes of Health\">National Institutes of Health</a> in February 2008 and published in the <i><a href=\"/wiki/Archives_of_General_Psychiatry\" class=\"mw-redirect\" title=\"Archives of General Psychiatry\">Archives of General Psychiatry</a>,</i> has shown that alcoholics having a certain variant of the opioid receptor gene (G polymorphism of <a href=\"/wiki/Single-nucleotide_polymorphism\" title=\"Single-nucleotide polymorphism\">SNP</a> Rs1799971 in the gene <i><a href=\"/wiki/OPRM1\" class=\"mw-redirect\" title=\"OPRM1\">OPRM1</a></i>), known as Asp40, demonstrated strong response to naltrexone and were far more likely to experience success at cutting back or discontinuing their alcohol intake altogether, while for those lacking the gene variant, naltrexone appeared to be no different from placebo.<sup id=\"cite_ref-ctidNCT00006206_31-0\" class=\"reference\"><a href=\"#cite_note-ctidNCT00006206-31\">&#91;31&#93;</a></sup> The G allele of <i>OPRM1</i> is most common in individuals of Asian descent, with 60% to 70% of people of Chinese, Japanese, and Indian ancestry having at least one copy, as opposed to 30% of Europeans and few Africans.<sup id=\"cite_ref-32\" class=\"reference\"><a href=\"#cite_note-32\">&#91;32&#93;</a></sup>\n</p><p>Because of the characteristics of the patient group in the US, the first study was done on white patients, and the next was without regard for ethnicity. Anton et al. found that patients of African descent did not have much success with naltrexone in treatment for alcohol dependence because of lacking the relevant gene.<sup id=\"cite_ref-ctidNCT00006206_31-1\" class=\"reference\"><a href=\"#cite_note-ctidNCT00006206-31\">&#91;31&#93;</a></sup>\n</p><p>As white patients with the gene had a five times greater rate of success in reducing drinking when given naltrexone than did patients without the gene, when used in a protocol of <a href=\"/wiki/Medical_management\" class=\"mw-redirect\" title=\"Medical management\">medical management</a> (MM), Anton et al. concluded, \n</p>\n<blockquote><p>\"Because almost 25% of the treatment-seeking population carries the Asp40 allele, genetic testing of individuals before naltrexone treatment might be worth the cost and effort, especially if structured behavioral treatment were not being considered.\"<sup id=\"cite_ref-ctidNCT00006206_31-2\" class=\"reference\"><a href=\"#cite_note-ctidNCT00006206-31\">&#91;31&#93;</a></sup> This would enable treatment to be targeted by genetics to patients for whom it would be most effective. They noted, \"Naltrexone is relatively easy to administer and free of serious adverse effects, and as we observed in the Asp40 carriers we studied, it appears to be highly effective.\"<sup id=\"cite_ref-ctidNCT00006206_31-3\" class=\"reference\"><a href=\"#cite_note-ctidNCT00006206-31\">&#91;31&#93;</a></sup></p></blockquote>\n<p>Studies have found naltrexone to be more efficacious among certain white subjects, because of the genetic basis, than among black subjects, who generally do not carry the relevant gene variant.<sup id=\"cite_ref-33\" class=\"reference\"><a href=\"#cite_note-33\">&#91;33&#93;</a></sup> A 2009 study of naltrexone as an alcohol-dependence treatment among African Americans failed to find any statistically significant differences between naltrexone and a placebo.<sup id=\"cite_ref-34\" class=\"reference\"><a href=\"#cite_note-34\">&#91;34&#93;</a></sup> Studies have suggested that carriers of the G allele may experience higher levels of craving and stronger \"high\" upon alcohol consumption, compared to carriers of the dominant allele, and naltrexone somewhat blunts these responses, leading to a reduction in alcohol use in some studies.<sup id=\"cite_ref-35\" class=\"reference\"><a href=\"#cite_note-35\">&#91;35&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Chemistry\">Chemistry</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Naltrexone&amp;action=edit&amp;section=13\" title=\"Edit section: Chemistry\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Naltrexone can be described as a substituted <a href=\"/wiki/Oxymorphone\" title=\"Oxymorphone\">oxymorphone</a> &#8211; here the <a href=\"/wiki/Tertiary_amine\" class=\"mw-redirect\" title=\"Tertiary amine\">tertiary amine</a> <a href=\"/wiki/Methyl\" class=\"mw-redirect\" title=\"Methyl\">methyl</a>-substituent is replaced with <a href=\"/wiki/Methylcyclopropane\" title=\"Methylcyclopropane\">methylcyclopropane</a>. Naltrexone is the N-cyclopropylmethyl derivative of oxymorphone.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (June 2017)\">citation needed</span></a></i>&#93;</sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Analogues\">Analogues</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Naltrexone&amp;action=edit&amp;section=14\" title=\"Edit section: Analogues\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The closely related medication, <a href=\"/wiki/Methylnaltrexone\" title=\"Methylnaltrexone\">methylnaltrexone</a>, is used to treat opioid-induced constipation, but does not treat addiction as it does not cross the <a href=\"/wiki/Blood%E2%80%93brain_barrier\" title=\"Blood\u2013brain barrier\">blood\u2013brain barrier</a>. <a href=\"/wiki/Nalmefene\" title=\"Nalmefene\">Nalmefene</a> is similar to naltrexone and is used for the same purposes as naltrexone. Naltrexone should not be confused with <a href=\"/wiki/Naloxone\" title=\"Naloxone\">naloxone</a>, which is used in emergency cases of opioid <a href=\"/wiki/Overdose\" class=\"mw-redirect\" title=\"Overdose\">overdose</a>. Other related opioid antagonists include <a href=\"/wiki/Nalodeine\" title=\"Nalodeine\">nalodeine</a> and <a href=\"/wiki/Samidorphan\" title=\"Samidorphan\">samidorphan</a>.\n</p>\n<h2><span class=\"mw-headline\" id=\"History\">History</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Naltrexone&amp;action=edit&amp;section=15\" title=\"Edit section: History\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Naltrexone was first <a href=\"/wiki/Chemical_synthesis\" title=\"Chemical synthesis\">synthesized</a> in 1963 by Metossian at Endo Laboratories, a small <a href=\"/wiki/Pharmaceutical_company\" class=\"mw-redirect\" title=\"Pharmaceutical company\">pharmaceutical company</a> in <a href=\"/wiki/New_York_City\" title=\"New York City\">New York City</a>.<sup id=\"cite_ref-Dependence1974_36-0\" class=\"reference\"><a href=\"#cite_note-Dependence1974-36\">&#91;36&#93;</a></sup> It was characterized by Blumberg, Dayton, and Wolf in 1965 and was found to be an <a href=\"/wiki/Oral_administration\" title=\"Oral administration\">orally active</a>, long-acting, and very <a href=\"/wiki/Potency_(pharmacology)\" title=\"Potency (pharmacology)\">potent</a> opioid antagonist.<sup id=\"cite_ref-Dependence1974_36-1\" class=\"reference\"><a href=\"#cite_note-Dependence1974-36\">&#91;36&#93;</a></sup><sup id=\"cite_ref-PadwaCunningham2010_37-0\" class=\"reference\"><a href=\"#cite_note-PadwaCunningham2010-37\">&#91;37&#93;</a></sup><sup id=\"cite_ref-Bennett2004_38-0\" class=\"reference\"><a href=\"#cite_note-Bennett2004-38\">&#91;38&#93;</a></sup><sup id=\"cite_ref-Sad2012_3-1\" class=\"reference\"><a href=\"#cite_note-Sad2012-3\">&#91;3&#93;</a></sup> The drug showed advantages over earlier opioid antagonists such as <a href=\"/wiki/Cyclazocine\" title=\"Cyclazocine\">cyclazocine</a>, <a href=\"/wiki/Nalorphine\" title=\"Nalorphine\">nalorphine</a>, and naloxone, including its oral activity, a long <a href=\"/wiki/Duration_of_action\" class=\"mw-redirect\" title=\"Duration of action\">duration of action</a> allowing for once-daily administration, and a lack of <a href=\"/wiki/Dysphoria\" title=\"Dysphoria\">dysphoria</a>, and was selected for further development.<sup id=\"cite_ref-Sad2012_3-2\" class=\"reference\"><a href=\"#cite_note-Sad2012-3\">&#91;3&#93;</a></sup> It was <a href=\"/wiki/Patent\" title=\"Patent\">patented</a> by Endo Laboratories in 1967 under the developmental code name EN-1639A and Endo Laboratories was acquired by <a href=\"/wiki/DuPont\" title=\"DuPont\">DuPont</a> in 1969.<sup id=\"cite_ref-Wouk2009_39-0\" class=\"reference\"><a href=\"#cite_note-Wouk2009-39\">&#91;39&#93;</a></sup> <a href=\"/wiki/Clinical_trial\" title=\"Clinical trial\">Clinical trials</a> for opioid dependence began in 1973, and a developmental collaboration of DuPont with the <a href=\"/wiki/National_Institute_on_Drug_Abuse\" title=\"National Institute on Drug Abuse\">National Institute on Drug Abuse</a>  for this indication started the next year in 1974.<sup id=\"cite_ref-Wouk2009_39-1\" class=\"reference\"><a href=\"#cite_note-Wouk2009-39\">&#91;39&#93;</a></sup> The drug was approved by the FDA for the oral treatment of opioid dependence in 1984, with the brand name Trexan, and for the oral treatment of alcohol dependence in 1995, when the brand name was changed by DuPont to ReVia.<sup id=\"cite_ref-Wouk2009_39-2\" class=\"reference\"><a href=\"#cite_note-Wouk2009-39\">&#91;39&#93;</a></sup><sup id=\"cite_ref-Milhorn2017_20-2\" class=\"reference\"><a href=\"#cite_note-Milhorn2017-20\">&#91;20&#93;</a></sup> A depot formulation for intramuscular injection was approved by the FDA under the brand name Vivitrol for alcohol dependence in 2006 and opioid dependence in 2010.<sup id=\"cite_ref-MedicalNewsToday2006_21-1\" class=\"reference\"><a href=\"#cite_note-MedicalNewsToday2006-21\">&#91;21&#93;</a></sup><sup id=\"cite_ref-Milhorn2017_20-3\" class=\"reference\"><a href=\"#cite_note-Milhorn2017-20\">&#91;20&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Society_and_culture\">Society and culture</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Naltrexone&amp;action=edit&amp;section=16\" title=\"Edit section: Society and culture\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<h3><span class=\"mw-headline\" id=\"Generic_names\">Generic names</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Naltrexone&amp;action=edit&amp;section=17\" title=\"Edit section: Generic names\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Naltrexone is the <a href=\"/wiki/Generic_term\" class=\"mw-redirect\" title=\"Generic term\">generic name</a> of the drug and its <a href=\"/wiki/International_Nonproprietary_Name\" class=\"mw-redirect\" title=\"International Nonproprietary Name\"><abbr title=\"International Nonproprietary Name\">INN</abbr></a>, <a href=\"/wiki/United_States_Adopted_Name\" title=\"United States Adopted Name\"><abbr title=\"United States Adopted Name\">USAN</abbr></a>, <a href=\"/wiki/British_Approved_Name\" title=\"British Approved Name\"><abbr title=\"British Approved Name\">BAN</abbr></a>, <a href=\"/wiki/D%C3%A9nomination_Commune_Fran%C3%A7aise\" title=\"D\u00e9nomination Commune Fran\u00e7aise\"><abbr title=\"D\u00e9nomination Commune Fran\u00e7aise\">DCF</abbr></a>, and <a href=\"/wiki/Denominazione_Comune_Italiana\" title=\"Denominazione Comune Italiana\"><abbr title=\"Denominazione Comune Italiana\">DCIT</abbr></a>, while naltrexone hydrochloride is its <a href=\"/wiki/United_States_Pharmacopeia\" title=\"United States Pharmacopeia\"><abbr title=\"United States Pharmacopeia\">USP</abbr></a> and <a href=\"/wiki/British_Approved_Name\" title=\"British Approved Name\"><abbr title=\"British Approved Name\">BANM</abbr></a>.<sup id=\"cite_ref-Elks2014_40-0\" class=\"reference\"><a href=\"#cite_note-Elks2014-40\">&#91;40&#93;</a></sup><sup id=\"cite_ref-IndexNominum2000_41-0\" class=\"reference\"><a href=\"#cite_note-IndexNominum2000-41\">&#91;41&#93;</a></sup><sup id=\"cite_ref-MortonHall2012_42-0\" class=\"reference\"><a href=\"#cite_note-MortonHall2012-42\">&#91;42&#93;</a></sup><sup id=\"cite_ref-Drugs.com_43-0\" class=\"reference\"><a href=\"#cite_note-Drugs.com-43\">&#91;43&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Brand_names\">Brand names</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Naltrexone&amp;action=edit&amp;section=18\" title=\"Edit section: Brand names\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Naltrexone is or has been marketed under a variety of brand names, including Adepend, Antaxone, Celupan, Depade, Nalorex, Narcoral, Nemexin, Revia/ReVia, Trexan, and Vivitrol.<sup id=\"cite_ref-Elks2014_40-1\" class=\"reference\"><a href=\"#cite_note-Elks2014-40\">&#91;40&#93;</a></sup><sup id=\"cite_ref-IndexNominum2000_41-1\" class=\"reference\"><a href=\"#cite_note-IndexNominum2000-41\">&#91;41&#93;</a></sup><sup id=\"cite_ref-MortonHall2012_42-1\" class=\"reference\"><a href=\"#cite_note-MortonHall2012-42\">&#91;42&#93;</a></sup><sup id=\"cite_ref-Drugs.com_43-1\" class=\"reference\"><a href=\"#cite_note-Drugs.com-43\">&#91;43&#93;</a></sup> It is also marketed in combination with <a href=\"/wiki/Bupropion\" title=\"Bupropion\">bupropion</a> (<a href=\"/wiki/Bupropion/naltrexone\" title=\"Bupropion/naltrexone\">bupropion/naltrexone</a>) as Contrave and was marketed with <a href=\"/wiki/Morphine\" title=\"Morphine\">morphine</a> (<a href=\"/wiki/Morphine/naltrexone\" title=\"Morphine/naltrexone\">morphine/naltrexone</a>) as Embeda.<sup id=\"cite_ref-Drugs.com_43-2\" class=\"reference\"><a href=\"#cite_note-Drugs.com-43\">&#91;43&#93;</a></sup> A combination of naltrexone with <a href=\"/wiki/Buprenorphine\" title=\"Buprenorphine\">buprenorphine</a> (<a href=\"/wiki/Buprenorphine/naltrexone\" title=\"Buprenorphine/naltrexone\">buprenorphine/naltrexone</a>) has been developed, but has not been marketed.<sup id=\"cite_ref-pmid18212797_44-0\" class=\"reference\"><a href=\"#cite_note-pmid18212797-44\">&#91;44&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Controversies\">Controversies</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Naltrexone&amp;action=edit&amp;section=19\" title=\"Edit section: Controversies\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The FDA authorized use of injectable naltrexone for opioid addiction using a single study<sup id=\"cite_ref-45\" class=\"reference\"><a href=\"#cite_note-45\">&#91;45&#93;</a></sup> that was led by Evgeny Krupitsky at Bekhterev Research Psychoneurological Institute, St Petersburg State Pavlov Medical University, St Petersburg, Russia,<sup id=\"cite_ref-Lancet_Krupitsky_2011_naltrexone_46-0\" class=\"reference\"><a href=\"#cite_note-Lancet_Krupitsky_2011_naltrexone-46\">&#91;46&#93;</a></sup> a country where opioid agonists such as methadone and buprenorphine are not available. The study was a \"double-blind, placebo-controlled, randomized\", 24-week trial running \"from July 3, 2008, through October 5, 2009\" with \"250 patients with opioid dependence disorder\" at \"13 clinical sites in Russia\" on the use of injectable naltrexone (XR-NTX) for opioid dependence. The study was funded by the Boston-based biotech <a href=\"/wiki/Alkermes_(company)\" title=\"Alkermes (company)\">Alkermes</a> firm which produces and markets naltrexone in the United States.  A 2011 article reported that this single trial of naltrexone was performed not by comparing it to the best available, evidence-based treatment (methadone or buprenorphine), but by comparing it with a placebo.<sup id=\"cite_ref-47\" class=\"reference\"><a href=\"#cite_note-47\">&#91;47&#93;</a></sup> A subsequent RCT in Norway did compare injectable naltrexone to buprenorphine and found them to be similar in outcomes.<sup id=\"cite_ref-48\" class=\"reference\"><a href=\"#cite_note-48\">&#91;48&#93;</a></sup>\n</p><p>In May 2017, <a href=\"/wiki/United_States_Secretary_of_Health_and_Human_Services\" title=\"United States Secretary of Health and Human Services\">United States Secretary of Health and Human Services</a> <a href=\"/wiki/Tom_Price_(American_politician)\" title=\"Tom Price (American politician)\">Tom Price</a>, praised [Vivitrol] as the future of opioid addiction treatment after visiting the company\u2019s plant in Ohio.<sup id=\"cite_ref-NYT_2017_Vivitrol_49-0\" class=\"reference\"><a href=\"#cite_note-NYT_2017_Vivitrol-49\">&#91;49&#93;</a></sup> His remarks set off sharp criticism with almost 700 experts in the field of substance abuse submitting a letter to Price cautioning him about Vivitrol's \"marketing tactics\" and warning him that his comment \"ignore widely accepted science\".<sup id=\"cite_ref-Tom-Price-Letter-Re-MAT_2017_50-0\" class=\"reference\"><a href=\"#cite_note-Tom-Price-Letter-Re-MAT_2017-50\">&#91;50&#93;</a></sup> The experts pointed out that Vivitrol's competitors, buprenorphine and methadone, are \"less expensive\", \"more widely used\", and have been \"rigorously studied\".\n</p><p>Price had claimed that buprenorphine and methadone were \"simply substitute[s]\" for \"illicit drugs\"<sup id=\"cite_ref-NYT_2017_Vivitrol_49-1\" class=\"reference\"><a href=\"#cite_note-NYT_2017_Vivitrol-49\">&#91;49&#93;</a></sup> whereas according to the letter, \"the substantial body of research evidence supporting these treatments is summarized in guidance from within your own agency, including the Substance Abuse and Mental Health Services Administration, the US Surgeon General, the National Institute on Drug Abuse, and the Centers for Disease Control and Prevention. To briefly summarize, buprenorphine and methadone have been demonstrated to be highly effective in managing the core symptoms of opioid use disorder, reducing the risk of relapse and fatal overdose, and encouraging long-term recovery.\"<sup id=\"cite_ref-Tom-Price-Letter-Re-MAT_2017_50-1\" class=\"reference\"><a href=\"#cite_note-Tom-Price-Letter-Re-MAT_2017-50\">&#91;50&#93;</a></sup>\n</p><p>According to a June 11, 2017, <i><a href=\"/wiki/The_New_York_Times\" title=\"The New York Times\">The New York Times</a></i> article, <a href=\"/wiki/Alkermes_(company)\" title=\"Alkermes (company)\">Alkermes</a> \"has spent years coaxing, with a deft lobbying strategy that has targeted lawmakers and law enforcement officials. The company has spent millions of dollars on contributions to officials struggling to stem the epidemic of opioid abuse. It has also provided thousands of free doses to encourage the use of Vivitrol in jails and prisons, which have by default become major detox centers\".<sup id=\"cite_ref-NYT_2017_Vivitrol_49-2\" class=\"reference\"><a href=\"#cite_note-NYT_2017_Vivitrol-49\">&#91;49&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Research\">Research</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Naltrexone&amp;action=edit&amp;section=20\" title=\"Edit section: Research\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<h3><span class=\"mw-headline\" id=\"Depersonalization\">Depersonalization</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Naltrexone&amp;action=edit&amp;section=21\" title=\"Edit section: Depersonalization\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Naltrexone is sometimes used in the treatment of <a href=\"/wiki/Dissociation_(psychology)\" title=\"Dissociation (psychology)\">dissociative</a> symptoms such as <a href=\"/wiki/Depersonalization\" title=\"Depersonalization\">depersonalization</a> and <a href=\"/wiki/Derealization\" title=\"Derealization\">derealization</a>.<sup id=\"cite_ref-SimeonAbugel2008_51-0\" class=\"reference\"><a href=\"#cite_note-SimeonAbugel2008-51\">&#91;51&#93;</a></sup><sup id=\"cite_ref-PhDPhD2014_52-0\" class=\"reference\"><a href=\"#cite_note-PhDPhD2014-52\">&#91;52&#93;</a></sup> Some studies suggest it might help.<sup id=\"cite_ref-53\" class=\"reference\"><a href=\"#cite_note-53\">&#91;53&#93;</a></sup> Other small, preliminary studies have also shown benefit.<sup id=\"cite_ref-SimeonAbugel2008_51-1\" class=\"reference\"><a href=\"#cite_note-SimeonAbugel2008-51\">&#91;51&#93;</a></sup><sup id=\"cite_ref-PhDPhD2014_52-1\" class=\"reference\"><a href=\"#cite_note-PhDPhD2014-52\">&#91;52&#93;</a></sup> Blockade of the KOR by naltrexone and naloxone is thought to be responsible for their effectiveness in ameliorating depersonalization and derealization.<sup id=\"cite_ref-SimeonAbugel2008_51-2\" class=\"reference\"><a href=\"#cite_note-SimeonAbugel2008-51\">&#91;51&#93;</a></sup><sup id=\"cite_ref-PhDPhD2014_52-2\" class=\"reference\"><a href=\"#cite_note-PhDPhD2014-52\">&#91;52&#93;</a></sup> Since these drugs are less efficacious in blocking the KOR relative to the MOR, higher doses than typically used seem to be necessary.<sup id=\"cite_ref-SimeonAbugel2008_51-3\" class=\"reference\"><a href=\"#cite_note-SimeonAbugel2008-51\">&#91;51&#93;</a></sup><sup id=\"cite_ref-PhDPhD2014_52-3\" class=\"reference\"><a href=\"#cite_note-PhDPhD2014-52\">&#91;52&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Low-dose\">Low-dose</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Naltrexone&amp;action=edit&amp;section=22\" title=\"Edit section: Low-dose\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<div role=\"note\" class=\"hatnote navigation-not-searchable\">Main article: <a href=\"/wiki/Low-dose_naltrexone\" title=\"Low-dose naltrexone\">Low-dose naltrexone</a></div>\n<p>\"Low-dose naltrexone\" (LDN) describes the \"<a href=\"/wiki/Off-label_use\" title=\"Off-label use\">off-label</a>\" use of naltrexone at low doses for diseases not related to chemical dependency or intoxication, such as <a href=\"/wiki/Multiple_sclerosis\" title=\"Multiple sclerosis\">multiple sclerosis</a>.<sup id=\"cite_ref-Novella_54-0\" class=\"reference\"><a href=\"#cite_note-Novella-54\">&#91;54&#93;</a></sup> More research needs to be done before it can be recommended for clinical use.\n</p><p>Although some scientific studies show its efficacy in some conditions such as <a href=\"/wiki/Fibromyalgia\" title=\"Fibromyalgia\">fibromyalgia</a>,<sup id=\"cite_ref-ldntxfm_55-0\" class=\"reference\"><a href=\"#cite_note-ldntxfm-55\">&#91;55&#93;</a></sup> other, more dramatic claims for its use in conditions such as <a href=\"/wiki/Cancer\" title=\"Cancer\">cancer</a> and <a href=\"/wiki/HIV\" title=\"HIV\">HIV</a> have less scientific support.<sup id=\"cite_ref-Novella_54-1\" class=\"reference\"><a href=\"#cite_note-Novella-54\">&#91;54&#93;</a></sup> This treatment has received significant attention on the <a href=\"/wiki/Internet\" title=\"Internet\">Internet</a>, especially through websites run by organizations promoting its use.<sup id=\"cite_ref-NMSS_56-0\" class=\"reference\"><a href=\"#cite_note-NMSS-56\">&#91;56&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Self-injury\">Self-injury</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Naltrexone&amp;action=edit&amp;section=23\" title=\"Edit section: Self-injury\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Some studies suggest that <a href=\"/wiki/Self-injury\" class=\"mw-redirect\" title=\"Self-injury\">self-injurious behaviors</a> present in persons with developmental disabilities (including autism) can sometimes be remedied with naltrexone.<sup id=\"cite_ref-57\" class=\"reference\"><a href=\"#cite_note-57\">&#91;57&#93;</a></sup>\nIn these cases,  the self-injury is believed to be done to release <a href=\"/wiki/Beta-endorphin\" class=\"mw-redirect\" title=\"Beta-endorphin\">beta-endorphin</a>, which binds to the same receptors as heroin and morphine.<sup id=\"cite_ref-58\" class=\"reference\"><a href=\"#cite_note-58\">&#91;58&#93;</a></sup> If the \"rush\" generated by self-injury is removed, the behavior may stop.\n</p>\n<h3><span class=\"mw-headline\" id=\"Behavioral_disorders\">Behavioral disorders</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Naltrexone&amp;action=edit&amp;section=24\" title=\"Edit section: Behavioral disorders\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Some indications exist that naltrexone might be beneficial in the treatment of impulse-control disorders such as <a href=\"/wiki/Kleptomania\" title=\"Kleptomania\">kleptomania</a>, compulsive gambling, or <a href=\"/wiki/Trichotillomania\" title=\"Trichotillomania\">trichotillomania</a> (compulsive hair pulling), but  evidence of its effectiveness for gambling is conflicting.<sup id=\"cite_ref-59\" class=\"reference\"><a href=\"#cite_note-59\">&#91;59&#93;</a></sup><sup id=\"cite_ref-gambling_60-0\" class=\"reference\"><a href=\"#cite_note-gambling-60\">&#91;60&#93;</a></sup><sup id=\"cite_ref-61\" class=\"reference\"><a href=\"#cite_note-61\">&#91;61&#93;</a></sup> A 2008 case study reported successful use of naltrexone in suppressing and treating an internet <a href=\"/wiki/Pornography_addiction\" title=\"Pornography addiction\">pornography addiction</a>.<sup id=\"cite_ref-62\" class=\"reference\"><a href=\"#cite_note-62\">&#91;62&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Interferon_alpha\">Interferon alpha</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Naltrexone&amp;action=edit&amp;section=25\" title=\"Edit section: Interferon alpha\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Naltrexone is effective in suppressing the <a href=\"/wiki/Cytokine\" title=\"Cytokine\">cytokine</a>-mediated adverse neuropsychiatric effects of <a href=\"/wiki/Interferon_alpha\" class=\"mw-redirect\" title=\"Interferon alpha\">interferon alpha</a> therapy.<sup id=\"cite_ref-pmid16142050_63-0\" class=\"reference\"><a href=\"#cite_note-pmid16142050-63\">&#91;63&#93;</a></sup><sup id=\"cite_ref-pmid17068950_64-0\" class=\"reference\"><a href=\"#cite_note-pmid17068950-64\">&#91;64&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"See_also\">See also</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Naltrexone&amp;action=edit&amp;section=26\" title=\"Edit section: See also\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a href=\"/wiki/Opioid_antagonist#List_of_opioid_antagonists\" title=\"Opioid antagonist\">Opioid antagonist \u00a7 List of opioid antagonists</a></li>\n<li><a href=\"/wiki/One_Little_Pill_(2014_film)\" class=\"mw-redirect\" title=\"One Little Pill (2014 film)\"><i>One Little Pill</i> (2014 film)</a> - documentary about using naltrexone to treat alcohol use disorder</li></ul>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Naltrexone&amp;action=edit&amp;section=27\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist columns references-column-width\" style=\"-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;\">\n<ol class=\"references\">\n<li id=\"cite_note-AHFS2017-1\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-AHFS2017_1-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-AHFS2017_1-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-AHFS2017_1-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-AHFS2017_1-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-AHFS2017_1-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-AHFS2017_1-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-AHFS2017_1-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-AHFS2017_1-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-AHFS2017_1-8\"><sup><i><b>i</b></i></sup></a> <a href=\"#cite_ref-AHFS2017_1-9\"><sup><i><b>j</b></i></sup></a> <a href=\"#cite_ref-AHFS2017_1-10\"><sup><i><b>k</b></i></sup></a> <a href=\"#cite_ref-AHFS2017_1-11\"><sup><i><b>l</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.drugs.com/monograph/naltrexone.html\">\"Naltrexone Monograph for Professionals - Drugs.com\"</a>. <i>Drugs.com</i>. American Society of Health-System Pharmacists. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20171109134845/https://www.drugs.com/monograph/naltrexone.html\">Archived</a> from the original on 9 November 2017<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">9 November</span> 2017</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Drugs.com&amp;rft.atitle=Naltrexone+Monograph+for+Professionals+-+Drugs.com&amp;rft_id=https%3A%2F%2Fwww.drugs.com%2Fmonograph%2Fnaltrexone.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-2\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Tran, TH; Griffin, BL; Stone, RH; Vest, KM; Todd, TJ (July 2017). \"Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women\". <i>Pharmacotherapy</i>. <b>37</b> (7): 824\u2013839. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/phar.1958\">10.1002/phar.1958</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/28543191\">28543191</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pharmacotherapy&amp;rft.atitle=Methadone%2C+Buprenorphine%2C+and+Naltrexone+for+the+Treatment+of+Opioid+Use+Disorder+in+Pregnant+Women.&amp;rft.volume=37&amp;rft.issue=7&amp;rft.pages=824-839&amp;rft.date=2017-07&amp;rft_id=info%3Adoi%2F10.1002%2Fphar.1958&amp;rft_id=info%3Apmid%2F28543191&amp;rft.aulast=Tran&amp;rft.aufirst=TH&amp;rft.au=Griffin%2C+BL&amp;rft.au=Stone%2C+RH&amp;rft.au=Vest%2C+KM&amp;rft.au=Todd%2C+TJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Sad2012-3\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Sad2012_3-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Sad2012_3-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Sad2012_3-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation book\">Sadock, Benjamin J.; Sadock, Virginia A.; Sussman, Norman (2012). <a rel=\"nofollow\" class=\"external text\" href=\"https://books.google.ca/books?id=qp-H3UruKvIC&amp;pg=PT265\"><i>Kaplan &amp; Sadock's Pocket Handbook of Psychiatric Drug Treatment</i></a>. Lippincott Williams &amp; Wilkins. p.&#160;265. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/9781451154467\" title=\"Special:BookSources/9781451154467\">9781451154467</a>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20171205042100/https://books.google.ca/books?id=qp-H3UruKvIC&amp;pg=PT265\">Archived</a> from the original on 2017-12-05.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Kaplan+%26+Sadock%27s+Pocket+Handbook+of+Psychiatric+Drug+Treatment&amp;rft.pages=265&amp;rft.pub=Lippincott+Williams+%26+Wilkins&amp;rft.date=2012&amp;rft.isbn=9781451154467&amp;rft.aulast=Sadock&amp;rft.aufirst=Benjamin+J.&amp;rft.au=Sadock%2C+Virginia+A.&amp;rft.au=Sussman%2C+Norman&amp;rft_id=https%3A%2F%2Fbooks.google.ca%2Fbooks%3Fid%3Dqp-H3UruKvIC%26pg%3DPT265&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-4\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.whocc.no/atc_ddd_index/?code=N07BB04\">\"Naltrexone\"</a>. <i>ATC/DDD Index</i>. WHO Collaborating Centre for Drug Statistics Methodology. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20160303220724/http://www.whocc.no/atc_ddd_index/?code=N07BB04\">Archived</a> from the original on 3 March 2016<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">11 July</span> 2016</span>. <q>DDD ... 50 mg</q></cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ATC%2FDDD+Index&amp;rft.atitle=Naltrexone&amp;rft_id=http%3A%2F%2Fwww.whocc.no%2Fatc_ddd_index%2F%3Fcode%3DN07BB04&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Medi2017-5\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Medi2017_5-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Medi2017_5-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://data.medicaid.gov/Drug-Pricing-and-Payment/NADAC-as-of-2017-11-29/pmhw-skdi\">\"NADAC as of 2017-11-29\"</a>. <i>Centers for Medicare and Medicaid Services</i>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20171203153928/https://data.medicaid.gov/Drug-Pricing-and-Payment/NADAC-as-of-2017-11-29/pmhw-skdi\">Archived</a> from the original on 3 December 2017<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">3 December</span> 2017</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Centers+for+Medicare+and+Medicaid+Services&amp;rft.atitle=NADAC+as+of+2017-11-29&amp;rft_id=https%3A%2F%2Fdata.medicaid.gov%2FDrug-Pricing-and-Payment%2FNADAC-as-of-2017-11-29%2Fpmhw-skdi&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-6\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">\"Naltrexone/bupropion for obesity\". <i>Drug and therapeutics bulletin</i>. <b>55</b> (11): 126\u2013129. November 2017. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1136/dtb.2017.11.0550\">10.1136/dtb.2017.11.0550</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/29117992\">29117992</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Drug+and+therapeutics+bulletin&amp;rft.atitle=Naltrexone%2Fbupropion+for+obesity.&amp;rft.volume=55&amp;rft.issue=11&amp;rft.pages=126-129&amp;rft.date=2017-11&amp;rft_id=info%3Adoi%2F10.1136%2Fdtb.2017.11.0550&amp;rft_id=info%3Apmid%2F29117992&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-7\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Aboujaoude, E; Salame, WO (August 2016). \"Naltrexone: A Pan-Addiction Treatment?\". <i>CNS Drugs</i>. <b>30</b> (8): 719\u201333. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s40263-016-0373-0\">10.1007/s40263-016-0373-0</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/27401883\">27401883</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CNS+Drugs&amp;rft.atitle=Naltrexone%3A+A+Pan-Addiction+Treatment%3F&amp;rft.volume=30&amp;rft.issue=8&amp;rft.pages=719-33&amp;rft.date=2016-08&amp;rft_id=info%3Adoi%2F10.1007%2Fs40263-016-0373-0&amp;rft_id=info%3Apmid%2F27401883&amp;rft.aulast=Aboujaoude&amp;rft.aufirst=E&amp;rft.au=Salame%2C+WO&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Ros2010-8\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Ros2010_8-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">R\u00f6sner, S; Hackl-Herrwerth, A; Leucht, S; Vecchi, S; Srisurapanont, M; Soyka, M (8 December 2010). \"Opioid antagonists for alcohol dependence\". <i>The Cochrane Database of Systematic Reviews</i> (12): CD001867. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/14651858.CD001867.pub2\">10.1002/14651858.CD001867.pub2</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21154349\">21154349</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Opioid+antagonists+for+alcohol+dependence.&amp;rft.issue=12&amp;rft.pages=CD001867&amp;rft.date=2010-12-08&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD001867.pub2&amp;rft_id=info%3Apmid%2F21154349&amp;rft.aulast=R%C3%B6sner&amp;rft.aufirst=S&amp;rft.au=Hackl-Herrwerth%2C+A&amp;rft.au=Leucht%2C+S&amp;rft.au=Vecchi%2C+S&amp;rft.au=Srisurapanont%2C+M&amp;rft.au=Soyka%2C+M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-9\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-9\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Donoghue, Kim; Elzerbi, Catherine; Saunders, Rob; Whittington, Craig; Pilling, Stephen; Drummond, Colin (2015). \"The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence, Europe versus the rest of the world: A meta-analysis\". <i>Addiction</i>. <b>110</b> (6): 920\u201330. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/add.12875\">10.1111/add.12875</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25664494\">25664494</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Addiction&amp;rft.atitle=The+efficacy+of+acamprosate+and+naltrexone+in+the+treatment+of+alcohol+dependence%2C+Europe+versus+the+rest+of+the+world%3A+A+meta-analysis&amp;rft.volume=110&amp;rft.issue=6&amp;rft.pages=920-30&amp;rft.date=2015&amp;rft_id=info%3Adoi%2F10.1111%2Fadd.12875&amp;rft_id=info%3Apmid%2F25664494&amp;rft.aulast=Donoghue&amp;rft.aufirst=Kim&amp;rft.au=Elzerbi%2C+Catherine&amp;rft.au=Saunders%2C+Rob&amp;rft.au=Whittington%2C+Craig&amp;rft.au=Pilling%2C+Stephen&amp;rft.au=Drummond%2C+Colin&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-10\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-10\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">c. Garbutt, James (2010). \"Efficacy and Tolerability of Naltrexone in the Management of Alcohol Dependence\". <i>Current Pharmaceutical Design</i>. <b>16</b> (19): 2091\u20137. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.2174/138161210791516459\">10.2174/138161210791516459</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20482515\">20482515</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Pharmaceutical+Design&amp;rft.atitle=Efficacy+and+Tolerability+of+Naltrexone+in+the+Management+of+Alcohol+Dependence&amp;rft.volume=16&amp;rft.issue=19&amp;rft.pages=2091-7&amp;rft.date=2010&amp;rft_id=info%3Adoi%2F10.2174%2F138161210791516459&amp;rft_id=info%3Apmid%2F20482515&amp;rft.aulast=c.+Garbutt&amp;rft.aufirst=James&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Mai2013-11\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Mai2013_11-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Maisel, Natalya C.; Blodgett, Janet C.; Wilbourne, Paula L.; Humphreys, Keith; Finney, John W. (October 17, 2012). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3970823\">\"Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: When are these medications most helpful?\"</a>. <i>Addiction</i>. <b>108</b> (2): 275\u201393. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/j.1360-0443.2012.04054.x\">10.1111/j.1360-0443.2012.04054.x</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3970823\">3970823</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23075288\">23075288</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Addiction&amp;rft.atitle=Meta-analysis+of+naltrexone+and+acamprosate+for+treating+alcohol+use+disorders%3A+When+are+these+medications+most+helpful%3F&amp;rft.volume=108&amp;rft.issue=2&amp;rft.pages=275-93&amp;rft.date=2012-10-17&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3970823&amp;rft_id=info%3Apmid%2F23075288&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1360-0443.2012.04054.x&amp;rft.aulast=Maisel&amp;rft.aufirst=Natalya+C.&amp;rft.au=Blodgett%2C+Janet+C.&amp;rft.au=Wilbourne%2C+Paula+L.&amp;rft.au=Humphreys%2C+Keith&amp;rft.au=Finney%2C+John+W.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3970823&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-12\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-12\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Anderson, Kenneth (Jul 28, 2013). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.psychologytoday.com/blog/overcoming-addiction/201307/drink-your-way-sober-naltrexone\">\"Drink Your Way Sober with Naltrexone\"</a>. <i>Psychology Today</i>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20160917232955/https://www.psychologytoday.com/blog/overcoming-addiction/201307/drink-your-way-sober-naltrexone\">Archived</a> from the original on 17 September 2016<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">18 July</span> 2016</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Psychology+Today&amp;rft.atitle=Drink+Your+Way+Sober+with+Naltrexone&amp;rft.date=2013-07-28&amp;rft.aulast=Anderson&amp;rft.aufirst=Kenneth&amp;rft_id=https%3A%2F%2Fwww.psychologytoday.com%2Fblog%2Fovercoming-addiction%2F201307%2Fdrink-your-way-sober-naltrexone&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Sin2001-13\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Sin2001_13-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Sin2001_13-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sinclair, J. D. (2001). \"Evidence about the use of naltrexone and for different ways of using it in the treatment of alcoholism\". <i>Alcohol and Alcoholism</i>. <b>36</b> (1): 2\u201310. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1093/alcalc/36.1.2\">10.1093/alcalc/36.1.2</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11139409\">11139409</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Alcohol+and+Alcoholism&amp;rft.atitle=Evidence+about+the+use+of+naltrexone+and+for+different+ways+of+using+it+in+the+treatment+of+alcoholism&amp;rft.volume=36&amp;rft.issue=1&amp;rft.pages=2-10&amp;rft.date=2001&amp;rft_id=info%3Adoi%2F10.1093%2Falcalc%2F36.1.2&amp;rft_id=info%3Apmid%2F11139409&amp;rft.aulast=Sinclair&amp;rft.aufirst=J.+D.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Shar2017-14\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Shar2017_14-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Shar2017_14-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sharma, A; Kelly, SM; Mitchell, SG; Gryczynski, J; O'Grady, KE; Schwartz, RP (June 2017). \"Update on Barriers to Pharmacotherapy for Opioid Use Disorders\". <i>Current psychiatry reports</i>. <b>19</b> (6): 35. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s11920-017-0783-9\">10.1007/s11920-017-0783-9</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/28526967\">28526967</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+psychiatry+reports&amp;rft.atitle=Update+on+Barriers+to+Pharmacotherapy+for+Opioid+Use+Disorders.&amp;rft.volume=19&amp;rft.issue=6&amp;rft.pages=35&amp;rft.date=2017-06&amp;rft_id=info%3Adoi%2F10.1007%2Fs11920-017-0783-9&amp;rft_id=info%3Apmid%2F28526967&amp;rft.aulast=Sharma&amp;rft.aufirst=A&amp;rft.au=Kelly%2C+SM&amp;rft.au=Mitchell%2C+SG&amp;rft.au=Gryczynski%2C+J&amp;rft.au=O%27Grady%2C+KE&amp;rft.au=Schwartz%2C+RP&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-15\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-15\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sharma, B; Bruner, A; Barnett, G; Fishman, M (July 2016). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4920977\">\"Opioid Use Disorders\"</a>. <i>Child and adolescent psychiatric clinics of North America</i>. <b>25</b> (3): 473\u201387. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.chc.2016.03.002\">10.1016/j.chc.2016.03.002</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4920977\">4920977</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/27338968\">27338968</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Child+and+adolescent+psychiatric+clinics+of+North+America&amp;rft.atitle=Opioid+Use+Disorders.&amp;rft.volume=25&amp;rft.issue=3&amp;rft.pages=473-87&amp;rft.date=2016-07&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4920977&amp;rft_id=info%3Apmid%2F27338968&amp;rft_id=info%3Adoi%2F10.1016%2Fj.chc.2016.03.002&amp;rft.aulast=Sharma&amp;rft.aufirst=B&amp;rft.au=Bruner%2C+A&amp;rft.au=Barnett%2C+G&amp;rft.au=Fishman%2C+M&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4920977&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-ComerSullivan2006-16\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-ComerSullivan2006_16-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Comer, Sandra D.; Sullivan, Maria A.; Yu, Elmer; Rothenberg, Jami L.; Kleber, Herbert D.; Kampman, Kyle; Dackis, Charles; o'Brien, Charles P. (2006). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4200530\">\"Injectable, Sustained-Release Naltrexone for the Treatment of Opioid Dependence\"</a>. <i>Archives of General Psychiatry</i>. <b>63</b> (2): 210\u20138. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1001/archpsyc.63.2.210\">10.1001/archpsyc.63.2.210</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4200530\">4200530</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/16461865\">16461865</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Archives+of+General+Psychiatry&amp;rft.atitle=Injectable%2C+Sustained-Release+Naltrexone+for+the+Treatment+of+Opioid+Dependence&amp;rft.volume=63&amp;rft.issue=2&amp;rft.pages=210-8&amp;rft.date=2006&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4200530&amp;rft_id=info%3Apmid%2F16461865&amp;rft_id=info%3Adoi%2F10.1001%2Farchpsyc.63.2.210&amp;rft.aulast=Comer&amp;rft.aufirst=Sandra+D.&amp;rft.au=Sullivan%2C+Maria+A.&amp;rft.au=Yu%2C+Elmer&amp;rft.au=Rothenberg%2C+Jami+L.&amp;rft.au=Kleber%2C+Herbert+D.&amp;rft.au=Kampman%2C+Kyle&amp;rft.au=Dackis%2C+Charles&amp;rft.au=o%27Brien%2C+Charles+P.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4200530&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-17\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-17\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Minozzi, S; Amato, L; Vecchi, S; Davoli, M; Kirchmayer, U; Verster, A (13 April 2011). \"Oral naltrexone maintenance treatment for opioid dependence\". <i>The Cochrane Database of Systematic Reviews</i> (4): CD001333. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/14651858.CD001333.pub4\">10.1002/14651858.CD001333.pub4</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21491383\">21491383</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Oral+naltrexone+maintenance+treatment+for+opioid+dependence.&amp;rft.issue=4&amp;rft.pages=CD001333&amp;rft.date=2011-04-13&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD001333.pub4&amp;rft_id=info%3Apmid%2F21491383&amp;rft.aulast=Minozzi&amp;rft.aufirst=S&amp;rft.au=Amato%2C+L&amp;rft.au=Vecchi%2C+S&amp;rft.au=Davoli%2C+M&amp;rft.au=Kirchmayer%2C+U&amp;rft.au=Verster%2C+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-18\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-18\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Johansson, Bj\u00f6rn Axel; Berglund, Mats; Lindgren, Anna (2006). \"Efficacy of maintenance treatment with naltrexone for opioid dependence: A meta-analytical review\". <i>Addiction</i>. <b>101</b> (4): 491\u2013503. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/j.1360-0443.2006.01369.x\">10.1111/j.1360-0443.2006.01369.x</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/16548929\">16548929</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Addiction&amp;rft.atitle=Efficacy+of+maintenance+treatment+with+naltrexone+for+opioid+dependence%3A+A+meta-analytical+review&amp;rft.volume=101&amp;rft.issue=4&amp;rft.pages=491-503&amp;rft.date=2006&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1360-0443.2006.01369.x&amp;rft_id=info%3Apmid%2F16548929&amp;rft.aulast=Johansson&amp;rft.aufirst=Bj%C3%B6rn+Axel&amp;rft.au=Berglund%2C+Mats&amp;rft.au=Lindgren%2C+Anna&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-19\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-19\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">David, Sean P.; Lancaster, Tim; Stead, Lindsay F.; Evins, A. Eden; Prochaska, Judith J. (6 June 2013). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4038652\">\"Opioid antagonists for smoking cessation\"</a>. <i>The Cochrane Database of Systematic Reviews</i> (6): CD003086. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/14651858.CD003086.pub3\">10.1002/14651858.CD003086.pub3</a>. <a href=\"/wiki/International_Standard_Serial_Number\" title=\"International Standard Serial Number\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/1469-493X\">1469-493X</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4038652\">4038652</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23744347\">23744347</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Opioid+antagonists+for+smoking+cessation&amp;rft.issue=6&amp;rft.pages=CD003086&amp;rft.date=2013-06-06&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4038652&amp;rft.issn=1469-493X&amp;rft_id=info%3Apmid%2F23744347&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD003086.pub3&amp;rft.aulast=David&amp;rft.aufirst=Sean+P.&amp;rft.au=Lancaster%2C+Tim&amp;rft.au=Stead%2C+Lindsay+F.&amp;rft.au=Evins%2C+A.+Eden&amp;rft.au=Prochaska%2C+Judith+J.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4038652&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Milhorn2017-20\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Milhorn2017_20-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Milhorn2017_20-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Milhorn2017_20-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Milhorn2017_20-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation book\">H. Thomas Milhorn (17 October 2017). <a rel=\"nofollow\" class=\"external text\" href=\"https://books.google.com/books?id=wH86DwAAQBAJ&amp;pg=PA88\"><i>Substance Use Disorders: A Guide for the Primary Care Provider</i></a>. Springer International Publishing. pp.&#160;88\u2013. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-3-319-63040-3\" title=\"Special:BookSources/978-3-319-63040-3\">978-3-319-63040-3</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Substance+Use+Disorders%3A+A+Guide+for+the+Primary+Care+Provider&amp;rft.pages=88-&amp;rft.pub=Springer+International+Publishing&amp;rft.date=2017-10-17&amp;rft.isbn=978-3-319-63040-3&amp;rft.au=H.+Thomas+Milhorn&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DwH86DwAAQBAJ%26pg%3DPA88&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-MedicalNewsToday2006-21\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-MedicalNewsToday2006_21-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-MedicalNewsToday2006_21-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\">\"<a rel=\"nofollow\" class=\"external text\" href=\"http://www.medicalnewstoday.com/articles/41707.php\">Alcoholism Once A Month Injectable Drug, Vivitrol, Approved By FDA</a> <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20090105124047/http://www.medicalnewstoday.com/articles/41707.php\">Archived</a> 2009-01-05 at the <a href=\"/wiki/Wayback_Machine\" title=\"Wayback Machine\">Wayback Machine</a>.,\" Medical News Today, April 16, 2006.</span>\n</li>\n<li id=\"cite_note-TGA-22\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-TGA_22-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Therapeutic Goods Administration. <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ebs.tga.gov.au/ebs/ANZTPAR/PublicWeb.nsf/cuMedicines?OpenView\">\"Australian Register of Therapeutic Goods Medicines\"</a> <span style=\"font-size:85%;\">(Online database of approved medicines)</span>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20090514095145/https://www.ebs.tga.gov.au/ebs/ANZTPAR/PublicWeb.nsf/cuMedicines?OpenView\">Archived</a> from the original on 2009-05-14<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2009-03-22</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Australian+Register+of+Therapeutic+Goods+Medicines&amp;rft.au=Therapeutic+Goods+Administration&amp;rft_id=https%3A%2F%2Fwww.ebs.tga.gov.au%2Febs%2FANZTPAR%2FPublicWeb.nsf%2FcuMedicines%3FOpenView&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-23\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-23\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Therapeutic Goods Administration. <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ebs.tga.gov.au/servlet/xmlmillr6?dbid=ebs%2FPublicHTML%2FpdfStore.nsf&amp;docid=12AA89E8C8E53B46CA257FA7004211EE&amp;agid=(PrintDetailsPublic)&amp;actionid=1\">\"Australian Register of Therapeutic Goods Medicines\"</a> <span style=\"font-size:85%;\">(Online database of approved medicines, specific entry for \"O'Neil Long Acting Naltrexone Implant\")</span><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2017-04-27</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Australian+Register+of+Therapeutic+Goods+Medicines&amp;rft.au=Therapeutic+Goods+Administration&amp;rft_id=https%3A%2F%2Fwww.ebs.tga.gov.au%2Fservlet%2Fxmlmillr6%3Fdbid%3Debs%252FPublicHTML%252FpdfStore.nsf%26docid%3D12AA89E8C8E53B46CA257FA7004211EE%26agid%3D%28PrintDetailsPublic%29%26actionid%3D1&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-24\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-24\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Hulse, Gary K.; Morris, Noella; Arnold-Reed, Diane; Tait, Robert J. (2009). \"Improving Clinical Outcomes in Treating Heroin Dependence\". <i>Archives of General Psychiatry</i>. <b>66</b> (10): 1108\u201315. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1001/archgenpsychiatry.2009.130\">10.1001/archgenpsychiatry.2009.130</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19805701\">19805701</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Archives+of+General+Psychiatry&amp;rft.atitle=Improving+Clinical+Outcomes+in+Treating+Heroin+Dependence&amp;rft.volume=66&amp;rft.issue=10&amp;rft.pages=1108-15&amp;rft.date=2009&amp;rft_id=info%3Adoi%2F10.1001%2Farchgenpsychiatry.2009.130&amp;rft_id=info%3Apmid%2F19805701&amp;rft.aulast=Hulse&amp;rft.aufirst=Gary+K.&amp;rft.au=Morris%2C+Noella&amp;rft.au=Arnold-Reed%2C+Diane&amp;rft.au=Tait%2C+Robert+J.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-25\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-25\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Pfohl, David N.; Allen, John I.; Atkinson, Richard L.; Knopman, David S.; Malcolm, Robert J.; Mitchell, James E.; Morley, John E. (1986). <a rel=\"nofollow\" class=\"external text\" href=\"https://archives.drugabuse.gov/pdf/monographs/download67.html\">\"Naltrexone hydrochloride (Trexan): A review of serum transaminase elevations at high dosage\"</a>. <i>NIDA research monograph</i>. <b>67</b>: 66\u201372. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/3092099\">3092099</a>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20170121150620/https://archives.drugabuse.gov/pdf/monographs/download67.html\">Archived</a> from the original on 2017-01-21.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=NIDA+research+monograph&amp;rft.atitle=Naltrexone+hydrochloride+%28Trexan%29%3A+A+review+of+serum+transaminase+elevations+at+high+dosage&amp;rft.volume=67&amp;rft.pages=66-72&amp;rft.date=1986&amp;rft_id=info%3Apmid%2F3092099&amp;rft.aulast=Pfohl&amp;rft.aufirst=David+N.&amp;rft.au=Allen%2C+John+I.&amp;rft.au=Atkinson%2C+Richard+L.&amp;rft.au=Knopman%2C+David+S.&amp;rft.au=Malcolm%2C+Robert+J.&amp;rft.au=Mitchell%2C+James+E.&amp;rft.au=Morley%2C+John+E.&amp;rft_id=https%3A%2F%2Farchives.drugabuse.gov%2Fpdf%2Fmonographs%2Fdownload67.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-galanter-26\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-galanter_26-0\">^</a></b></span> <span class=\"reference-text\">Galanter, Marc; Kleber, Herbert.  The American Psychiatric Publishing Textbook of Substance Abuse Treatment, 4th Edition. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/1585622761\" title=\"Special:BookSources/1585622761\">1585622761</a><sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citing_sources\" title=\"Wikipedia:Citing sources\"><span title=\"This citation requires a reference to the specific page or range of pages in which the material appears. (January 2017)\">page&#160;needed</span></a></i>&#93;</sup></span>\n</li>\n<li id=\"cite_note-pmid8114680-27\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid8114680_27-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Raynor K, Kong H, Chen Y, Yasuda K, Yu L, Bell GI, Reisine T (1994). <a rel=\"nofollow\" class=\"external text\" href=\"http://molpharm.aspetjournals.org/content/45/2/330.short\">\"Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors\"</a>. <i>Mol. Pharmacol</i>. <b>45</b> (2): 330\u20134. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/8114680\">8114680</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Mol.+Pharmacol.&amp;rft.atitle=Pharmacological+characterization+of+the+cloned+kappa-%2C+delta-%2C+and+mu-opioid+receptors&amp;rft.volume=45&amp;rft.issue=2&amp;rft.pages=330-4&amp;rft.date=1994&amp;rft_id=info%3Apmid%2F8114680&amp;rft.aulast=Raynor&amp;rft.aufirst=K&amp;rft.au=Kong%2C+H&amp;rft.au=Chen%2C+Y&amp;rft.au=Yasuda%2C+K&amp;rft.au=Yu%2C+L&amp;rft.au=Bell%2C+GI&amp;rft.au=Reisine%2C+T&amp;rft_id=http%3A%2F%2Fmolpharm.aspetjournals.org%2Fcontent%2F45%2F2%2F330.short&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid7562497-28\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid7562497_28-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Codd, E. E.; Shank, R. P.; Schupsky, J. J.; Raffa, R. B. (1995). <a rel=\"nofollow\" class=\"external text\" href=\"http://jpet.aspetjournals.org/content/274/3/1263.short\">\"Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: Structural determinants and role in antinociception\"</a>. <i>The Journal of Pharmacology and Experimental Therapeutics</i>. <b>274</b> (3): 1263\u201370. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/7562497\">7562497</a>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20170202020241/http://jpet.aspetjournals.org/content/274/3/1263.short\">Archived</a> from the original on 2017-02-02.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Pharmacology+and+Experimental+Therapeutics&amp;rft.atitle=Serotonin+and+norepinephrine+uptake+inhibiting+activity+of+centrally+acting+analgesics%3A+Structural+determinants+and+role+in+antinociception&amp;rft.volume=274&amp;rft.issue=3&amp;rft.pages=1263-70&amp;rft.date=1995&amp;rft_id=info%3Apmid%2F7562497&amp;rft.aulast=Codd&amp;rft.aufirst=E.+E.&amp;rft.au=Shank%2C+R.+P.&amp;rft.au=Schupsky%2C+J.+J.&amp;rft.au=Raffa%2C+R.+B.&amp;rft_id=http%3A%2F%2Fjpet.aspetjournals.org%2Fcontent%2F274%2F3%2F1263.short&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-29\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-29\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Niciu, Mark J.; Arias, Albert J. (2013). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4600601\">\"Targeted Opioid Receptor Antagonists in the Treatment of Alcohol Use Disorders\"</a>. <i>CNS Drugs</i>. <b>27</b> (10): 777\u201387. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s40263-013-0096-4\">10.1007/s40263-013-0096-4</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4600601\">4600601</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23881605\">23881605</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CNS+Drugs&amp;rft.atitle=Targeted+Opioid+Receptor+Antagonists+in+the+Treatment+of+Alcohol+Use+Disorders&amp;rft.volume=27&amp;rft.issue=10&amp;rft.pages=777-87&amp;rft.date=2013&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4600601&amp;rft_id=info%3Apmid%2F23881605&amp;rft_id=info%3Adoi%2F10.1007%2Fs40263-013-0096-4&amp;rft.aulast=Niciu&amp;rft.aufirst=Mark+J.&amp;rft.au=Arias%2C+Albert+J.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4600601&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-HaberRoske1996-30\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-HaberRoske1996_30-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Haber, Hanka; Roske, Irmgard; Rottmann, Matthias; Georgi, Monika; Melzig, Matthias F. (1996). \"Alcohol induces formation of morphine precursors in the striatum of rats\". <i>Life Sciences</i>. <b>60</b> (2): 79\u201389. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0024-3205%2896%2900597-8\">10.1016/S0024-3205(96)00597-8</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/9000113\">9000113</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Life+Sciences&amp;rft.atitle=Alcohol+induces+formation+of+morphine+precursors+in+the+striatum+of+rats&amp;rft.volume=60&amp;rft.issue=2&amp;rft.pages=79-89&amp;rft.date=1996&amp;rft_id=info%3Adoi%2F10.1016%2FS0024-3205%2896%2900597-8&amp;rft_id=info%3Apmid%2F9000113&amp;rft.aulast=Haber&amp;rft.aufirst=Hanka&amp;rft.au=Roske%2C+Irmgard&amp;rft.au=Rottmann%2C+Matthias&amp;rft.au=Georgi%2C+Monika&amp;rft.au=Melzig%2C+Matthias+F.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-ctidNCT00006206-31\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-ctidNCT00006206_31-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-ctidNCT00006206_31-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-ctidNCT00006206_31-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-ctidNCT00006206_31-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Anton, Raymond F.; Oroszi, Gabor; o'Malley, Stephanie; Couper, David; Swift, Robert; Pettinati, Helen; Goldman, David (2008). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2666924\">\"An Evaluation of \u03bc-Opioid Receptor (OPRM1) as a Predictor of Naltrexone Response in the Treatment of Alcohol Dependence\"</a>. <i>Archives of General Psychiatry</i>. <b>65</b> (2): 135\u201344. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1001/archpsyc.65.2.135\">10.1001/archpsyc.65.2.135</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2666924\">2666924</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18250251\">18250251</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Archives+of+General+Psychiatry&amp;rft.atitle=An+Evaluation+of+%CE%BC-Opioid+Receptor+%28OPRM1%29+as+a+Predictor+of+Naltrexone+Response+in+the+Treatment+of+Alcohol+Dependence&amp;rft.volume=65&amp;rft.issue=2&amp;rft.pages=135-44&amp;rft.date=2008&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2666924&amp;rft_id=info%3Apmid%2F18250251&amp;rft_id=info%3Adoi%2F10.1001%2Farchpsyc.65.2.135&amp;rft.aulast=Anton&amp;rft.aufirst=Raymond+F.&amp;rft.au=Oroszi%2C+Gabor&amp;rft.au=o%27Malley%2C+Stephanie&amp;rft.au=Couper%2C+David&amp;rft.au=Swift%2C+Robert&amp;rft.au=Pettinati%2C+Helen&amp;rft.au=Goldman%2C+David&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2666924&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-32\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-32\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.snpedia.com/index.php/Rs1799971\">\"Rs1799971 (SNPedia)\"</a>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20111127185453/http://www.snpedia.com/index.php/Rs1799971\">Archived</a> from the original on 2011-11-27.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Rs1799971+%28SNPedia%29&amp;rft_id=http%3A%2F%2Fwww.snpedia.com%2Findex.php%2FRs1799971&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-33\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-33\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Kranzler, Henry R.; Kirk, Jeffrey (2001). \"Efficacy of Naltrexone and Acamprosate for Alcoholism Treatment: A Meta-Analysis\". <i>Alcoholism: Clinical and Experimental Research</i>. <b>25</b> (9): 1335\u201341. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/j.1530-0277.2001.tb02356.x\">10.1111/j.1530-0277.2001.tb02356.x</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11584154\">11584154</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Alcoholism%3A+Clinical+and+Experimental+Research&amp;rft.atitle=Efficacy+of+Naltrexone+and+Acamprosate+for+Alcoholism+Treatment%3A+A+Meta-Analysis&amp;rft.volume=25&amp;rft.issue=9&amp;rft.pages=1335-41&amp;rft.date=2001&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1530-0277.2001.tb02356.x&amp;rft_id=info%3Apmid%2F11584154&amp;rft.aulast=Kranzler&amp;rft.aufirst=Henry+R.&amp;rft.au=Kirk%2C+Jeffrey&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-34\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-34\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Ray, Lara A.; Oslin, David W. (2009). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3409877\">\"Naltrexone for the treatment of alcohol dependence among African Americans: Results from the COMBINE Study\"</a>. <i>Drug and Alcohol Dependence</i>. <b>105</b> (3): 256\u20138. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.drugalcdep.2009.07.006\">10.1016/j.drugalcdep.2009.07.006</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3409877\">3409877</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19717248\">19717248</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Drug+and+Alcohol+Dependence&amp;rft.atitle=Naltrexone+for+the+treatment+of+alcohol+dependence+among+African+Americans%3A+Results+from+the+COMBINE+Study&amp;rft.volume=105&amp;rft.issue=3&amp;rft.pages=256-8&amp;rft.date=2009&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3409877&amp;rft_id=info%3Apmid%2F19717248&amp;rft_id=info%3Adoi%2F10.1016%2Fj.drugalcdep.2009.07.006&amp;rft.aulast=Ray&amp;rft.aufirst=Lara+A.&amp;rft.au=Oslin%2C+David+W.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3409877&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-35\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-35\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Ray, Lara A.; Barr, Christina S.; Blendy, Julie A.; Oslin, David; Goldman, David; Anton, Raymond F. (2012). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3249007\">\"The Role of the Asn40Asp Polymorphism of the Mu Opioid Receptor Gene (OPRM1) on Alcoholism Etiology and Treatment: A Critical Review\"</a>. <i>Alcoholism: Clinical and Experimental Research</i>. <b>36</b> (3): 385\u201394. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/j.1530-0277.2011.01633.x\">10.1111/j.1530-0277.2011.01633.x</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3249007\">3249007</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21895723\">21895723</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Alcoholism%3A+Clinical+and+Experimental+Research&amp;rft.atitle=The+Role+of+the+Asn40Asp+Polymorphism+of+the+Mu+Opioid+Receptor+Gene+%28OPRM1%29+on+Alcoholism+Etiology+and+Treatment%3A+A+Critical+Review&amp;rft.volume=36&amp;rft.issue=3&amp;rft.pages=385-94&amp;rft.date=2012&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3249007&amp;rft_id=info%3Apmid%2F21895723&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1530-0277.2011.01633.x&amp;rft.aulast=Ray&amp;rft.aufirst=Lara+A.&amp;rft.au=Barr%2C+Christina+S.&amp;rft.au=Blendy%2C+Julie+A.&amp;rft.au=Oslin%2C+David&amp;rft.au=Goldman%2C+David&amp;rft.au=Anton%2C+Raymond+F.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3249007&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Dependence1974-36\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Dependence1974_36-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Dependence1974_36-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation book\">National Research Council (U.S.). Committee on Problems of Drug Dependence (1974). <a rel=\"nofollow\" class=\"external text\" href=\"https://books.google.com/books?id=pEYrAAAAYAAJ&amp;pg=PA265\"><i>Report of the Thirty-sixth Annual Scientific Meeting: Committee on Problems of Drug Dependence, Mexico City, March 10-14, 1974</i></a>. National Academies. pp.&#160;265\u2013. NAP:13963.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Report+of+the+Thirty-sixth+Annual+Scientific+Meeting%3A+Committee+on+Problems+of+Drug+Dependence%2C+Mexico+City%2C+March+10-14%2C+1974&amp;rft.pages=265-&amp;rft.pub=National+Academies&amp;rft.date=1974&amp;rft.au=National+Research+Council+%28U.S.%29.+Committee+on+Problems+of+Drug+Dependence&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DpEYrAAAAYAAJ%26pg%3DPA265&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-PadwaCunningham2010-37\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-PadwaCunningham2010_37-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Howard Padwa; Jacob Cunningham (2010). <a rel=\"nofollow\" class=\"external text\" href=\"https://books.google.com/books?id=hdMAnL5neAAC&amp;pg=PA207\"><i>Addiction: A Reference Encyclopedia</i></a>. ABC-CLIO. pp.&#160;207\u2013. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-1-59884-229-6\" title=\"Special:BookSources/978-1-59884-229-6\">978-1-59884-229-6</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Addiction%3A+A+Reference+Encyclopedia&amp;rft.pages=207-&amp;rft.pub=ABC-CLIO&amp;rft.date=2010&amp;rft.isbn=978-1-59884-229-6&amp;rft.au=Howard+Padwa&amp;rft.au=Jacob+Cunningham&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DhdMAnL5neAAC%26pg%3DPA207&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Bennett2004-38\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Bennett2004_38-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">G Bennett (14 January 2004). <a rel=\"nofollow\" class=\"external text\" href=\"https://books.google.com/books?id=ft6IAgAAQBAJ&amp;pg=PT112\"><i>Treating Drug Abusers</i></a>. Routledge. pp.&#160;112\u2013. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-1-134-93173-6\" title=\"Special:BookSources/978-1-134-93173-6\">978-1-134-93173-6</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Treating+Drug+Abusers&amp;rft.pages=112-&amp;rft.pub=Routledge&amp;rft.date=2004-01-14&amp;rft.isbn=978-1-134-93173-6&amp;rft.au=G+Bennett&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3Dft6IAgAAQBAJ%26pg%3DPT112&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Wouk2009-39\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Wouk2009_39-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Wouk2009_39-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Wouk2009_39-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation book\">Joseph Wouk (1 March 2009). <a rel=\"nofollow\" class=\"external text\" href=\"https://books.google.com/books?id=9hOBAgAAQBAJ&amp;pg=RA1-PA78\"><i>Google Ldn&#160;!</i></a>. Lulu.com. pp.&#160;78\u201388. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-0-578-00439-6\" title=\"Special:BookSources/978-0-578-00439-6\">978-0-578-00439-6</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Google+Ldn+%21&amp;rft.pages=78-88&amp;rft.pub=Lulu.com&amp;rft.date=2009-03-01&amp;rft.isbn=978-0-578-00439-6&amp;rft.au=Joseph+Wouk&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3D9hOBAgAAQBAJ%26pg%3DRA1-PA78&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Elks2014-40\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Elks2014_40-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Elks2014_40-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation book\">J. Elks (14 November 2014). <a rel=\"nofollow\" class=\"external text\" href=\"https://books.google.com/books?id=0vXTBwAAQBAJ&amp;pg=PA851\"><i>The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies</i></a>. Springer. pp.&#160;851\u2013. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-1-4757-2085-3\" title=\"Special:BookSources/978-1-4757-2085-3\">978-1-4757-2085-3</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=The+Dictionary+of+Drugs%3A+Chemical+Data%3A+Chemical+Data%2C+Structures+and+Bibliographies&amp;rft.pages=851-&amp;rft.pub=Springer&amp;rft.date=2014-11-14&amp;rft.isbn=978-1-4757-2085-3&amp;rft.au=J.+Elks&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3D0vXTBwAAQBAJ%26pg%3DPA851&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-IndexNominum2000-41\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-IndexNominum2000_41-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-IndexNominum2000_41-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation book\"><a rel=\"nofollow\" class=\"external text\" href=\"https://books.google.com/books?id=5GpcTQD_L2oC&amp;pg=PA715\"><i>Index Nominum 2000: International Drug Directory</i></a>. Taylor &amp; Francis. 2000. pp.&#160;715\u2013. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-3-88763-075-1\" title=\"Special:BookSources/978-3-88763-075-1\">978-3-88763-075-1</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Index+Nominum+2000%3A+International+Drug+Directory&amp;rft.pages=715-&amp;rft.pub=Taylor+%26+Francis&amp;rft.date=2000&amp;rft.isbn=978-3-88763-075-1&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3D5GpcTQD_L2oC%26pg%3DPA715&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-MortonHall2012-42\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-MortonHall2012_42-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-MortonHall2012_42-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation book\">I.K. Morton; Judith M. Hall (6 December 2012). <a rel=\"nofollow\" class=\"external text\" href=\"https://books.google.com/books?id=tsjrCAAAQBAJ&amp;pg=PA189\"><i>Concise Dictionary of Pharmacological Agents: Properties and Synonyms</i></a>. Springer Science &amp; Business Media. pp.&#160;189\u2013. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-94-011-4439-1\" title=\"Special:BookSources/978-94-011-4439-1\">978-94-011-4439-1</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Concise+Dictionary+of+Pharmacological+Agents%3A+Properties+and+Synonyms&amp;rft.pages=189-&amp;rft.pub=Springer+Science+%26+Business+Media&amp;rft.date=2012-12-06&amp;rft.isbn=978-94-011-4439-1&amp;rft.au=I.K.+Morton&amp;rft.au=Judith+M.+Hall&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DtsjrCAAAQBAJ%26pg%3DPA189&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Drugs.com-43\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Drugs.com_43-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Drugs.com_43-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Drugs.com_43-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.drugs.com/international/naltrexone.html\">\"Archived copy\"</a>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20171204114601/https://www.drugs.com/international/naltrexone.html\">Archived</a> from the original on 2017-12-04<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2017-12-04</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Archived+copy&amp;rft_id=https%3A%2F%2Fwww.drugs.com%2Finternational%2Fnaltrexone.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid18212797-44\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid18212797_44-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">McCann DJ (2008). \"Potential of buprenorphine/naltrexone in treating polydrug addiction and co-occurring psychiatric disorders\". <i>Clin. Pharmacol. Ther</i>. <b>83</b> (4): 627\u201330. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/sj.clpt.6100503\">10.1038/sj.clpt.6100503</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18212797\">18212797</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clin.+Pharmacol.+Ther.&amp;rft.atitle=Potential+of+buprenorphine%2Fnaltrexone+in+treating+polydrug+addiction+and+co-occurring+psychiatric+disorders&amp;rft.volume=83&amp;rft.issue=4&amp;rft.pages=627-30&amp;rft.date=2008&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.clpt.6100503&amp;rft_id=info%3Apmid%2F18212797&amp;rft.aulast=McCann&amp;rft.aufirst=DJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-45\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-45\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Armstrong, Walter (7 May 2013). <a rel=\"nofollow\" class=\"external text\" href=\"https://psmag.com/social-justice/vivitrol-help-control-addictions-57261\">\"A Shot in the Dark: Can Vivitrol Help Us Control Our Addictions?\"</a>. <i>Pacific Standard</i>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20170913135050/https://psmag.com/social-justice/vivitrol-help-control-addictions-57261\">Archived</a> from the original on 13 September 2017.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Pacific+Standard&amp;rft.atitle=A+Shot+in+the+Dark%3A+Can+Vivitrol+Help+Us+Control+Our+Addictions%3F&amp;rft.date=2013-05-07&amp;rft.aulast=Armstrong&amp;rft.aufirst=Walter&amp;rft_id=https%3A%2F%2Fpsmag.com%2Fsocial-justice%2Fvivitrol-help-control-addictions-57261&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Lancet_Krupitsky_2011_naltrexone-46\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Lancet_Krupitsky_2011_naltrexone_46-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Krupitsky, Evgeny; Nunes, Edward V.; Ling, Walter; Illeperuma, Ari; Gastfriend, David R.; Silverman, Bernard L. (April 28, 2011). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.researchgate.net/profile/Evgeny_Krupitsky/publication/51086253_Krupitsky_E_Nunes_EV_Ling_W_Illeperuma_A_Gastfriend_DR_Silverman_BL_Injectable_extended-release_naltrexone_for_opioid_dependence_a_double-blind_placebo-controlled_multicentre_randomised_trial_Lancet_3/links/0deec521d0385a2aff000000/Krupitsky-E-Nunes-EV-Ling-W-Illeperuma-A-Gastfriend-DR-Silverman-BL-Injectable-extended-release-naltrexone-for-opioid-dependence-a-double-blind-placebo-controlled-multicentre-randomised-trial-L.pdf\">\"Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial\"</a> <span style=\"font-size:85%;\">(PDF)</span>. <i>The Lancet</i>. <b>377</b> (9776): 1506\u201313. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/s0140-6736%2811%2960358-9\">10.1016/s0140-6736(11)60358-9</a>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20170912192327/https://www.researchgate.net/profile/Evgeny_Krupitsky/publication/51086253_Krupitsky_E_Nunes_EV_Ling_W_Illeperuma_A_Gastfriend_DR_Silverman_BL_Injectable_extended-release_naltrexone_for_opioid_dependence_a_double-blind_placebo-controlled_multicentre_randomised_trial_Lancet_3/links/0deec521d0385a2aff000000/Krupitsky-E-Nunes-EV-Ling-W-Illeperuma-A-Gastfriend-DR-Silverman-BL-Injectable-extended-release-naltrexone-for-opioid-dependence-a-double-blind-placebo-controlled-multicentre-randomised-trial-L.pdf\">Archived</a> <span style=\"font-size:85%;\">(PDF)</span> from the original on September 12, 2017<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">June 11,</span> 2017</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet&amp;rft.atitle=Injectable+extended-release+naltrexone+for+opioid+dependence%3A+a+double-blind%2C+placebo-controlled%2C+multicentre+randomised+trial&amp;rft.volume=377&amp;rft.issue=9776&amp;rft.pages=1506-13&amp;rft.date=2011-04-28&amp;rft_id=info%3Adoi%2F10.1016%2Fs0140-6736%2811%2960358-9&amp;rft.aulast=Krupitsky&amp;rft.aufirst=Evgeny&amp;rft.au=Nunes%2C+Edward+V.&amp;rft.au=Ling%2C+Walter&amp;rft.au=Illeperuma%2C+Ari&amp;rft.au=Gastfriend%2C+David+R.&amp;rft.au=Silverman%2C+Bernard+L.&amp;rft_id=https%3A%2F%2Fwww.researchgate.net%2Fprofile%2FEvgeny_Krupitsky%2Fpublication%2F51086253_Krupitsky_E_Nunes_EV_Ling_W_Illeperuma_A_Gastfriend_DR_Silverman_BL_Injectable_extended-release_naltrexone_for_opioid_dependence_a_double-blind_placebo-controlled_multicentre_randomised_trial_Lancet_3%2Flinks%2F0deec521d0385a2aff000000%2FKrupitsky-E-Nunes-EV-Ling-W-Illeperuma-A-Gastfriend-DR-Silverman-BL-Injectable-extended-release-naltrexone-for-opioid-dependence-a-double-blind-placebo-controlled-multicentre-randomised-trial-L.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-47\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-47\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Wolfe, Daniel; Carrieri, MP; Dasgupta, Nabarun; Bruce, Douglas; Wodak, Alex (2011). \"Injectable extended-release naltrexone for opioid dependence \u2013 Authors' reply\". <i>The Lancet</i>. <b>378</b> (9792): 666. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0140-6736%2811%2961333-0\">10.1016/S0140-6736(11)61333-0</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet&amp;rft.atitle=Injectable+extended-release+naltrexone+for+opioid+dependence+%E2%80%93+Authors%27+reply&amp;rft.volume=378&amp;rft.issue=9792&amp;rft.pages=666&amp;rft.date=2011&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2811%2961333-0&amp;rft.aulast=Wolfe&amp;rft.aufirst=Daniel&amp;rft.au=Carrieri%2C+MP&amp;rft.au=Dasgupta%2C+Nabarun&amp;rft.au=Bruce%2C+Douglas&amp;rft.au=Wodak%2C+Alex&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-48\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-48\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Tanum, L; Solli, KK; Latif, ZE; Benth, J\u0160; Opheim, A; Sharma-Haase, K; Krajci, P; Kun\u00f8e, N (18 October 2017). \"The Effectiveness of Injectable Extended-Release Naltrexone vs Daily Buprenorphine-Naloxone for Opioid Dependence: A Randomized Clinical Noninferiority Trial\". <i>JAMA Psychiatry</i>. <b>74</b> (12): 1197\u20131205. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1001/jamapsychiatry.2017.3206\">10.1001/jamapsychiatry.2017.3206</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/29049469\">29049469</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA+Psychiatry&amp;rft.atitle=The+Effectiveness+of+Injectable+Extended-Release+Naltrexone+vs+Daily+Buprenorphine-Naloxone+for+Opioid+Dependence%3A+A+Randomized+Clinical+Noninferiority+Trial&amp;rft.volume=74&amp;rft.issue=12&amp;rft.pages=1197-1205&amp;rft.date=2017-10-18&amp;rft_id=info%3Adoi%2F10.1001%2Fjamapsychiatry.2017.3206&amp;rft_id=info%3Apmid%2F29049469&amp;rft.aulast=Tanum&amp;rft.aufirst=L&amp;rft.au=Solli%2C+KK&amp;rft.au=Latif%2C+ZE&amp;rft.au=Benth%2C+J%C5%A0&amp;rft.au=Opheim%2C+A&amp;rft.au=Sharma-Haase%2C+K&amp;rft.au=Krajci%2C+P&amp;rft.au=Kun%C3%B8e%2C+N&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-NYT_2017_Vivitrol-49\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-NYT_2017_Vivitrol_49-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-NYT_2017_Vivitrol_49-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-NYT_2017_Vivitrol_49-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation news\">Goodnough, Abby; Zernike, Kate (June 11, 2017). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.nytimes.com/2017/06/11/health/vivitrol-drug-opioid-addiction.html\">\"Seizing on Opioid Crisis, a Drug Maker Lobbies Hard for Its Product\"</a>. <i><a href=\"/wiki/The_New_York_Times\" title=\"The New York Times\">The New York Times</a></i>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20170611133547/https://www.nytimes.com/2017/06/11/health/vivitrol-drug-opioid-addiction.html\">Archived</a> from the original on June 11, 2017<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">June 11,</span> 2017</span>. <q>Advertising for Vivitrol on a subway car in Brooklyn last month. Marketing for the drug has shifted into high gear.</q></cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Seizing+on+Opioid+Crisis%2C+a+Drug+Maker+Lobbies+Hard+for+Its+Product&amp;rft.date=2017-06-11&amp;rft.aulast=Goodnough&amp;rft.aufirst=Abby&amp;rft.au=Zernike%2C+Kate&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2017%2F06%2F11%2Fhealth%2Fvivitrol-drug-opioid-addiction.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Tom-Price-Letter-Re-MAT_2017-50\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Tom-Price-Letter-Re-MAT_2017_50-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Tom-Price-Letter-Re-MAT_2017_50-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.documentcloud.org/documents/3723472-Tom-Price-Letter-Re-MAT.html\">\"Letter to Tom Price\"</a>. May 2017. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20170625103407/http://www.documentcloud.org/documents/3723472-Tom-Price-Letter-Re-MAT.html\">Archived</a> from the original on June 25, 2017<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">June 11,</span> 2017</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Letter+to+Tom+Price&amp;rft.date=2017-05&amp;rft_id=https%3A%2F%2Fwww.documentcloud.org%2Fdocuments%2F3723472-Tom-Price-Letter-Re-MAT.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-SimeonAbugel2008-51\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-SimeonAbugel2008_51-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-SimeonAbugel2008_51-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-SimeonAbugel2008_51-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-SimeonAbugel2008_51-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation book\">Daphne Simeon; Jeffrey Abugel (10 October 2008). <a rel=\"nofollow\" class=\"external text\" href=\"https://books.google.com/books?id=ONLyq-mVLuIC&amp;pg=PA166\"><i>Feeling Unreal: Depersonalization Disorder and the Loss of the Self</i></a>. Oxford University Press. pp.&#160;166\u2013. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-0-19-976635-2\" title=\"Special:BookSources/978-0-19-976635-2\">978-0-19-976635-2</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Feeling+Unreal%3A+Depersonalization+Disorder+and+the+Loss+of+the+Self&amp;rft.pages=166-&amp;rft.pub=Oxford+University+Press&amp;rft.date=2008-10-10&amp;rft.isbn=978-0-19-976635-2&amp;rft.au=Daphne+Simeon&amp;rft.au=Jeffrey+Abugel&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DONLyq-mVLuIC%26pg%3DPA166&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-PhDPhD2014-52\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-PhDPhD2014_52-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-PhDPhD2014_52-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-PhDPhD2014_52-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-PhDPhD2014_52-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation book\">Ulrich F. Lanius, PhD; Sandra L. Paulsen, PhD; Frank M. Corrigan, MD (13 May 2014). <a rel=\"nofollow\" class=\"external text\" href=\"https://books.google.com/books?id=0i-FAwAAQBAJ&amp;pg=PA489\"><i>Neurobiology and Treatment of Traumatic Dissociation: Towards an Embodied Self</i></a>. Springer Publishing Company. pp.&#160;489\u2013. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-0-8261-0632-2\" title=\"Special:BookSources/978-0-8261-0632-2\">978-0-8261-0632-2</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Neurobiology+and+Treatment+of+Traumatic+Dissociation%3A+Towards+an+Embodied+Self&amp;rft.pages=489-&amp;rft.pub=Springer+Publishing+Company&amp;rft.date=2014-05-13&amp;rft.isbn=978-0-8261-0632-2&amp;rft.au=Ulrich+F.+Lanius%2C+PhD&amp;rft.au=Sandra+L.+Paulsen%2C+PhD&amp;rft.au=Frank+M.+Corrigan%2C+MD&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3D0i-FAwAAQBAJ%26pg%3DPA489&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-53\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-53\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sierra, Mauricio (2014). \"Depersonalization disorder: Pharmacological approaches\". <i>Expert Review of Neurotherapeutics</i>. <b>8</b> (1): 19\u201326. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1586/14737175.8.1.19\">10.1586/14737175.8.1.19</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18088198\">18088198</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Expert+Review+of+Neurotherapeutics&amp;rft.atitle=Depersonalization+disorder%3A+Pharmacological+approaches&amp;rft.volume=8&amp;rft.issue=1&amp;rft.pages=19-26&amp;rft.date=2014&amp;rft_id=info%3Adoi%2F10.1586%2F14737175.8.1.19&amp;rft_id=info%3Apmid%2F18088198&amp;rft.aulast=Sierra&amp;rft.aufirst=Mauricio&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Novella-54\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Novella_54-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Novella_54-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\">Novella, Steven (5 May 2010). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.sciencebasedmedicine.org/index.php/low-dose-naltrexone-bogus-or-cutting-edge-science/\">\"Low Dose Naltrexone \u2013 Bogus or Cutting Edge Science?\"</a>. <i>Science-Based Medicine</i>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20110708043917/http://www.sciencebasedmedicine.org/index.php/low-dose-naltrexone-bogus-or-cutting-edge-science/\">Archived</a> from the original on 8 July 2011<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">5 July</span> 2011</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Science-Based+Medicine&amp;rft.atitle=Low+Dose+Naltrexone+%E2%80%93+Bogus+or+Cutting+Edge+Science%3F&amp;rft.date=2010-05-05&amp;rft.aulast=Novella&amp;rft.aufirst=Steven&amp;rft_id=http%3A%2F%2Fwww.sciencebasedmedicine.org%2Findex.php%2Flow-dose-naltrexone-bogus-or-cutting-edge-science%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-ldntxfm-55\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-ldntxfm_55-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Younger, Jarred; MacKey, Sean (2009). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2891387\">\"Fibromyalgia Symptoms Are Reduced by Low-Dose Naltrexone: A Pilot Study\"</a>. <i>Pain Medicine</i>. <b>10</b> (4): 663\u201372. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/j.1526-4637.2009.00613.x\">10.1111/j.1526-4637.2009.00613.x</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2891387\">2891387</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19453963\">19453963</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pain+Medicine&amp;rft.atitle=Fibromyalgia+Symptoms+Are+Reduced+by+Low-Dose+Naltrexone%3A+A+Pilot+Study&amp;rft.volume=10&amp;rft.issue=4&amp;rft.pages=663-72&amp;rft.date=2009&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2891387&amp;rft_id=info%3Apmid%2F19453963&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1526-4637.2009.00613.x&amp;rft.aulast=Younger&amp;rft.aufirst=Jarred&amp;rft.au=MacKey%2C+Sean&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2891387&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-NMSS-56\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NMSS_56-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Bowling, Allen C. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20111222063116/http://www.nationalmssociety.org/multimedia-library/momentum-magazine/back-issues/momentum-spring-09/index.aspx\">\"Low-dose naltrexone (LDN) The \"411\" on LDN\"</a>. National Multiple Sclerosis Society. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://www.nationalmssociety.org/multimedia-library/momentum-magazine/back-issues/momentum-spring-09/index.aspx\">the original</a> on 22 December 2011<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">6 July</span> 2011</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Low-dose+naltrexone+%28LDN%29+The+%22411%22+on+LDN&amp;rft.pub=National+Multiple+Sclerosis+Society&amp;rft.aulast=Bowling&amp;rft.aufirst=Allen+C.&amp;rft_id=http%3A%2F%2Fwww.nationalmssociety.org%2Fmultimedia-library%2Fmomentum-magazine%2Fback-issues%2Fmomentum-spring-09%2Findex.aspx&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-57\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-57\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Smith, Stanley G.; Gupta, Krishan K.; Smith, Sylvia H. (1995). \"Effects of naltrexone on self-injury, stereotypy, and social behavior of adults with developmental disabilities\". <i>Journal of Developmental and Physical Disabilities</i>. <b>7</b> (2): 137\u201346. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/BF02684958\">10.1007/BF02684958</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Developmental+and+Physical+Disabilities&amp;rft.atitle=Effects+of+naltrexone+on+self-injury%2C+stereotypy%2C+and+social+behavior+of+adults+with+developmental+disabilities&amp;rft.volume=7&amp;rft.issue=2&amp;rft.pages=137-46&amp;rft.date=1995&amp;rft_id=info%3Adoi%2F10.1007%2FBF02684958&amp;rft.aulast=Smith&amp;rft.aufirst=Stanley+G.&amp;rft.au=Gupta%2C+Krishan+K.&amp;rft.au=Smith%2C+Sylvia+H.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-58\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-58\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Manley, Cynthia (1998-03-20). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.mc.vanderbilt.edu/reporter/index.html?ID=461\">\"Self-injuries may have biochemical base: study\"</a>. The Reporter. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20090105011250/http://www.mc.vanderbilt.edu/reporter/index.html?ID=461\">Archived</a> from the original on 2009-01-05.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Self-injuries+may+have+biochemical+base%3A+study&amp;rft.date=1998-03-20&amp;rft.aulast=Manley&amp;rft.aufirst=Cynthia&amp;rft_id=http%3A%2F%2Fwww.mc.vanderbilt.edu%2Freporter%2Findex.html%3FID%3D461&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-59\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-59\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Grant, Jon E.; Kim, Suck Won; Odlaug, Brian L. (2009). \"A Double-Blind, Placebo-Controlled Study of the Opiate Antagonist, Naltrexone, in the Treatment of Kleptomania\". <i>Biological Psychiatry</i>. <b>65</b> (7): 600\u20136. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.biopsych.2008.11.022\">10.1016/j.biopsych.2008.11.022</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19217077\">19217077</a>. <a rel=\"nofollow\" class=\"external text\" href=\"https://www.sciencedaily.com/releases/2009/04/090401101900.htm\">Lay summary</a> &#8211; <i>Science Daily</i> (April 3, 2009).</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biological+Psychiatry&amp;rft.atitle=A+Double-Blind%2C+Placebo-Controlled+Study+of+the+Opiate+Antagonist%2C+Naltrexone%2C+in+the+Treatment+of+Kleptomania&amp;rft.volume=65&amp;rft.issue=7&amp;rft.pages=600-6&amp;rft.date=2009&amp;rft_id=info%3Adoi%2F10.1016%2Fj.biopsych.2008.11.022&amp;rft_id=info%3Apmid%2F19217077&amp;rft.aulast=Grant&amp;rft.aufirst=Jon+E.&amp;rft.au=Kim%2C+Suck+Won&amp;rft.au=Odlaug%2C+Brian+L.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-gambling-60\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-gambling_60-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://ichgcp.net/clinical-trials-registry/NCT00326807\">\"A Randomized, Double-Blind, Placebo-Controlled Trial of Naltrexone in the Treatment of Concurrent Alcohol Dependence and Pathological Gambling - ICH GCP - Clinical Trials Registry\"</a>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20150626114447/http://ichgcp.net/clinical-trials-registry/NCT00326807\">Archived</a> from the original on 2015-06-26.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=A+Randomized%2C+Double-Blind%2C+Placebo-Controlled+Trial+of+Naltrexone+in+the+Treatment+of+Concurrent+Alcohol+Dependence+and+Pathological+Gambling+-+ICH+GCP+-+Clinical+Trials+Registry&amp;rft_id=http%3A%2F%2Fichgcp.net%2Fclinical-trials-registry%2FNCT00326807&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-61\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-61\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Kim, Suck Won; Grant, Jon E; Adson, David E; Shin, Young Chul (2001). \"Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling\". <i>Biological Psychiatry</i>. <b>49</b> (11): 914\u201321. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0006-3223%2801%2901079-4\">10.1016/S0006-3223(01)01079-4</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11377409\">11377409</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biological+Psychiatry&amp;rft.atitle=Double-blind+naltrexone+and+placebo+comparison+study+in+the+treatment+of+pathological+gambling&amp;rft.volume=49&amp;rft.issue=11&amp;rft.pages=914-21&amp;rft.date=2001&amp;rft_id=info%3Adoi%2F10.1016%2FS0006-3223%2801%2901079-4&amp;rft_id=info%3Apmid%2F11377409&amp;rft.aulast=Kim&amp;rft.aufirst=Suck+Won&amp;rft.au=Grant%2C+Jon+E&amp;rft.au=Adson%2C+David+E&amp;rft.au=Shin%2C+Young+Chul&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-62\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-62\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Bostwick, J. Michael; Bucci, Jeffrey A. (2008). \"Internet Sex Addiction Treated with Naltrexone\". <i>Mayo Clinic Proceedings</i>. <b>83</b> (2): 226\u201330. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.4065/83.2.226\">10.4065/83.2.226</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18241634\">18241634</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Mayo+Clinic+Proceedings&amp;rft.atitle=Internet+Sex+Addiction+Treated+with+Naltrexone&amp;rft.volume=83&amp;rft.issue=2&amp;rft.pages=226-30&amp;rft.date=2008&amp;rft_id=info%3Adoi%2F10.4065%2F83.2.226&amp;rft_id=info%3Apmid%2F18241634&amp;rft.aulast=Bostwick&amp;rft.aufirst=J.+Michael&amp;rft.au=Bucci%2C+Jeffrey+A.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid16142050-63\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid16142050_63-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Vignau, J.; Karila, L.; Costisella, O.; Canva, V. (2005). \"H\u00e9patite C, Interf\u00e9ron \u03b1 et d\u00e9pression&#160;: Principales hypoth\u00e8ses physiopathologiques\" &#91;Hepatitis C, interferon a and depression: main physiopathologic hypothesis&#93;. <i>L'Enc\u00e9phale</i> (in French). <b>31</b> (3): 349\u201357. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/s0013-7006%2805%2982400-5\">10.1016/s0013-7006(05)82400-5</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/16142050\">16142050</a>. <a href=\"/wiki/Institut_de_l%27information_scientifique_et_technique\" title=\"Institut de l&#39;information scientifique et technique\">INIST</a>:<a rel=\"nofollow\" class=\"external text\" href=\"http://cat.inist.fr/?aModele=afficheN&amp;cpsidt=16920336\">16920336</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=L%27Enc%C3%A9phale&amp;rft.atitle=H%C3%A9patite+C%2C+Interf%C3%A9ron+%CE%B1+et+d%C3%A9pression+%3A+Principales+hypoth%C3%A8ses+physiopathologiques&amp;rft.volume=31&amp;rft.issue=3&amp;rft.pages=349-57&amp;rft.date=2005&amp;rft_id=info%3Adoi%2F10.1016%2Fs0013-7006%2805%2982400-5&amp;rft_id=info%3Apmid%2F16142050&amp;rft.aulast=Vignau&amp;rft.aufirst=J.&amp;rft.au=Karila%2C+L.&amp;rft.au=Costisella%2C+O.&amp;rft.au=Canva%2C+V.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid17068950-64\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid17068950_64-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Ma\u0142yszczak, Krzysztof; Inglot, Ma\u0142gorzata; Paw\u0142owski, Tomasz; Czarnecki, Marcin; Rymer, Weronika; Kiejna, Andrzej (2006). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.psychiatriapsychoterapia.pl/?a=articles_show&amp;id=459\">\"Objawy neuropsychiatryczne w trakcie leczenia interferonem alfa\"</a> &#91;Neuropsychiatric symptoms related to interferon alpha&#93;. <i>Psychiatria polska</i> (in Polish). <b>40</b> (4): 787\u201397. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/17068950\">17068950</a>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20170202010519/http://www.psychiatriapsychoterapia.pl/?a=articles_show&amp;id=459\">Archived</a> from the original on 2017-02-02.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Psychiatria+polska&amp;rft.atitle=Objawy+neuropsychiatryczne+w+trakcie+leczenia+interferonem+alfa&amp;rft.volume=40&amp;rft.issue=4&amp;rft.pages=787-97&amp;rft.date=2006&amp;rft_id=info%3Apmid%2F17068950&amp;rft.aulast=Ma%C5%82yszczak&amp;rft.aufirst=Krzysztof&amp;rft.au=Inglot%2C+Ma%C5%82gorzata&amp;rft.au=Paw%C5%82owski%2C+Tomasz&amp;rft.au=Czarnecki%2C+Marcin&amp;rft.au=Rymer%2C+Weronika&amp;rft.au=Kiejna%2C+Andrzej&amp;rft_id=http%3A%2F%2Fwww.psychiatriapsychoterapia.pl%2F%3Fa%3Darticles_show%26id%3D459&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANaltrexone\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div>\n<div role=\"navigation\" class=\"navbox\" aria-labelledby=\"Treatment_of_drug_dependence_(N07B)\" style=\"padding:3px\"><table class=\"nowraplinks collapsible autocollapse navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\"><div class=\"plainlinks hlist navbar mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:Dependence_treatment\" title=\"Template:Dependence treatment\"><abbr title=\"View this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:Dependence_treatment\" title=\"Template talk:Dependence treatment\"><abbr title=\"Discuss this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Template:Dependence_treatment&amp;action=edit\"><abbr title=\"Edit this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">e</abbr></a></li></ul></div><div id=\"Treatment_of_drug_dependence_(N07B)\" style=\"font-size:114%;margin:0 4em\">Treatment of <a href=\"/wiki/Substance_dependence\" title=\"Substance dependence\">drug dependence</a> (<a href=\"/wiki/ATC_code_N07#N07B\" title=\"ATC code N07\">N07B</a>)</div></th></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Nicotine_dependence\" title=\"Nicotine dependence\">Nicotine dependence</a></th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Bupropion\" title=\"Bupropion\">Bupropion</a></li>\n<li><a href=\"/wiki/Cytisine\" title=\"Cytisine\">Cytisine</a></li>\n<li><a href=\"/wiki/Lobeline\" title=\"Lobeline\">Lobeline</a></li>\n<li><a href=\"/wiki/Mecamylamine\" title=\"Mecamylamine\">Mecamylamine</a></li>\n<li><a href=\"/wiki/Varenicline\" title=\"Varenicline\">Varenicline</a></li>\n<li><i><a href=\"/wiki/Adrenergic_agonist\" title=\"Adrenergic agonist\"><abbr title=\"Adrenergic agonist\">AA</abbr></a></i> (<a href=\"/wiki/Clonidine\" title=\"Clonidine\">Clonidine</a>)</li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Alcohol_dependence\" title=\"Alcohol dependence\">Alcohol dependence</a></th><td class=\"navbox-list navbox-even hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><i><a href=\"/wiki/Acetaldehyde_dehydrogenase_inhibitor\" class=\"mw-redirect\" title=\"Acetaldehyde dehydrogenase inhibitor\"><abbr title=\"Acetaldehyde dehydrogenase\">AD</abbr> inhibitor</a></i> (<a href=\"/wiki/Disulfiram\" title=\"Disulfiram\">Disulfiram</a></li>\n<li><a href=\"/wiki/Calcium_carbimide\" title=\"Calcium carbimide\">Calcium carbimide</a></li>\n<li><a href=\"/wiki/Hydrogen_cyanamide\" class=\"mw-redirect\" title=\"Hydrogen cyanamide\">Hydrogen cyanamide</a>)</li>\n<li><a href=\"/wiki/Acamprosate\" title=\"Acamprosate\">Acamprosate</a></li>\n<li><i><a href=\"/wiki/Opioid_antagonist\" title=\"Opioid antagonist\">Opioid antagonists</a></i> (<a class=\"mw-selflink selflink\">Naltrexone</a></li>\n<li><a href=\"/wiki/Nalmefene\" title=\"Nalmefene\">Nalmefene</a>)</li>\n<li><a href=\"/wiki/Topiramate\" title=\"Topiramate\">Topiramate</a></li>\n<li><i><a href=\"/wiki/Adrenergic_agonist\" title=\"Adrenergic agonist\"><abbr title=\"Adrenergic agonist\">AA</abbr></a></i> (<a href=\"/wiki/Clonidine\" title=\"Clonidine\">Clonidine</a>)</li>\n<li><a href=\"/wiki/Baclofen\" title=\"Baclofen\">Baclofen</a></li>\n<li><a href=\"/wiki/Metadoxine\" title=\"Metadoxine\">Metadoxine</a></li>\n<li><a href=\"/wiki/Phenibut\" title=\"Phenibut\">Phenibut</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Opioid_dependence\" class=\"mw-redirect\" title=\"Opioid dependence\">Opioid dependence</a></th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><i><a href=\"/wiki/Adrenergic_agonist\" title=\"Adrenergic agonist\"><abbr title=\"Adrenergic agonist\">AA</abbr></a></i> (<a href=\"/wiki/Clonidine\" title=\"Clonidine\">Clonidine</a></li>\n<li><a href=\"/wiki/Lofexidine\" title=\"Lofexidine\">Lofexidine</a>)</li>\n<li><a href=\"/wiki/Ibogaine\" title=\"Ibogaine\">Ibogaine</a></li>\n<li><i><a href=\"/wiki/Opioid\" title=\"Opioid\">Opioids</a></i>\n<ul><li><a href=\"/wiki/Buprenorphine\" title=\"Buprenorphine\">Buprenorphine</a> (<a href=\"/wiki/Buprenorphine/naloxone\" title=\"Buprenorphine/naloxone\">+naloxone</a>)</li>\n<li><a href=\"/wiki/Levacetylmethadol\" title=\"Levacetylmethadol\">Levacetylmethadol</a></li>\n<li><a href=\"/wiki/Methadone\" title=\"Methadone\">Methadone</a></li>\n<li><a href=\"/wiki/Dihydrocodeine\" title=\"Dihydrocodeine\">Dihydrocodeine</a></li>\n<li><a href=\"/wiki/Dihydroetorphine\" title=\"Dihydroetorphine\">Dihydroetorphine</a></li>\n<li><a href=\"/wiki/Hydromorphone\" title=\"Hydromorphone\">Hydromorphone (extended-release)</a></li>\n<li><a href=\"/wiki/Morphine\" title=\"Morphine\">Morphine (extended-release)</a></li></ul></li>\n<li><i><a href=\"/wiki/Opioid_antagonist\" title=\"Opioid antagonist\">Opioid antagonists</a></i> (<a class=\"mw-selflink selflink\">Naltrexone</a></li>\n<li><a href=\"/wiki/Nalmefene\" title=\"Nalmefene\">Nalmefene</a>)</li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Benzodiazepine_dependence\" title=\"Benzodiazepine dependence\">Benzodiazepine dependence</a></th><td class=\"navbox-list navbox-even hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><i><a href=\"/wiki/Adrenergic_agonist\" title=\"Adrenergic agonist\"><abbr title=\"Adrenergic agonist\">AA</abbr></a></i> (<a href=\"/wiki/Clonidine\" title=\"Clonidine\">Clonidine</a>)</li>\n<li><i><a href=\"/wiki/Benzodiazepine\" title=\"Benzodiazepine\">Benzodiazepines</a></i> (<a href=\"/wiki/Diazepam\" title=\"Diazepam\">Diazepam</a></li>\n<li><a href=\"/wiki/Lorazepam\" title=\"Lorazepam\">Lorazepam</a></li>\n<li><a href=\"/wiki/Chlordiazepoxide\" title=\"Chlordiazepoxide\">Chlordiazepoxide</a></li>\n<li><a href=\"/wiki/Oxazepam\" title=\"Oxazepam\">Oxazepam</a>)</li>\n<li><i><a href=\"/wiki/Barbiturate\" title=\"Barbiturate\">Barbiturates</a></i> (<a href=\"/wiki/Phenobarbital\" title=\"Phenobarbital\">Phenobarbital</a>)</li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Research</th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"><i><a href=\"/wiki/Salvia_divinorum\" title=\"Salvia divinorum\">Salvia divinorum</a></i></div></td></tr></tbody></table></div>\n<div role=\"navigation\" class=\"navbox\" aria-labelledby=\"Opioid_receptor_modulators\" style=\"padding:3px\"><table class=\"nowraplinks collapsible collapsed navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\"><div class=\"plainlinks hlist navbar mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:Opioid_receptor_modulators\" title=\"Template:Opioid receptor modulators\"><abbr title=\"View this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:Opioid_receptor_modulators\" title=\"Template talk:Opioid receptor modulators\"><abbr title=\"Discuss this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Template:Opioid_receptor_modulators&amp;action=edit\"><abbr title=\"Edit this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">e</abbr></a></li></ul></div><div id=\"Opioid_receptor_modulators\" style=\"font-size:114%;margin:0 4em\"><a href=\"/wiki/Opioid_receptor\" title=\"Opioid receptor\">Opioid receptor</a> <a href=\"/wiki/Receptor_modulator\" title=\"Receptor modulator\">modulators</a></div></th></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align:center;\"><a href=\"/wiki/%CE%9C-opioid_receptor\" title=\"\u039c-opioid receptor\"><abbr title=\"\u03bc-opioid receptor\">MOR</abbr></a></th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><b>Agonists</b> <i>(abridged; see <a href=\"/wiki/List_of_opioids\" title=\"List of opioids\">here</a> for a full list)</i><b>:</b> <a href=\"/wiki/3-HO-PCP\" title=\"3-HO-PCP\">3-HO-PCP</a></li>\n<li><a href=\"/w/index.php?title=7-Acetoxymitragynine&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"7-Acetoxymitragynine (page does not exist)\">7-Acetoxymitragynine</a></li>\n<li><a href=\"/wiki/7-Hydroxymitragynine\" title=\"7-Hydroxymitragynine\">7-Hydroxymitragynine</a></li>\n<li><a href=\"/w/index.php?title=%CE%A8-Akuammigine&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"\u03a8-Akuammigine (page does not exist)\">\u03c8-Akuammigine</a></li>\n<li><a href=\"/wiki/%CE%91-Chlornaltrexamine\" class=\"mw-redirect\" title=\"\u0391-Chlornaltrexamine\">\u03b1-Chlornaltrexamine</a></li>\n<li><a href=\"/w/index.php?title=Alpha-Narcotine&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Alpha-Narcotine (page does not exist)\">\u03b1-Narcotine</a></li>\n<li><a href=\"/wiki/Acetyldihydrocodeine\" title=\"Acetyldihydrocodeine\">Acetyldihydrocodeine</a></li>\n<li><a href=\"/wiki/Acetylfentanyl\" title=\"Acetylfentanyl\">Acetylfentanyl</a></li>\n<li><a href=\"/wiki/Acrylfentanyl\" title=\"Acrylfentanyl\">Acrylfentanyl</a></li>\n<li><a href=\"/wiki/Adrenorphin\" title=\"Adrenorphin\">Adrenorphin (metorphamide)</a></li>\n<li><a href=\"/wiki/AH-7921\" title=\"AH-7921\">AH-7921</a></li>\n<li><a href=\"/wiki/Akuammicine\" title=\"Akuammicine\">Akuammicine</a></li>\n<li><a href=\"/w/index.php?title=Akuammidine&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Akuammidine (page does not exist)\">Akuammidine</a></li>\n<li><a href=\"/wiki/Alfentanil\" title=\"Alfentanil\">Alfentanil</a></li>\n<li><a href=\"/wiki/Anileridine\" title=\"Anileridine\">Anileridine</a></li>\n<li><a href=\"/wiki/Apparicine\" title=\"Apparicine\">Apparicine</a></li>\n<li><a href=\"/wiki/%CE%92-Endorphin\" class=\"mw-redirect\" title=\"\u0392-Endorphin\">\u03b2-Endorphin</a></li>\n<li><a href=\"/w/index.php?title=Bovine_adrenal_medullary_peptide-12P&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Bovine adrenal medullary peptide-12P (page does not exist)\">BAM-12P</a></li>\n<li><a href=\"/w/index.php?title=Bovine_adrenal_medullary_peptide-18P&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Bovine adrenal medullary peptide-18P (page does not exist)\">BAM-18P</a></li>\n<li><a href=\"/w/index.php?title=Bovine_adrenal_medullary_peptide-22P&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Bovine adrenal medullary peptide-22P (page does not exist)\">BAM-22P</a></li>\n<li><a href=\"/wiki/Benzhydrocodone\" title=\"Benzhydrocodone\">Benzhydrocodone</a></li>\n<li><a href=\"/wiki/Benzylmorphine\" title=\"Benzylmorphine\">Benzylmorphine</a></li>\n<li><a href=\"/wiki/Bezitramide\" title=\"Bezitramide\">Bezitramide</a></li>\n<li><a href=\"/wiki/Biphalin\" title=\"Biphalin\">Biphalin</a></li>\n<li><a href=\"/w/index.php?title=BU08070&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"BU08070 (page does not exist)\">BU08070</a></li>\n<li><a href=\"/wiki/Buprenorphine\" title=\"Buprenorphine\">Buprenorphine</a></li>\n<li><a href=\"/w/index.php?title=Butorphan&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Butorphan (page does not exist)\">Butorphan</a></li>\n<li><a href=\"/wiki/Butorphanol\" title=\"Butorphanol\">Butorphanol</a></li>\n<li><a href=\"/wiki/Butyrfentanyl\" title=\"Butyrfentanyl\">Butyrfentanyl</a></li>\n<li><a href=\"/wiki/BW-373U86\" class=\"mw-redirect\" title=\"BW-373U86\">BW-373U86</a></li>\n<li><a href=\"/wiki/Carfentanil\" title=\"Carfentanil\">Carfentanil</a></li>\n<li><a href=\"/wiki/Casokefamide\" title=\"Casokefamide\">Casokefamide</a></li>\n<li><a href=\"/wiki/Cebranopadol\" title=\"Cebranopadol\">Cebranopadol</a></li>\n<li><a href=\"/wiki/Chloroxymorphamine\" title=\"Chloroxymorphamine\">Chloroxymorphamine</a></li>\n<li><a href=\"/wiki/Codeine\" title=\"Codeine\">Codeine</a></li>\n<li><a href=\"/wiki/DADLE\" title=\"DADLE\">DADLE</a></li>\n<li><a href=\"/wiki/DAMGO\" title=\"DAMGO\">DAMGO (DAGO)</a></li>\n<li><a href=\"/wiki/Dermorphin\" title=\"Dermorphin\">Dermorphin</a></li>\n<li><a href=\"/wiki/Desmetramadol\" title=\"Desmetramadol\">Desmetramadol (desmethyltramadol)</a></li>\n<li><a href=\"/wiki/Desomorphine\" title=\"Desomorphine\">Desomorphine</a></li>\n<li><a href=\"/wiki/Dextromoramide\" title=\"Dextromoramide\">Dextromoramide</a></li>\n<li><a href=\"/wiki/Dextropropoxyphene\" title=\"Dextropropoxyphene\">Dextropropoxyphene (propoxyphene)</a></li>\n<li><a href=\"/wiki/Dezocine\" title=\"Dezocine\">Dezocine</a></li>\n<li><a href=\"/wiki/Dimenoxadol\" title=\"Dimenoxadol\">Dimenoxadol</a></li>\n<li><a href=\"/wiki/Dimethylaminopivalophenone\" title=\"Dimethylaminopivalophenone\">Dimethylaminopivalophenone</a></li>\n<li><a href=\"/wiki/Eluxadoline\" title=\"Eluxadoline\">Eluxadoline</a></li>\n<li><a href=\"/wiki/Heroin\" title=\"Heroin\">Diamorphine (heroin)</a></li>\n<li><a href=\"/wiki/Dihydrocodeine\" title=\"Dihydrocodeine\">Dihydrocodeine</a></li>\n<li><a href=\"/wiki/Dihydroetorphine\" title=\"Dihydroetorphine\">Dihydroetorphine</a></li>\n<li><a href=\"/wiki/Dihydromorphine\" title=\"Dihydromorphine\">Dihydromorphine</a></li>\n<li><a href=\"/wiki/Dinalbuphine_sebacate\" title=\"Dinalbuphine sebacate\">Dinalbuphine sebacate</a></li>\n<li><a href=\"/wiki/Diphenoxylate\" title=\"Diphenoxylate\">Diphenoxylate</a></li>\n<li><a href=\"/wiki/Dipipanone\" title=\"Dipipanone\">Dipipanone</a></li>\n<li><a href=\"/wiki/Dynorphin_A\" title=\"Dynorphin A\">Dynorphin A</a></li>\n<li><a href=\"/wiki/Embutramide\" title=\"Embutramide\">Embutramide</a></li>\n<li><a href=\"/wiki/Endomorphin-1\" title=\"Endomorphin-1\">Endomorphin-1</a></li>\n<li><a href=\"/wiki/Endomorphin-2\" title=\"Endomorphin-2\">Endomorphin-2</a></li>\n<li><a href=\"/wiki/Eseroline\" title=\"Eseroline\">Eseroline</a></li>\n<li><a href=\"/wiki/Ethylmorphine\" title=\"Ethylmorphine\">Ethylmorphine</a></li>\n<li><a href=\"/wiki/Etorphine\" title=\"Etorphine\">Etorphine</a></li>\n<li><a href=\"/wiki/Fentanyl\" title=\"Fentanyl\">Fentanyl</a></li>\n<li><a href=\"/wiki/Fluorophen\" title=\"Fluorophen\">Fluorophen</a></li>\n<li><a href=\"/wiki/Frakefamide\" title=\"Frakefamide\">Frakefamide</a></li>\n<li><a href=\"/wiki/Furanylfentanyl\" title=\"Furanylfentanyl\">Furanylfentanyl</a></li>\n<li><a href=\"/wiki/Hemorphin-4\" title=\"Hemorphin-4\">Hemorphin-4</a></li>\n<li><a href=\"/wiki/Herkinorin\" title=\"Herkinorin\">Herkinorin</a></li>\n<li><a href=\"/wiki/Hodgkinsine\" title=\"Hodgkinsine\">Hodgkinsine</a></li>\n<li><a href=\"/wiki/Hydrocodone\" title=\"Hydrocodone\">Hydrocodone</a></li>\n<li><a href=\"/wiki/Hydromorphinol\" title=\"Hydromorphinol\">Hydromorphinol</a></li>\n<li><a href=\"/wiki/Hydromorphone\" title=\"Hydromorphone\">Hydromorphone</a></li>\n<li><a href=\"/wiki/IBNtxA\" title=\"IBNtxA\">IBNtxA</a></li>\n<li><a href=\"/wiki/Ketamine\" title=\"Ketamine\">Ketamine</a></li>\n<li><a href=\"/wiki/Ketobemidone\" title=\"Ketobemidone\">Ketobemidone</a></li>\n<li><a href=\"/wiki/Mitragyna_speciosa\" title=\"Mitragyna speciosa\">Kratom</a></li>\n<li><a href=\"/wiki/Laudanosine\" title=\"Laudanosine\">Laudanosine</a></li>\n<li><a href=\"/wiki/Lefetamine\" title=\"Lefetamine\">Lefetamine</a></li>\n<li><a href=\"/wiki/Leu-enkephalin\" title=\"Leu-enkephalin\">Leu-enkephalin</a></li>\n<li><a href=\"/wiki/Levacetylmethadol\" title=\"Levacetylmethadol\">Levacetylmethadol</a></li>\n<li><a href=\"/wiki/Levomethorphan\" title=\"Levomethorphan\">Levomethorphan</a></li>\n<li><a href=\"/wiki/Levorphanol\" title=\"Levorphanol\">Levorphanol</a></li>\n<li><a href=\"/w/index.php?title=Lexanopadol&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Lexanopadol (page does not exist)\">Lexanopadol</a></li>\n<li><a href=\"/wiki/Loperamide\" title=\"Loperamide\">Loperamide</a></li>\n<li><a href=\"/w/index.php?title=Loxicodegol&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Loxicodegol (page does not exist)\">Loxicodegol</a></li>\n<li><a href=\"/wiki/Matrine\" title=\"Matrine\">Matrine</a></li>\n<li><a href=\"/wiki/Meptazinol\" title=\"Meptazinol\">Meptazinol</a></li>\n<li><a href=\"/wiki/Met-enkephalin\" title=\"Met-enkephalin\">Met-enkephalin (metenkefalin)</a></li>\n<li><a href=\"/wiki/Methadone\" title=\"Methadone\">Methadone</a></li>\n<li><a href=\"/wiki/Metkefamide\" title=\"Metkefamide\">Metkefamide</a></li>\n<li><a href=\"/wiki/Metopon\" title=\"Metopon\">Metopon</a></li>\n<li><a href=\"/wiki/Mitragynine\" title=\"Mitragynine\">Mitragynine</a></li>\n<li><a href=\"/wiki/Mitragynine_pseudoindoxyl\" title=\"Mitragynine pseudoindoxyl\">Mitragynine pseudoindoxyl</a></li>\n<li><a href=\"/wiki/Morphiceptin\" title=\"Morphiceptin\">Morphiceptin</a></li>\n<li><a href=\"/wiki/Morphine\" title=\"Morphine\">Morphine</a></li>\n<li><a href=\"/wiki/Nalbuphine\" title=\"Nalbuphine\">Nalbuphine</a></li>\n<li><a href=\"/w/index.php?title=Naloxone_benzoylhydrazone&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Naloxone benzoylhydrazone (page does not exist)\">NalBzOH</a></li>\n<li><a href=\"/wiki/Nalmexone\" title=\"Nalmexone\">Nalmexone</a></li>\n<li><a href=\"/wiki/Naltalimide\" title=\"Naltalimide\">Naltalimide</a></li>\n<li><a href=\"/w/index.php?title=Neopine&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Neopine (page does not exist)\">Neopine</a></li>\n<li><a href=\"/wiki/NFEPP\" title=\"NFEPP\">NFEPP</a></li>\n<li><a href=\"/wiki/Nicocodeine\" title=\"Nicocodeine\">Nicocodeine</a></li>\n<li><a href=\"/wiki/Nicodicodeine\" title=\"Nicodicodeine\">Nicodicodeine</a></li>\n<li><a href=\"/wiki/Nicomorphine\" title=\"Nicomorphine\">Nicomorphine</a></li>\n<li><a href=\"/w/index.php?title=NKTR-181&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"NKTR-181 (page does not exist)\">NKTR-181</a></li>\n<li><a href=\"/wiki/Norketamine\" title=\"Norketamine\">Norketamine</a></li>\n<li><a href=\"/wiki/Octreotide\" title=\"Octreotide\">Octreotide</a></li>\n<li><a href=\"/wiki/Oliceridine\" title=\"Oliceridine\">Oliceridine</a></li>\n<li><a href=\"/wiki/Oxymorphone-3-methoxynaltrexonazine\" title=\"Oxymorphone-3-methoxynaltrexonazine\">OM-3-MNZ</a></li>\n<li><a href=\"/wiki/Oripavine\" title=\"Oripavine\">Oripavine</a></li>\n<li><a href=\"/wiki/Oxycodone\" title=\"Oxycodone\">Oxycodone</a></li>\n<li><a href=\"/wiki/Oxymorphazone\" title=\"Oxymorphazone\">Oxymorphazone</a></li>\n<li><a href=\"/w/index.php?title=Oxymorphonazine&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Oxymorphonazine (page does not exist)\">Oxymorphonazine</a></li>\n<li><a href=\"/wiki/Oxymorphone\" title=\"Oxymorphone\">Oxymorphone</a></li>\n<li><a href=\"/w/index.php?title=Oxymorphone_phenylhydrazone&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Oxymorphone phenylhydrazone (page does not exist)\">Oxymorphone phenylhydrazone</a></li>\n<li><a href=\"/w/index.php?title=Oxymorphone_p-nitrophenylhydrazone&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Oxymorphone p-nitrophenylhydrazone (page does not exist)\">OxyPNPH</a></li>\n<li><i><a href=\"/wiki/Papaver_somniferum\" title=\"Papaver somniferum\">Papaver somniferum</a></i> (<a href=\"/wiki/Opium\" title=\"Opium\">opium</a>)</li>\n<li><a href=\"/wiki/Pentazocine\" title=\"Pentazocine\">Pentazocine</a></li>\n<li><a href=\"/wiki/Pericine\" title=\"Pericine\">Pericine</a></li>\n<li><a href=\"/wiki/Pethidine\" title=\"Pethidine\">Pethidine (meperidine)</a></li>\n<li><a href=\"/wiki/Phenazocine\" title=\"Phenazocine\">Phenazocine</a></li>\n<li><a href=\"/wiki/Phencyclidine\" title=\"Phencyclidine\">Phencyclidine</a></li>\n<li><a href=\"/wiki/Piminodine\" title=\"Piminodine\">Piminodine</a></li>\n<li><a href=\"/wiki/Piritramide\" title=\"Piritramide\">Piritramide</a></li>\n<li><a href=\"/w/index.php?title=PL-017&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"PL-017 (page does not exist)\">PL-017</a></li>\n<li><a href=\"/wiki/Prodine\" title=\"Prodine\">Prodine</a></li>\n<li><a href=\"/wiki/Propiram\" title=\"Propiram\">Propiram</a></li>\n<li><a href=\"/wiki/PZM21\" title=\"PZM21\">PZM21</a></li>\n<li><a href=\"/wiki/Racemethorphan\" class=\"mw-redirect\" title=\"Racemethorphan\">Racemethorphan</a></li>\n<li><a href=\"/wiki/Racemorphan\" title=\"Racemorphan\">Racemorphan</a></li>\n<li><a href=\"/wiki/Remifentanil\" title=\"Remifentanil\">Remifentanil</a></li>\n<li><a href=\"/w/index.php?title=Salsolinol&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Salsolinol (page does not exist)\">Salsolinol</a></li>\n<li><a href=\"/wiki/SC-17599\" title=\"SC-17599\">SC-17599</a></li>\n<li><a href=\"/wiki/Sinomenine\" title=\"Sinomenine\">Sinomenine</a></li>\n<li><a href=\"/wiki/Sufentanil\" title=\"Sufentanil\">Sufentanil</a></li>\n<li><a href=\"/wiki/Tapentadol\" title=\"Tapentadol\">Tapentadol</a></li>\n<li><a href=\"/wiki/Tetrahydropapaveroline\" title=\"Tetrahydropapaveroline\">Tetrahydropapaveroline</a></li>\n<li><a href=\"/w/index.php?title=TH-030418&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"TH-030418 (page does not exist)\">TH-030418</a></li>\n<li><a href=\"/wiki/Thebaine\" title=\"Thebaine\">Thebaine</a></li>\n<li><a href=\"/wiki/Thienorphine\" title=\"Thienorphine\">Thienorphine</a></li>\n<li><a href=\"/wiki/Tianeptine\" title=\"Tianeptine\">Tianeptine</a></li>\n<li><a href=\"/wiki/Tilidine\" title=\"Tilidine\">Tilidine</a></li>\n<li><a href=\"/wiki/Tramadol\" title=\"Tramadol\">Tramadol</a></li>\n<li><a href=\"/wiki/Trimebutine\" title=\"Trimebutine\">Trimebutine</a></li>\n<li><a href=\"/wiki/TRIMU_5\" title=\"TRIMU 5\">TRIMU 5</a></li>\n<li><a href=\"/w/index.php?title=TRV734&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"TRV734 (page does not exist)\">TRV734</a></li>\n<li><a href=\"/w/index.php?title=Tubotaiwine&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Tubotaiwine (page does not exist)\">Tubotaiwine</a></li>\n<li><a href=\"/wiki/U-47700\" title=\"U-47700\">U-47700</a></li>\n<li><a href=\"/wiki/Valorphin\" title=\"Valorphin\">Valorphin</a></li>\n<li><a href=\"/wiki/Viminol\" title=\"Viminol\">Viminol</a></li>\n<li><a href=\"/wiki/Xorphanol\" title=\"Xorphanol\">Xorphanol</a></li></ul>\n<ul><li><b>PAMs:</b> <a href=\"/w/index.php?title=BMS-986121&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"BMS-986121 (page does not exist)\">BMS-986121</a></li>\n<li><a href=\"/w/index.php?title=BMS-986122&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"BMS-986122 (page does not exist)\">BMS-986122</a></li></ul>\n<ul><li><b>Antagonists:</b> <a href=\"/wiki/Picenadol\" title=\"Picenadol\">(3S,4S)-Picenadol</a></li>\n<li><a href=\"/wiki/Viminol\" title=\"Viminol\">2-(S)-N,N-(R)-Viminol</a></li>\n<li><a href=\"/w/index.php?title=3CS-nalmefene&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"3CS-nalmefene (page does not exist)\">3CS-nalmefene</a></li>\n<li><a href=\"/wiki/4-Caffeoyl-1,5-quinide\" title=\"4-Caffeoyl-1,5-quinide\">4-Caffeoyl-1,5-quinide</a></li>\n<li><a href=\"/w/index.php?title=4%E2%80%B2-Hydroxyflavanone&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"4\u2032-Hydroxyflavanone (page does not exist)\">4\u2032-Hydroxyflavanone</a></li>\n<li><a href=\"/wiki/4%27,7-Dihydroxyflavone\" title=\"4&#39;,7-Dihydroxyflavone\">4',7-Dihydroxyflavone</a></li>\n<li><a href=\"/wiki/6%CE%B2-Naltrexol\" title=\"6\u03b2-Naltrexol\">6\u03b2-Naltrexol</a></li>\n<li><a href=\"/wiki/6%CE%B2-Naltrexol-d4\" title=\"6\u03b2-Naltrexol-d4\">6\u03b2-Naltrexol-d4</a></li>\n<li><a href=\"/wiki/18-Methoxycoronaridine\" title=\"18-Methoxycoronaridine\">18-MC</a></li>\n<li><a href=\"/w/index.php?title=Alpha-Gliadin&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Alpha-Gliadin (page does not exist)\">\u03b1-Gliadin</a></li>\n<li><a href=\"/wiki/%CE%92-Chlornaltrexamine\" class=\"mw-redirect\" title=\"\u0392-Chlornaltrexamine\">\u03b2-Chlornaltrexamine</a></li>\n<li><a href=\"/wiki/Beta-Funaltrexamine\" title=\"Beta-Funaltrexamine\">\u03b2-Funaltrexamine</a></li>\n<li><a href=\"/wiki/Akuammine\" title=\"Akuammine\">Akuammine</a></li>\n<li><a href=\"/wiki/Alvimopan\" title=\"Alvimopan\">Alvimopan</a></li>\n<li><a href=\"/wiki/AM251\" class=\"mw-redirect\" title=\"AM251\">AM-251</a></li>\n<li><a href=\"/wiki/Apigenin\" title=\"Apigenin\">Apigenin</a></li>\n<li><a href=\"/wiki/AT-076\" title=\"AT-076\">AT-076</a></li>\n<li><a href=\"/wiki/Axelopran\" title=\"Axelopran\">Axelopran</a></li>\n<li><a href=\"/wiki/Bevenopran\" title=\"Bevenopran\">Bevenopran</a></li>\n<li><a href=\"/wiki/Catechin\" title=\"Catechin\">Catechin</a></li>\n<li><a href=\"/wiki/Catechin_gallate\" class=\"mw-redirect\" title=\"Catechin gallate\">Catechin gallate</a></li>\n<li><a href=\"/wiki/Clocinnamox\" title=\"Clocinnamox\">Clocinnamox</a></li>\n<li><a href=\"/w/index.php?title=CTAP&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"CTAP (page does not exist)\">CTAP</a></li>\n<li><a href=\"/w/index.php?title=CTOP&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"CTOP (page does not exist)\">CTOP</a></li>\n<li><a href=\"/w/index.php?title=Cyclofoxy&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Cyclofoxy (page does not exist)\">Cyclofoxy</a></li>\n<li><a href=\"/wiki/Cyprodime\" title=\"Cyprodime\">Cyprodime</a></li>\n<li><a href=\"/wiki/Diacetylnalorphine\" title=\"Diacetylnalorphine\">Diacetylnalorphine</a></li>\n<li><a href=\"/wiki/Diprenorphine\" title=\"Diprenorphine\">Diprenorphine</a></li>\n<li><a href=\"/wiki/Epicatechin_gallate\" title=\"Epicatechin gallate\">ECG</a></li>\n<li><a href=\"/wiki/Epigallocatechin\" class=\"mw-redirect\" title=\"Epigallocatechin\">EGC</a></li>\n<li><a href=\"/wiki/Epicatechin\" class=\"mw-redirect\" title=\"Epicatechin\">Epicatechin</a></li>\n<li><a href=\"/wiki/Eptazocine\" title=\"Eptazocine\">Eptazocine</a></li>\n<li><a href=\"/wiki/Gemazocine\" title=\"Gemazocine\">Gemazocine</a></li>\n<li><a href=\"/w/index.php?title=Ginsenoside_R&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Ginsenoside R (page does not exist)\">Ginsenoside R</a></li>\n<li><a href=\"/wiki/Hyperoside\" title=\"Hyperoside\">Hyperoside</a></li>\n<li><a href=\"/wiki/Ibogaine\" title=\"Ibogaine\">Ibogaine</a></li>\n<li><a href=\"/wiki/Levallorphan\" title=\"Levallorphan\">Levallorphan</a></li>\n<li><a href=\"/wiki/Lobeline\" title=\"Lobeline\">Lobeline</a></li>\n<li><a href=\"/wiki/LY-255582\" title=\"LY-255582\">LY-255582</a></li>\n<li><a href=\"/w/index.php?title=LY-2196044&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"LY-2196044 (page does not exist)\">LY-2196044</a></li>\n<li><a href=\"/w/index.php?title=Methocinnamox&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Methocinnamox (page does not exist)\">Methocinnamox</a></li>\n<li><a href=\"/wiki/Methylnaltrexone\" title=\"Methylnaltrexone\">Methylnaltrexone</a></li>\n<li><a href=\"/w/index.php?title=Methylsamidorphan_chloride&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Methylsamidorphan chloride (page does not exist)\">Methylsamidorphan chloride</a></li>\n<li><a href=\"/wiki/Naldemedine\" title=\"Naldemedine\">Naldemedine</a></li>\n<li><a href=\"/wiki/Nalmefene\" title=\"Nalmefene\">Nalmefene</a></li>\n<li><a href=\"/wiki/Nalodeine\" title=\"Nalodeine\">Nalodeine (N-allylnorcodeine)</a></li>\n<li><a href=\"/wiki/Nalorphine\" title=\"Nalorphine\">Nalorphine</a></li>\n<li><a href=\"/wiki/Nalorphine_dinicotinate\" title=\"Nalorphine dinicotinate\">Nalorphine dinicotinate</a></li>\n<li><a href=\"/wiki/Naloxazone\" title=\"Naloxazone\">Naloxazone</a></li>\n<li><a href=\"/wiki/Naloxegol\" title=\"Naloxegol\">Naloxegol</a></li>\n<li><a href=\"/wiki/Naloxol\" title=\"Naloxol\">Naloxol</a></li>\n<li><a href=\"/wiki/Naloxonazine\" title=\"Naloxonazine\">Naloxonazine</a></li>\n<li><a href=\"/wiki/Naloxone\" title=\"Naloxone\">Naloxone</a></li>\n<li><a href=\"/w/index.php?title=Naltrexazone&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Naltrexazone (page does not exist)\">Naltrexazone</a></li>\n<li><a href=\"/w/index.php?title=Naltrexonazine&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Naltrexonazine (page does not exist)\">Naltrexonazine</a></li>\n<li><a class=\"mw-selflink selflink\">Naltrexone</a></li>\n<li><a href=\"/wiki/Naltrindole\" title=\"Naltrindole\">Naltrindole</a></li>\n<li><a href=\"/wiki/Naringenin\" title=\"Naringenin\">Naringenin</a></li>\n<li><a href=\"/wiki/Noribogaine\" title=\"Noribogaine\">Noribogaine</a></li>\n<li><a href=\"/wiki/Oxilorphan\" title=\"Oxilorphan\">Oxilorphan</a></li>\n<li><a href=\"/wiki/Pawhuskin_A\" title=\"Pawhuskin A\">Pawhuskin A</a></li>\n<li><a href=\"/wiki/Rimonabant\" title=\"Rimonabant\">Rimonabant</a></li>\n<li><a href=\"/wiki/Quadazocine\" title=\"Quadazocine\">Quadazocine</a></li>\n<li><a href=\"/wiki/Samidorphan\" title=\"Samidorphan\">Samidorphan</a></li>\n<li><a href=\"/wiki/Taxifolin\" title=\"Taxifolin\">Taxifolin</a></li></ul>\n<ul><li><b>Unknown/unsorted:</b> <a href=\"/wiki/Cannabidiol\" title=\"Cannabidiol\">Cannabidiol</a></li>\n<li><a href=\"/wiki/Coronaridine\" title=\"Coronaridine\">Coronaridine</a></li>\n<li><a href=\"/wiki/Cyproterone_acetate\" title=\"Cyproterone acetate\">Cyproterone acetate</a></li>\n<li><a href=\"/w/index.php?title=Dihydroakuuamine&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Dihydroakuuamine (page does not exist)\">Dihydroakuuamine</a></li>\n<li><a href=\"/wiki/Tabernanthine\" title=\"Tabernanthine\">Tabernanthine</a></li>\n<li><a href=\"/wiki/Tetrahydrocannabinol\" title=\"Tetrahydrocannabinol\">Tetrahydrocannabinol</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align:center;\"><a href=\"/wiki/%CE%94-opioid_receptor\" title=\"\u0394-opioid receptor\"><abbr title=\"\u03b4-opioid receptor\">DOR</abbr></a></th><td class=\"navbox-list navbox-even hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><b>Agonists:</b> <a href=\"/w/index.php?title=3CS-nalmefene&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"3CS-nalmefene (page does not exist)\">3CS-nalmefene</a></li>\n<li><a href=\"/wiki/6%27-Guanidinonaltrindole\" title=\"6&#39;-Guanidinonaltrindole\">6'-GNTI</a></li>\n<li><a href=\"/wiki/7-Spiroindanyloxymorphone\" title=\"7-Spiroindanyloxymorphone\">7-SIOM</a></li>\n<li><a href=\"/w/index.php?title=ADL-5747&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"ADL-5747 (page does not exist)\">ADL-5747 (PF-04856881)</a></li>\n<li><a href=\"/w/index.php?title=ADL-5859&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"ADL-5859 (page does not exist)\">ADL-5859</a></li>\n<li><a href=\"/wiki/Alazocine\" title=\"Alazocine\">Alazocine (SKF-10047)</a></li>\n<li><a href=\"/wiki/Amoxapine\" title=\"Amoxapine\">Amoxapine</a></li>\n<li><a href=\"/w/index.php?title=AR-M100390&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"AR-M100390 (page does not exist)\">AR-M100390 (ARM390)</a></li>\n<li><a href=\"/w/index.php?title=AZD2327&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"AZD2327 (page does not exist)\">AZD2327</a></li>\n<li><a href=\"/wiki/%CE%92-Endorphin\" class=\"mw-redirect\" title=\"\u0392-Endorphin\">\u03b2-Endorphin</a></li>\n<li><a href=\"/w/index.php?title=Bovine_adrenal_medullary_peptide-18P&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Bovine adrenal medullary peptide-18P (page does not exist)\">BAM-18P</a></li>\n<li><a href=\"/wiki/Biphalin\" title=\"Biphalin\">Biphalin</a></li>\n<li><a href=\"/wiki/BU-48\" title=\"BU-48\">BU-48</a></li>\n<li><a href=\"/w/index.php?title=Butorphan&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Butorphan (page does not exist)\">Butorphan</a></li>\n<li><a href=\"/wiki/Butorphanol\" title=\"Butorphanol\">Butorphanol</a></li>\n<li><a href=\"/wiki/BW-373U86\" class=\"mw-redirect\" title=\"BW-373U86\">BW-373U86</a></li>\n<li><a href=\"/wiki/Casokefamide\" title=\"Casokefamide\">Casokefamide</a></li>\n<li><a href=\"/wiki/Cebranopadol\" title=\"Cebranopadol\">Cebranopadol</a></li>\n<li><a href=\"/wiki/Codeine\" title=\"Codeine\">Codeine</a></li>\n<li><a href=\"/wiki/Cyclazocine\" title=\"Cyclazocine\">Cyclazocine</a></li>\n<li><a href=\"/wiki/DADLE\" title=\"DADLE\">DADLE</a></li>\n<li><a href=\"/wiki/Deltorphin\" title=\"Deltorphin\">Deltorphin A</a></li>\n<li><a href=\"/wiki/Deltorphin_I\" title=\"Deltorphin I\">Deltorphin I</a></li>\n<li><a href=\"/w/index.php?title=Deltorphin_II&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Deltorphin II (page does not exist)\">Deltorphin II</a></li>\n<li><a href=\"/wiki/Desmethylclozapine\" title=\"Desmethylclozapine\">Desmethylclozapine</a></li>\n<li><a href=\"/wiki/Desmetramadol\" title=\"Desmetramadol\">Desmetramadol (desmethyltramadol)</a></li>\n<li><a href=\"/wiki/Dezocine\" title=\"Dezocine\">Dezocine</a></li>\n<li><a href=\"/wiki/Heroin\" title=\"Heroin\">Diamorphine (heroin)</a></li>\n<li><a href=\"/wiki/Dihydroetorphine\" title=\"Dihydroetorphine\">Dihydroetorphine</a></li>\n<li><a href=\"/wiki/Dihydromorphine\" title=\"Dihydromorphine\">Dihydromorphine</a></li>\n<li><a href=\"/wiki/DPDPE\" title=\"DPDPE\">DPDPE</a></li>\n<li><a href=\"/wiki/DPI-221\" title=\"DPI-221\">DPI-221</a></li>\n<li><a href=\"/wiki/DPI-3290\" title=\"DPI-3290\">DPI-3290</a></li>\n<li><a href=\"/w/index.php?title=(D-Ser2,_Leu5,_Thr6)-Enkephalin&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"(D-Ser2, Leu5, Thr6)-Enkephalin (page does not exist)\">DSLET</a></li>\n<li><a href=\"/wiki/Ethylketazocine\" title=\"Ethylketazocine\">Ethylketazocine</a></li>\n<li><a href=\"/wiki/Etorphine\" title=\"Etorphine\">Etorphine</a></li>\n<li><a href=\"/wiki/Fentanyl\" title=\"Fentanyl\">Fentanyl</a></li>\n<li><a href=\"/w/index.php?title=Fentanyl_isothiocyanate&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Fentanyl isothiocyanate (page does not exist)\">FIT</a></li>\n<li><a href=\"/wiki/Fluorophen\" title=\"Fluorophen\">Fluorophen</a></li>\n<li><a href=\"/wiki/Hemorphin-4\" title=\"Hemorphin-4\">Hemorphin-4</a></li>\n<li><a href=\"/wiki/Hydrocodone\" title=\"Hydrocodone\">Hydrocodone</a></li>\n<li><a href=\"/wiki/Hydromorphone\" title=\"Hydromorphone\">Hydromorphone</a></li>\n<li><a href=\"/wiki/Ibogaine\" title=\"Ibogaine\">Ibogaine</a></li>\n<li><a href=\"/wiki/Isomethadone\" title=\"Isomethadone\">Isomethadone</a></li>\n<li><a href=\"/w/index.php?title=JNJ-20788560&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"JNJ-20788560 (page does not exist)\">JNJ-20788560</a></li>\n<li><a href=\"/w/index.php?title=KNT-127&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"KNT-127 (page does not exist)\">KNT-127</a></li>\n<li><a href=\"/wiki/Mitragyna_speciosa\" title=\"Mitragyna speciosa\">Kratom</a></li>\n<li><a href=\"/wiki/Laudanosine\" title=\"Laudanosine\">Laudanosine</a></li>\n<li><a href=\"/wiki/Leu-enkephalin\" title=\"Leu-enkephalin\">Leu-enkephalin</a></li>\n<li><a href=\"/wiki/Levomethorphan\" title=\"Levomethorphan\">Levomethorphan</a></li>\n<li><a href=\"/wiki/Levorphanol\" title=\"Levorphanol\">Levorphanol</a></li>\n<li><a href=\"/w/index.php?title=Lexanopadol&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Lexanopadol (page does not exist)\">Lexanopadol</a></li>\n<li><a href=\"/wiki/Lofentanil\" title=\"Lofentanil\">Lofentanil</a></li>\n<li><a href=\"/wiki/Met-enkephalin\" title=\"Met-enkephalin\">Met-enkephalin (metenkefalin)</a></li>\n<li><a href=\"/wiki/Metazocine\" title=\"Metazocine\">Metazocine</a></li>\n<li><a href=\"/wiki/Metkefamide\" title=\"Metkefamide\">Metkefamide</a></li>\n<li><a href=\"/wiki/Mitragynine\" title=\"Mitragynine\">Mitragynine</a></li>\n<li><a href=\"/wiki/Mitragynine_pseudoindoxyl\" title=\"Mitragynine pseudoindoxyl\">Mitragynine pseudoindoxyl</a></li>\n<li><a href=\"/wiki/Morphine\" title=\"Morphine\">Morphine</a></li>\n<li><a href=\"/wiki/N-Phenethyl-14-ethoxymetopon\" title=\"N-Phenethyl-14-ethoxymetopon\">N-Phenethyl-14-ethoxymetopon</a></li>\n<li><a href=\"/wiki/Norbuprenorphine\" title=\"Norbuprenorphine\">Norbuprenorphine</a></li>\n<li><a href=\"/w/index.php?title=Naloxone_benzoylhydrazone&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Naloxone benzoylhydrazone (page does not exist)\">NalBzOH</a></li>\n<li><a href=\"/wiki/Oripavine\" title=\"Oripavine\">Oripavine</a></li>\n<li><a href=\"/wiki/Oxycodone\" title=\"Oxycodone\">Oxycodone</a></li>\n<li><a href=\"/wiki/Oxymorphone\" title=\"Oxymorphone\">Oxymorphone</a></li>\n<li><a href=\"/wiki/Pethidine\" title=\"Pethidine\">Pethidine (meperidine)</a></li>\n<li><a href=\"/wiki/Proglumide\" title=\"Proglumide\">Proglumide</a></li>\n<li><a href=\"/wiki/Racemethorphan\" class=\"mw-redirect\" title=\"Racemethorphan\">Racemethorphan</a></li>\n<li><a href=\"/wiki/Racemorphan\" title=\"Racemorphan\">Racemorphan</a></li>\n<li><a href=\"/wiki/RWJ-394674\" title=\"RWJ-394674\">RWJ-394674</a></li>\n<li><a href=\"/wiki/Samidorphan\" title=\"Samidorphan\">Samidorphan</a></li>\n<li><a href=\"/w/index.php?title=SB-235863&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"SB-235863 (page does not exist)\">SB-235863</a></li>\n<li><a href=\"/wiki/SNC-80\" title=\"SNC-80\">SNC-80</a></li>\n<li><a href=\"/w/index.php?title=SNC-162&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"SNC-162 (page does not exist)\">SNC-162</a></li>\n<li><a href=\"/wiki/TAN-67\" title=\"TAN-67\">TAN-67 (SB-205,607)</a></li>\n<li><a href=\"/w/index.php?title=TH-030418&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"TH-030418 (page does not exist)\">TH-030418</a></li>\n<li><a href=\"/wiki/Thebaine\" title=\"Thebaine\">Thebaine</a></li>\n<li><a href=\"/wiki/Thiobromadol\" class=\"mw-redirect\" title=\"Thiobromadol\">Thiobromadol (C-8813)</a></li>\n<li><a href=\"/wiki/Tonazocine\" title=\"Tonazocine\">Tonazocine</a></li>\n<li><a href=\"/wiki/Tramadol\" title=\"Tramadol\">Tramadol</a></li>\n<li><a href=\"/w/index.php?title=TRV250&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"TRV250 (page does not exist)\">TRV250</a></li>\n<li><a href=\"/wiki/Xorphanol\" title=\"Xorphanol\">Xorphanol</a></li>\n<li><a href=\"/wiki/Zenazocine\" title=\"Zenazocine\">Zenazocine</a></li></ul>\n<ul><li><b>Antagonists:</b> <a href=\"/wiki/4%27,7-Dihydroxyflavone\" title=\"4&#39;,7-Dihydroxyflavone\">4',7-Dihydroxyflavone</a></li>\n<li><a href=\"/w/index.php?title=Naltrindole-5%27-isothiocyanate&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Naltrindole-5&#39;-isothiocyanate (page does not exist)\">5'-NTII</a></li>\n<li><a href=\"/wiki/6%CE%B2-Naltrexol\" title=\"6\u03b2-Naltrexol\">6\u03b2-Naltrexol</a></li>\n<li><a href=\"/wiki/6%CE%B2-Naltrexol-d4\" title=\"6\u03b2-Naltrexol-d4\">6\u03b2-Naltrexol-d4</a></li>\n<li><a href=\"/w/index.php?title=Alpha-Santolol&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Alpha-Santolol (page does not exist)\">\u03b1-Santolol</a></li>\n<li><a href=\"/wiki/%CE%92-Chlornaltrexamine\" class=\"mw-redirect\" title=\"\u0392-Chlornaltrexamine\">\u03b2-Chlornaltrexamine</a></li>\n<li><a href=\"/wiki/Apigenin\" title=\"Apigenin\">Apigenin</a></li>\n<li><a href=\"/wiki/AT-076\" title=\"AT-076\">AT-076</a></li>\n<li><a href=\"/wiki/Axelopran\" title=\"Axelopran\">Axelopran</a></li>\n<li><a href=\"/wiki/Bevenopran\" title=\"Bevenopran\">Bevenopran</a></li>\n<li><a href=\"/w/index.php?title=7-Benzylidenenaltrexone&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"7-Benzylidenenaltrexone (page does not exist)\">BNTX</a></li>\n<li><a href=\"/wiki/Catechin\" title=\"Catechin\">Catechin</a></li>\n<li><a href=\"/wiki/Catechin_gallate\" class=\"mw-redirect\" title=\"Catechin gallate\">Catechin gallate</a></li>\n<li><a href=\"/wiki/Clocinnamox\" title=\"Clocinnamox\">Clocinnamox</a></li>\n<li><a href=\"/wiki/Diacetylnalorphine\" title=\"Diacetylnalorphine\">Diacetylnalorphine</a></li>\n<li><a href=\"/wiki/Diprenorphine\" title=\"Diprenorphine\">Diprenorphine</a></li>\n<li><a href=\"/wiki/Epicatechin_gallate\" title=\"Epicatechin gallate\">ECG</a></li>\n<li><a href=\"/wiki/Epigallocatechin\" class=\"mw-redirect\" title=\"Epigallocatechin\">EGC</a></li>\n<li><a href=\"/wiki/Eluxadoline\" title=\"Eluxadoline\">Eluxadoline</a></li>\n<li><a href=\"/wiki/Epicatechin\" class=\"mw-redirect\" title=\"Epicatechin\">Epicatechin</a></li>\n<li><a href=\"/w/index.php?title=ICI-154129&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"ICI-154129 (page does not exist)\">ICI-154129</a></li>\n<li><a href=\"/w/index.php?title=ICI-174864&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"ICI-174864 (page does not exist)\">ICI-174864</a></li>\n<li><a href=\"/wiki/LY-255582\" title=\"LY-255582\">LY-255582</a></li>\n<li><a href=\"/w/index.php?title=LY-2196044&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"LY-2196044 (page does not exist)\">LY-2196044</a></li>\n<li><a href=\"/wiki/Methylnaltrexone\" title=\"Methylnaltrexone\">Methylnaltrexone</a></li>\n<li><a href=\"/w/index.php?title=Methylnaltrindole&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Methylnaltrindole (page does not exist)\">Methylnaltrindole</a></li>\n<li><a href=\"/w/index.php?title=N-Benzylnaltrindole&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"N-Benzylnaltrindole (page does not exist)\">N-Benzylnaltrindole</a></li>\n<li><a href=\"/wiki/Nalmefene\" title=\"Nalmefene\">Nalmefene</a></li>\n<li><a href=\"/wiki/Nalorphine\" title=\"Nalorphine\">Nalorphine</a></li>\n<li><a class=\"mw-selflink selflink\">Naltrexone</a></li>\n<li><a href=\"/wiki/Naltriben\" title=\"Naltriben\">Naltriben</a></li>\n<li><a href=\"/wiki/Naltrindole\" title=\"Naltrindole\">Naltrindole</a></li>\n<li><a href=\"/wiki/Naloxone\" title=\"Naloxone\">Naloxone</a></li>\n<li><a href=\"/wiki/Naringenin\" title=\"Naringenin\">Naringenin</a></li>\n<li><a href=\"/wiki/Noribogaine\" title=\"Noribogaine\">Noribogaine</a></li>\n<li><a href=\"/wiki/Pawhuskin_A\" title=\"Pawhuskin A\">Pawhuskin A</a></li>\n<li><a href=\"/wiki/Quadazocine\" title=\"Quadazocine\">Quadazocine</a></li>\n<li><a href=\"/w/index.php?title=SDM25N&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"SDM25N (page does not exist)\">SDM25N</a></li>\n<li><a href=\"/wiki/SoRI-9409\" title=\"SoRI-9409\">SoRI-9409</a></li>\n<li><a href=\"/wiki/Taxifolin\" title=\"Taxifolin\">Taxifolin</a></li>\n<li><a href=\"/wiki/Thienorphine\" title=\"Thienorphine\">Thienorphine</a></li></ul>\n<ul><li><b>Unknown/unsorted:</b> <a href=\"/wiki/18-Methoxycoronaridine\" title=\"18-Methoxycoronaridine\">18-MC</a></li>\n<li><a href=\"/wiki/Cannabidiol\" title=\"Cannabidiol\">Cannabidiol</a></li>\n<li><a href=\"/wiki/Coronaridine\" title=\"Coronaridine\">Coronaridine</a></li>\n<li><a href=\"/wiki/Cyproterone_acetate\" title=\"Cyproterone acetate\">Cyproterone acetate</a></li>\n<li><a href=\"/wiki/Tabernanthine\" title=\"Tabernanthine\">Tabernanthine</a></li>\n<li><a href=\"/wiki/Tetrahydrocannabinol\" title=\"Tetrahydrocannabinol\">Tetrahydrocannabinol</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align:center;\"><a href=\"/wiki/%CE%9A-opioid_receptor\" title=\"\u039a-opioid receptor\"><abbr title=\"\u03ba-opioid receptor\">KOR</abbr></a></th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><b>Agonists:</b> <a href=\"/w/index.php?title=3CS-nalmefene&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"3CS-nalmefene (page does not exist)\">3CS-nalmefene</a></li>\n<li><a href=\"/wiki/6%27-Guanidinonaltrindole\" title=\"6&#39;-Guanidinonaltrindole\">6'-GNTI</a></li>\n<li><a href=\"/wiki/8-Carboxamidocyclazocine\" title=\"8-Carboxamidocyclazocine\">8-CAC</a></li>\n<li><a href=\"/wiki/18-Methoxycoronaridine\" title=\"18-Methoxycoronaridine\">18-MC</a></li>\n<li><a href=\"/wiki/14-Methoxymetopon\" title=\"14-Methoxymetopon\">14-Methoxymetopon</a></li>\n<li><a href=\"/wiki/%CE%92-Chlornaltrexamine\" class=\"mw-redirect\" title=\"\u0392-Chlornaltrexamine\">\u03b2-Chlornaltrexamine</a></li>\n<li><a href=\"/wiki/Beta-Funaltrexamine\" title=\"Beta-Funaltrexamine\">\u03b2-Funaltrexamine</a></li>\n<li><a href=\"/wiki/Adrenorphin\" title=\"Adrenorphin\">Adrenorphin (metorphamide)</a></li>\n<li><a href=\"/w/index.php?title=Akuuamicine&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Akuuamicine (page does not exist)\">Akuuamicine</a></li>\n<li><a href=\"/wiki/Alazocine\" title=\"Alazocine\">Alazocine (SKF-10047)</a></li>\n<li><a href=\"/w/index.php?title=Allomatrine&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Allomatrine (page does not exist)\">Allomatrine</a></li>\n<li><a href=\"/w/index.php?title=Apadoline&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Apadoline (page does not exist)\">Apadoline</a></li>\n<li><a href=\"/wiki/Asimadoline\" title=\"Asimadoline\">Asimadoline</a></li>\n<li><a href=\"/w/index.php?title=Bovine_adrenal_medullary_peptide-12P&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Bovine adrenal medullary peptide-12P (page does not exist)\">BAM-12P</a></li>\n<li><a href=\"/w/index.php?title=Bovine_adrenal_medullary_peptide-18P&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Bovine adrenal medullary peptide-18P (page does not exist)\">BAM-18P</a></li>\n<li><a href=\"/w/index.php?title=Bovine_adrenal_medullary_peptide-22P&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Bovine adrenal medullary peptide-22P (page does not exist)\">BAM-22P</a></li>\n<li><a href=\"/wiki/Big_dynorphin\" title=\"Big dynorphin\">Big dynorphin</a></li>\n<li><a href=\"/wiki/Bremazocine\" title=\"Bremazocine\">Bremazocine</a></li>\n<li><a href=\"/wiki/BRL-52537\" title=\"BRL-52537\">BRL-52537</a></li>\n<li><a href=\"/w/index.php?title=Butorphan&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Butorphan (page does not exist)\">Butorphan</a></li>\n<li><a href=\"/wiki/Butorphanol\" title=\"Butorphanol\">Butorphanol</a></li>\n<li><a href=\"/wiki/BW-373U86\" class=\"mw-redirect\" title=\"BW-373U86\">BW-373U86</a></li>\n<li><a href=\"/wiki/Cebranopadol\" title=\"Cebranopadol\">Cebranopadol</a></li>\n<li><a href=\"/wiki/Ciprefadol\" title=\"Ciprefadol\">Ciprefadol</a></li>\n<li><a href=\"/wiki/CR665\" title=\"CR665\">CR665</a></li>\n<li><a href=\"/wiki/Cyclazocine\" title=\"Cyclazocine\">Cyclazocine</a></li>\n<li><a href=\"/wiki/Cyclorphan\" title=\"Cyclorphan\">Cyclorphan</a></li>\n<li><a href=\"/wiki/Cyprenorphine\" title=\"Cyprenorphine\">Cyprenorphine</a></li>\n<li><a href=\"/wiki/Desmetramadol\" title=\"Desmetramadol\">Desmetramadol (desmethyltramadol)</a></li>\n<li><a href=\"/wiki/Heroin\" title=\"Heroin\">Diamorphine (heroin)</a></li>\n<li><a href=\"/wiki/Diacetylnalorphine\" title=\"Diacetylnalorphine\">Diacetylnalorphine</a></li>\n<li><a href=\"/wiki/Difelikefalin\" title=\"Difelikefalin\">Difelikefalin</a></li>\n<li><a href=\"/wiki/Dihydroetorphine\" title=\"Dihydroetorphine\">Dihydroetorphine</a></li>\n<li><a href=\"/wiki/Dihydromorphine\" title=\"Dihydromorphine\">Dihydromorphine</a></li>\n<li><a href=\"/wiki/Dinalbuphine_sebacate\" title=\"Dinalbuphine sebacate\">Dinalbuphine sebacate</a></li>\n<li><a href=\"/wiki/Diprenorphine\" title=\"Diprenorphine\">Diprenorphine</a></li>\n<li><a href=\"/wiki/Dynorphin_A\" title=\"Dynorphin A\">Dynorphin A</a></li>\n<li><a href=\"/wiki/Dynorphin_B\" title=\"Dynorphin B\">Dynorphin B (rimorphin)</a></li>\n<li><a href=\"/wiki/Eluxadoline\" title=\"Eluxadoline\">Eluxadoline</a></li>\n<li><a href=\"/wiki/Enadoline\" title=\"Enadoline\">Enadoline</a></li>\n<li><a href=\"/wiki/Eptazocine\" title=\"Eptazocine\">Eptazocine</a></li>\n<li><a href=\"/w/index.php?title=Erinacine_E&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Erinacine E (page does not exist)\">Erinacine E</a></li>\n<li><a href=\"/wiki/Ethylketazocine\" title=\"Ethylketazocine\">Ethylketazocine</a></li>\n<li><a href=\"/wiki/Etorphine\" title=\"Etorphine\">Etorphine</a></li>\n<li><a href=\"/wiki/Fedotozine\" title=\"Fedotozine\">Fedotozine</a></li>\n<li><a href=\"/wiki/Fentanyl\" title=\"Fentanyl\">Fentanyl</a></li>\n<li><a href=\"/wiki/Gemazocine\" title=\"Gemazocine\">Gemazocine</a></li>\n<li><a href=\"/wiki/GR-89696\" title=\"GR-89696\">GR-89696</a></li>\n<li><a href=\"/w/index.php?title=GR-103545&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"GR-103545 (page does not exist)\">GR-103545</a></li>\n<li><a href=\"/wiki/Hemorphin-4\" title=\"Hemorphin-4\">Hemorphin-4</a></li>\n<li><a href=\"/wiki/Herkinorin\" title=\"Herkinorin\">Herkinorin</a></li>\n<li><a href=\"/w/index.php?title=HS665&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"HS665 (page does not exist)\">HS665</a></li>\n<li><a href=\"/wiki/Hydromorphone\" title=\"Hydromorphone\">Hydromorphone</a></li>\n<li><a href=\"/wiki/HZ-2\" title=\"HZ-2\">HZ-2</a></li>\n<li><a href=\"/wiki/Ibogaine\" title=\"Ibogaine\">Ibogaine</a></li>\n<li><a href=\"/wiki/ICI-199,441\" title=\"ICI-199,441\">ICI-199,441</a></li>\n<li><a href=\"/wiki/ICI-204,448\" title=\"ICI-204,448\">ICI-204,448</a></li>\n<li><a href=\"/wiki/Ketamine\" title=\"Ketamine\">Ketamine</a></li>\n<li><a href=\"/wiki/Ketazocine\" title=\"Ketazocine\">Ketazocine</a></li>\n<li><a href=\"/wiki/Laudanosine\" title=\"Laudanosine\">Laudanosine</a></li>\n<li><a href=\"/wiki/Leumorphin\" title=\"Leumorphin\">Leumorphin (dynorphin B-29)</a></li>\n<li><a href=\"/wiki/Levallorphan\" title=\"Levallorphan\">Levallorphan</a></li>\n<li><a href=\"/wiki/Levomethorphan\" title=\"Levomethorphan\">Levomethorphan</a></li>\n<li><a href=\"/wiki/Levorphanol\" title=\"Levorphanol\">Levorphanol</a></li>\n<li><a href=\"/w/index.php?title=Lexanopadol&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Lexanopadol (page does not exist)\">Lexanopadol</a></li>\n<li><a href=\"/wiki/Lofentanil\" title=\"Lofentanil\">Lofentanil</a></li>\n<li><a href=\"/wiki/LPK-26\" title=\"LPK-26\">LPK-26</a></li>\n<li><a href=\"/wiki/Lufuradom\" title=\"Lufuradom\">Lufuradom</a></li>\n<li><a href=\"/wiki/Matrine\" title=\"Matrine\">Matrine</a></li>\n<li><a href=\"/w/index.php?title=MB-1C-OH&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"MB-1C-OH (page does not exist)\">MB-1C-OH</a></li>\n<li><a href=\"/wiki/Menthol\" title=\"Menthol\">Menthol</a></li>\n<li><a href=\"/wiki/Metazocine\" title=\"Metazocine\">Metazocine</a></li>\n<li><a href=\"/wiki/Metkefamide\" title=\"Metkefamide\">Metkefamide</a></li>\n<li><a href=\"/wiki/Mianserin\" title=\"Mianserin\">Mianserin</a></li>\n<li><a href=\"/wiki/Mirtazapine\" title=\"Mirtazapine\">Mirtazapine</a></li>\n<li><a href=\"/wiki/Morphine\" title=\"Morphine\">Morphine</a></li>\n<li><a href=\"/wiki/Moxazocine\" title=\"Moxazocine\">Moxazocine</a></li>\n<li><a href=\"/w/index.php?title=MR-2034&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"MR-2034 (page does not exist)\">MR-2034</a></li>\n<li><a href=\"/w/index.php?title=N-MPPP&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"N-MPPP (page does not exist)\">N-MPPP</a></li>\n<li><a href=\"/wiki/Nalbuphine\" title=\"Nalbuphine\">Nalbuphine</a></li>\n<li><a href=\"/w/index.php?title=Naloxone_benzoylhydrazone&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Naloxone benzoylhydrazone (page does not exist)\">NalBzOH</a></li>\n<li><a href=\"/wiki/Nalfurafine\" title=\"Nalfurafine\">Nalfurafine</a></li>\n<li><a href=\"/wiki/Nalmefene\" title=\"Nalmefene\">Nalmefene</a></li>\n<li><a href=\"/wiki/Nalodeine\" title=\"Nalodeine\">Nalodeine (N-allylnorcodeine)</a></li>\n<li><a href=\"/wiki/Nalorphine\" title=\"Nalorphine\">Nalorphine</a></li>\n<li><a href=\"/wiki/Naltriben\" title=\"Naltriben\">Naltriben</a></li>\n<li><a href=\"/w/index.php?title=Niravoline&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Niravoline (page does not exist)\">Niravoline</a></li>\n<li><a href=\"/wiki/Norbuprenorphine\" title=\"Norbuprenorphine\">Norbuprenorphine</a></li>\n<li><a href=\"/wiki/Norbuprenorphine-3-glucuronide\" title=\"Norbuprenorphine-3-glucuronide\">Norbuprenorphine-3-glucuronide</a></li>\n<li><a href=\"/wiki/Noribogaine\" title=\"Noribogaine\">Noribogaine</a></li>\n<li><a href=\"/wiki/Norketamine\" title=\"Norketamine\">Norketamine</a></li>\n<li><a href=\"/wiki/Oripavine\" title=\"Oripavine\">Oripavine</a></li>\n<li><a href=\"/wiki/Oxilorphan\" title=\"Oxilorphan\">Oxilorphan</a></li>\n<li><a href=\"/wiki/Oxycodone\" title=\"Oxycodone\">Oxycodone</a></li>\n<li><a href=\"/wiki/Pentazocine\" title=\"Pentazocine\">Pentazocine</a></li>\n<li><a href=\"/wiki/Pethidine\" title=\"Pethidine\">Pethidine (meperidine)</a></li>\n<li><a href=\"/wiki/Phenazocine\" title=\"Phenazocine\">Phenazocine</a></li>\n<li><a href=\"/wiki/Proxorphan\" title=\"Proxorphan\">Proxorphan</a></li>\n<li><a href=\"/wiki/Racemethorphan\" class=\"mw-redirect\" title=\"Racemethorphan\">Racemethorphan</a></li>\n<li><a href=\"/wiki/Racemorphan\" title=\"Racemorphan\">Racemorphan</a></li>\n<li><a href=\"/wiki/RB-64\" title=\"RB-64\">RB-64</a></li>\n<li><a href=\"/wiki/Salvinorin_A\" title=\"Salvinorin A\">Salvinorin A</a> (<a href=\"/wiki/Salvia_divinorum\" title=\"Salvia divinorum\">salvia</a>)</li>\n<li><a href=\"/wiki/Salvinorin_B_ethoxymethyl_ether\" class=\"mw-redirect\" title=\"Salvinorin B ethoxymethyl ether\">Salvinorin B ethoxymethyl ether</a></li>\n<li><a href=\"/wiki/Salvinorin_B_methoxymethyl_ether\" title=\"Salvinorin B methoxymethyl ether\">Salvinorin B methoxymethyl ether</a></li>\n<li><a href=\"/wiki/Samidorphan\" title=\"Samidorphan\">Samidorphan</a></li>\n<li><a href=\"/wiki/Spiradoline\" title=\"Spiradoline\">Spiradoline (U-62,066)</a></li>\n<li><a href=\"/w/index.php?title=TH-030418&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"TH-030418 (page does not exist)\">TH-030418</a></li>\n<li><a href=\"/wiki/Thienorphine\" title=\"Thienorphine\">Thienorphine</a></li>\n<li><a href=\"/wiki/Tifluadom\" title=\"Tifluadom\">Tifluadom</a></li>\n<li><a href=\"/wiki/Tricyclic_antidepressant\" title=\"Tricyclic antidepressant\">Tricyclic antidepressants</a> (e.g., <a href=\"/wiki/Amitriptyline\" title=\"Amitriptyline\">amitriptyline</a>, <a href=\"/wiki/Desipramine\" title=\"Desipramine\">desipramine</a>, <a href=\"/wiki/Imipramine\" title=\"Imipramine\">imipramine</a>, <a href=\"/wiki/Nortriptyline\" title=\"Nortriptyline\">nortriptyline</a>)</li>\n<li><a href=\"/wiki/U-50,488\" class=\"mw-redirect\" title=\"U-50,488\">U-50,488</a></li>\n<li><a href=\"/w/index.php?title=U-54,494A&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"U-54,494A (page does not exist)\">U-54,494A</a></li>\n<li><a href=\"/wiki/U-69,593\" title=\"U-69,593\">U-69,593</a></li>\n<li><a href=\"/wiki/Xorphanol\" title=\"Xorphanol\">Xorphanol</a></li></ul>\n<ul><li><b>Antagonists:</b> <a href=\"/w/index.php?title=4%E2%80%B2-Hydroxyflavanone&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"4\u2032-Hydroxyflavanone (page does not exist)\">4\u2032-Hydroxyflavanone</a></li>\n<li><a href=\"/wiki/4%27,7-Dihydroxyflavone\" title=\"4&#39;,7-Dihydroxyflavone\">4',7-Dihydroxyflavone</a></li>\n<li><a href=\"/wiki/5%27-Guanidinonaltrindole\" title=\"5&#39;-Guanidinonaltrindole\">5'-GNTI</a></li>\n<li><a href=\"/wiki/6%27-Guanidinonaltrindole\" title=\"6&#39;-Guanidinonaltrindole\">6'-GNTI</a></li>\n<li><a href=\"/wiki/6%CE%B2-Naltrexol\" title=\"6\u03b2-Naltrexol\">6\u03b2-Naltrexol</a></li>\n<li><a href=\"/wiki/6%CE%B2-Naltrexol-d4\" title=\"6\u03b2-Naltrexol-d4\">6\u03b2-Naltrexol-d4</a></li>\n<li><a href=\"/wiki/%CE%92-Chlornaltrexamine\" class=\"mw-redirect\" title=\"\u0392-Chlornaltrexamine\">\u03b2-Chlornaltrexamine</a></li>\n<li><a href=\"/wiki/Buprenorphine/samidorphan\" title=\"Buprenorphine/samidorphan\">Buprenorphine/samidorphan</a></li>\n<li><a href=\"/wiki/Amentoflavone\" title=\"Amentoflavone\">Amentoflavone</a></li>\n<li><a href=\"/w/index.php?title=5%27-Acetamidinoethylnaltrindole&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"5&#39;-Acetamidinoethylnaltrindole (page does not exist)\">ANTI</a></li>\n<li><a href=\"/wiki/Apigenin\" title=\"Apigenin\">Apigenin</a></li>\n<li><a href=\"/w/index.php?title=Arodyne&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Arodyne (page does not exist)\">Arodyne</a></li>\n<li><a href=\"/wiki/AT-076\" title=\"AT-076\">AT-076</a></li>\n<li><a href=\"/wiki/Axelopran\" title=\"Axelopran\">Axelopran</a></li>\n<li><a href=\"/w/index.php?title=AZ-MTAB&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"AZ-MTAB (page does not exist)\">AZ-MTAB</a></li>\n<li><a href=\"/wiki/Binaltorphimine\" title=\"Binaltorphimine\">Binaltorphimine</a></li>\n<li><a href=\"/wiki/BU09059\" title=\"BU09059\">BU09059</a></li>\n<li><a href=\"/wiki/Buprenorphine\" title=\"Buprenorphine\">Buprenorphine</a></li>\n<li><a href=\"/wiki/Catechin\" title=\"Catechin\">Catechin</a></li>\n<li><a href=\"/wiki/Catechin_gallate\" class=\"mw-redirect\" title=\"Catechin gallate\">Catechin gallate</a></li>\n<li><a href=\"/wiki/CERC-501\" title=\"CERC-501\">CERC-501 (LY-2456302)</a></li>\n<li><a href=\"/wiki/Clocinnamox\" title=\"Clocinnamox\">Clocinnamox</a></li>\n<li><a href=\"/w/index.php?title=Cyclofoxy&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Cyclofoxy (page does not exist)\">Cyclofoxy</a></li>\n<li><a href=\"/wiki/Dezocine\" title=\"Dezocine\">Dezocine</a></li>\n<li><a href=\"/w/index.php?title=DIPPA&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"DIPPA (page does not exist)\">DIPPA</a></li>\n<li><a href=\"/wiki/Epigallocatechin\" class=\"mw-redirect\" title=\"Epigallocatechin\">EGC</a></li>\n<li><a href=\"/wiki/Epicatechin_gallate\" title=\"Epicatechin gallate\">ECG</a></li>\n<li><a href=\"/wiki/Epicatechin\" class=\"mw-redirect\" title=\"Epicatechin\">Epicatechin</a></li>\n<li><a href=\"/wiki/Hyperoside\" title=\"Hyperoside\">Hyperoside</a></li>\n<li><a href=\"/wiki/JDTic\" title=\"JDTic\">JDTic</a></li>\n<li><a href=\"/wiki/LY-255582\" title=\"LY-255582\">LY-255582</a></li>\n<li><a href=\"/w/index.php?title=LY-2196044&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"LY-2196044 (page does not exist)\">LY-2196044</a></li>\n<li><a href=\"/w/index.php?title=LY-2444296&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"LY-2444296 (page does not exist)\">LY-2444296</a></li>\n<li><a href=\"/wiki/LY-2459989\" title=\"LY-2459989\">LY-2459989</a></li>\n<li><a href=\"/w/index.php?title=LY-2795050&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"LY-2795050 (page does not exist)\">LY-2795050</a></li>\n<li><a href=\"/w/index.php?title=MeJDTic&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"MeJDTic (page does not exist)\">MeJDTic</a></li>\n<li><a href=\"/wiki/Methylnaltrexone\" title=\"Methylnaltrexone\">Methylnaltrexone</a></li>\n<li><a href=\"/w/index.php?title=ML190&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"ML190 (page does not exist)\">ML190</a></li>\n<li><a href=\"/w/index.php?title=ML350&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"ML350 (page does not exist)\">ML350</a></li>\n<li><a href=\"/w/index.php?title=MR-2266&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"MR-2266 (page does not exist)\">MR-2266</a></li>\n<li><a href=\"/w/index.php?title=N-Fluoropropyl-JDTic&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"N-Fluoropropyl-JDTic (page does not exist)\">N-Fluoropropyl-JDTic</a></li>\n<li><a href=\"/wiki/Naloxone\" title=\"Naloxone\">Naloxone</a></li>\n<li><a class=\"mw-selflink selflink\">Naltrexone</a></li>\n<li><a href=\"/wiki/Naltrindole\" title=\"Naltrindole\">Naltrindole</a></li>\n<li><a href=\"/wiki/Naringenin\" title=\"Naringenin\">Naringenin</a></li>\n<li><a href=\"/wiki/Norbinaltorphimine\" title=\"Norbinaltorphimine\">Norbinaltorphimine</a></li>\n<li><a href=\"/wiki/Noribogaine\" title=\"Noribogaine\">Noribogaine</a></li>\n<li><a href=\"/wiki/Pawhuskin_A\" title=\"Pawhuskin A\">Pawhuskin A</a></li>\n<li><a href=\"/wiki/PF-4455242\" title=\"PF-4455242\">PF-4455242</a></li>\n<li><a href=\"/wiki/RB-64\" title=\"RB-64\">RB-64</a></li>\n<li><a href=\"/wiki/Quadazocine\" title=\"Quadazocine\">Quadazocine</a></li>\n<li><a href=\"/wiki/Taxifolin\" title=\"Taxifolin\">Taxifolin</a></li>\n<li><a href=\"/w/index.php?title=UPHIT&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"UPHIT (page does not exist)\">UPHIT</a></li>\n<li><a href=\"/wiki/Zyklophin\" title=\"Zyklophin\">Zyklophin</a></li></ul>\n<ul><li><b>Unknown/unsorted:</b> <a href=\"/wiki/Akuammicine\" title=\"Akuammicine\">Akuammicine</a></li>\n<li><a href=\"/wiki/Akuammine\" title=\"Akuammine\">Akuammine</a></li>\n<li><a href=\"/wiki/Coronaridine\" title=\"Coronaridine\">Coronaridine</a></li>\n<li><a href=\"/wiki/Cyproterone_acetate\" title=\"Cyproterone acetate\">Cyproterone acetate</a></li>\n<li><a href=\"/w/index.php?title=Dihydroakuuamine&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Dihydroakuuamine (page does not exist)\">Dihydroakuuamine</a></li>\n<li><a href=\"/wiki/Ibogamine\" title=\"Ibogamine\">Ibogamine</a></li>\n<li><a href=\"/wiki/Tabernanthine\" title=\"Tabernanthine\">Tabernanthine</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align:center;\"><a href=\"/wiki/Nociceptin_receptor\" title=\"Nociceptin receptor\"><abbr title=\"Nociceptin receptor\">NOP</abbr></a></th><td class=\"navbox-list navbox-even hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><b>Agonists:</b> <a href=\"/w/index.php?title=(Arg14,Lys15)Nociceptin&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"(Arg14,Lys15)Nociceptin (page does not exist)\">(Arg14,Lys15)Nociceptin</a></li>\n<li><a href=\"/w/index.php?title=((pF)Phe4)Nociceptin(1-13)NH2&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"((pF)Phe4)Nociceptin(1-13)NH2 (page does not exist)\">((pF)Phe<sup>4</sup>)Nociceptin(1-13)NH<sub>2</sub></a></li>\n<li><a href=\"/w/index.php?title=(Phe1%CE%A8(CH2-NH)Gly2)Nociceptin(1-13)NH2&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"(Phe1\u03a8(CH2-NH)Gly2)Nociceptin(1-13)NH2 (page does not exist)\">(Phe<sup>1</sup>\u03a8(CH<sub>2</sub>-NH)Gly<sup>2</sup>)Nociceptin(1-13)NH<sub>2</sub></a></li>\n<li><a href=\"/w/index.php?title=Ac-RYYRWK-NH2&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Ac-RYYRWK-NH2 (page does not exist)\">Ac-RYYRWK-NH<sub>2</sub></a></li>\n<li><a href=\"/w/index.php?title=Ac-RYYRIK-NH2&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Ac-RYYRIK-NH2 (page does not exist)\">Ac-RYYRIK-NH<sub>2</sub></a></li>\n<li><a href=\"/w/index.php?title=BU08070&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"BU08070 (page does not exist)\">BU08070</a></li>\n<li><a href=\"/wiki/Buprenorphine\" title=\"Buprenorphine\">Buprenorphine</a></li>\n<li><a href=\"/wiki/Cebranopadol\" title=\"Cebranopadol\">Cebranopadol</a></li>\n<li><a href=\"/wiki/Dihydroetorphine\" title=\"Dihydroetorphine\">Dihydroetorphine</a></li>\n<li><a href=\"/wiki/Etorphine\" title=\"Etorphine\">Etorphine</a></li>\n<li><a href=\"/w/index.php?title=JNJ-19385899&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"JNJ-19385899 (page does not exist)\">JNJ-19385899</a></li>\n<li><a href=\"/wiki/Levomethorphan\" title=\"Levomethorphan\">Levomethorphan</a></li>\n<li><a href=\"/wiki/Levorphanol\" title=\"Levorphanol\">Levorphanol</a></li>\n<li><a href=\"/wiki/Levorphanol\" title=\"Levorphanol\">Levorphanol</a></li>\n<li><a href=\"/w/index.php?title=Lexanopadol&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Lexanopadol (page does not exist)\">Lexanopadol</a></li>\n<li><a href=\"/wiki/MCOPPB\" title=\"MCOPPB\">MCOPPB</a></li>\n<li><a href=\"/w/index.php?title=MT-7716&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"MT-7716 (page does not exist)\">MT-7716</a></li>\n<li><a href=\"/wiki/NNC_63-0532\" title=\"NNC 63-0532\">NNC 63-0532</a></li>\n<li><a href=\"/wiki/Nociceptin\" title=\"Nociceptin\">Nociceptin (orphanin FQ)</a></li>\n<li><a href=\"/w/index.php?title=Nociceptin_(1-11)&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Nociceptin (1-11) (page does not exist)\">Nociceptin (1-11)</a></li>\n<li><a href=\"/w/index.php?title=Nociceptin_(1-13)NH2&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Nociceptin (1-13)NH2 (page does not exist)\">Nociceptin (1-13)NH<sub>2</sub></a></li>\n<li><a href=\"/wiki/Norbuprenorphine\" title=\"Norbuprenorphine\">Norbuprenorphine</a></li>\n<li><a href=\"/wiki/Racemethorphan\" class=\"mw-redirect\" title=\"Racemethorphan\">Racemethorphan</a></li>\n<li><a href=\"/wiki/Racemorphan\" title=\"Racemorphan\">Racemorphan</a></li>\n<li><a href=\"/wiki/Ro64-6198\" title=\"Ro64-6198\">Ro64-6198</a></li>\n<li><a href=\"/w/index.php?title=Ro65-6570&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Ro65-6570 (page does not exist)\">Ro65-6570</a></li>\n<li><a href=\"/w/index.php?title=SCH-221510&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"SCH-221510 (page does not exist)\">SCH-221510</a></li>\n<li><a href=\"/w/index.php?title=SCH-486757&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"SCH-486757 (page does not exist)\">SCH-486757</a></li>\n<li><a href=\"/w/index.php?title=SR-8993&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"SR-8993 (page does not exist)\">SR-8993</a></li>\n<li><a href=\"/w/index.php?title=SR-16435&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"SR-16435 (page does not exist)\">SR-16435</a></li>\n<li><a href=\"/w/index.php?title=TH-030418&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"TH-030418 (page does not exist)\">TH-030418</a></li></ul>\n<ul><li><b>Antagonists:</b> <a href=\"/w/index.php?title=(Nphe1)Nociceptin(1-13)NH2&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"(Nphe1)Nociceptin(1-13)NH2 (page does not exist)\">(Nphe<sup>1</sup>)Nociceptin(1-13)NH<sub>2</sub></a></li>\n<li><a href=\"/wiki/AT-076\" title=\"AT-076\">AT-076</a></li>\n<li><a href=\"/w/index.php?title=BAN-ORL-24&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"BAN-ORL-24 (page does not exist)\">BAN-ORL-24</a></li>\n<li><a href=\"/wiki/BTRX-246040\" title=\"BTRX-246040\">BTRX-246040 (LY-2940094)</a></li>\n<li><a href=\"/wiki/J-113397\" class=\"mw-redirect\" title=\"J-113397\">J-113397</a></li>\n<li><a href=\"/wiki/JTC-801\" title=\"JTC-801\">JTC-801</a></li>\n<li><a href=\"/w/index.php?title=Naloxone_benzoylhydrazone&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Naloxone benzoylhydrazone (page does not exist)\">NalBzOH</a></li>\n<li><a href=\"/w/index.php?title=Nociceptin_(1-7)&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Nociceptin (1-7) (page does not exist)\">Nociceptin (1-7)</a></li>\n<li><a href=\"/w/index.php?title=Nocistatin&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Nocistatin (page does not exist)\">Nocistatin</a></li>\n<li><a href=\"/wiki/SB-612111\" class=\"mw-redirect\" title=\"SB-612111\">SB-612111</a></li>\n<li><a href=\"/w/index.php?title=SR-16430&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"SR-16430 (page does not exist)\">SR-16430</a></li>\n<li><a href=\"/wiki/Thienorphine\" title=\"Thienorphine\">Thienorphine</a></li>\n<li><a href=\"/w/index.php?title=Trap-101&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Trap-101 (page does not exist)\">Trap-101</a></li>\n<li><a href=\"/w/index.php?title=UFP-101&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"UFP-101 (page does not exist)\">UFP-101</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align:center;\">Unsorted</th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/%CE%92-Casomorphin\" class=\"mw-redirect\" title=\"\u0392-Casomorphin\">\u03b2-Casomorphins</a></li>\n<li><a href=\"/wiki/Amidorphin\" title=\"Amidorphin\">Amidorphin</a></li>\n<li><a href=\"/w/index.php?title=BAM-20P&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"BAM-20P (page does not exist)\">BAM-20P</a></li>\n<li><a href=\"/wiki/Cytochrophin-4\" title=\"Cytochrophin-4\">Cytochrophin-4</a></li>\n<li><a href=\"/w/index.php?title=Deprolorphin&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Deprolorphin (page does not exist)\">Deprolorphin</a></li>\n<li><a href=\"/wiki/Gliadorphin\" title=\"Gliadorphin\">Gliadorphin (gluteomorphin)</a></li>\n<li><a href=\"/wiki/Gluten_exorphin\" title=\"Gluten exorphin\">Gluten exorphins</a></li>\n<li><a href=\"/wiki/Hemorphin\" title=\"Hemorphin\">Hemorphins</a></li>\n<li><a href=\"/wiki/Kava\" title=\"Kava\">Kava</a> constituents</li>\n<li><a href=\"/w/index.php?title=Met5-Enkephalin-Arg6,Phe7,Leu8&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Met5-Enkephalin-Arg6,Phe7,Leu8 (page does not exist)\">MEAGL</a></li>\n<li><a href=\"/w/index.php?title=Met5-Enkephalin-Arg6,Phe7&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Met5-Enkephalin-Arg6,Phe7 (page does not exist)\">MEAP</a></li>\n<li><a href=\"/wiki/N-Ethylmaleimide\" title=\"N-Ethylmaleimide\">NEM</a></li>\n<li><a href=\"/wiki/Neoendorphin\" title=\"Neoendorphin\">Neoendorphins</a></li>\n<li><a href=\"/wiki/Nepetalactone\" title=\"Nepetalactone\">Nepetalactone</a> (<a href=\"/wiki/Catnip\" title=\"Catnip\">catnip</a>)</li>\n<li><a href=\"/w/index.php?title=Peptide_B&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Peptide B (page does not exist)\">Peptide B</a></li>\n<li><a href=\"/w/index.php?title=Peptide_E&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Peptide E (page does not exist)\">Peptide E</a></li>\n<li><a href=\"/w/index.php?title=Peptide_F&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Peptide F (page does not exist)\">Peptide F</a></li>\n<li><a href=\"/w/index.php?title=Peptide_I&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Peptide I (page does not exist)\">Peptide I</a></li>\n<li><a href=\"/wiki/Rubiscolin\" title=\"Rubiscolin\">Rubiscolins</a></li>\n<li><a href=\"/w/index.php?title=Soymorphin&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Soymorphin (page does not exist)\">Soymorphins</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align:center;\">Others</th><td class=\"navbox-list navbox-even hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><b><a href=\"/wiki/Enkephalinase_inhibitor\" title=\"Enkephalinase inhibitor\">Enkephalinase inhibitors</a>:</b> <a href=\"/wiki/Amastatin\" title=\"Amastatin\">Amastatin</a></li>\n<li><a href=\"/w/index.php?title=BL-2401&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"BL-2401 (page does not exist)\">BL-2401</a></li>\n<li><a href=\"/wiki/Candoxatril\" title=\"Candoxatril\">Candoxatril</a></li>\n<li><a href=\"/wiki/Phenylalanine#D-,_L-_and_DL-phenylalanine\" title=\"Phenylalanine\"><span style=\"font-size:90%;\">D </span>-Phenylalanine</a></li>\n<li><a href=\"/w/index.php?title=Dexecadotril&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Dexecadotril (page does not exist)\">Dexecadotril (retorphan)</a></li>\n<li><a href=\"/wiki/Ecadotril\" title=\"Ecadotril\">Ecadotril (sinorphan)</a></li>\n<li><a href=\"/wiki/Kelatorphan\" title=\"Kelatorphan\">Kelatorphan</a></li>\n<li><a href=\"/wiki/Racecadotril\" title=\"Racecadotril\">Racecadotril (acetorphan)</a></li>\n<li><a href=\"/wiki/RB-101\" title=\"RB-101\">RB-101</a></li>\n<li><a href=\"/wiki/RB-120\" title=\"RB-120\">RB-120</a></li>\n<li><a href=\"/wiki/RB-3007\" title=\"RB-3007\">RB-3007</a></li>\n<li><a href=\"/w/index.php?title=Opiorphan&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Opiorphan (page does not exist)\">Opiorphan</a></li>\n<li><a href=\"/wiki/Selank\" title=\"Selank\">Selank</a></li>\n<li><a href=\"/wiki/Semax\" title=\"Semax\">Semax</a></li>\n<li><a href=\"/wiki/Spinorphin\" title=\"Spinorphin\">Spinorphin</a></li>\n<li><a href=\"/wiki/Thiorphan\" title=\"Thiorphan\">Thiorphan</a></li>\n<li><a href=\"/wiki/Tynorphin\" title=\"Tynorphin\">Tynorphin</a></li>\n<li><a href=\"/wiki/Ubenimex\" title=\"Ubenimex\">Ubenimex (bestatin)</a></li></ul>\n<ul><li><b>Propeptides:</b> <a href=\"/wiki/%CE%92-Lipotropin\" class=\"mw-redirect\" title=\"\u0392-Lipotropin\">\u03b2-Lipotropin (proendorphin)</a></li>\n<li><a href=\"/wiki/Prodynorphin\" title=\"Prodynorphin\">Prodynorphin</a></li>\n<li><a href=\"/wiki/Proenkephalin\" title=\"Proenkephalin\">Proenkephalin</a></li>\n<li><a href=\"/w/index.php?title=Pronociceptin&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Pronociceptin (page does not exist)\">Pronociceptin</a></li>\n<li><a href=\"/wiki/Proopiomelanocortin\" title=\"Proopiomelanocortin\">Proopiomelanocortin (POMC)</a></li></ul>\n<ul><li><b>Others:</b> <a href=\"/wiki/Kyotorphin\" title=\"Kyotorphin\">Kyotorphin</a> (met-enkephalin releaser/degradation stabilizer)</li></ul>\n</div></td></tr><tr><td class=\"navbox-abovebelow\" colspan=\"2\"><div><i><b>See also:</b> <a href=\"/wiki/Template:Receptor_modulators\" title=\"Template:Receptor modulators\">Receptor/signaling modulators</a> \u2022 <a href=\"/wiki/Template:Signaling_peptide/protein_receptor_modulators\" title=\"Template:Signaling peptide/protein receptor modulators\">Signaling peptide/protein receptor modulators</a></i></div></td></tr></tbody></table></div>\n\n<!-- \nNewPP limit report\nParsed by mw1264\nCached time: 20180909111352\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 1.216 seconds\nReal time usage: 1.387 seconds\nPreprocessor visited node count: 9919/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 280860/2097152 bytes\nTemplate argument size: 11098/2097152 bytes\nHighest expansion depth: 16/40\nExpensive parser function count: 4/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 103893/5000000 bytes\nNumber of Wikibase entities loaded: 1/400\nLua time usage: 0.557/10.000 seconds\nLua memory usage: 10.27 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00% 1126.710      1 -total\n 49.42%  556.846      1 Template:Reflist\n 33.19%  373.918      1 Template:Drugbox\n 24.54%  276.471      1 Template:Infobox\n 21.05%  237.223     36 Template:Cite_journal\n  9.19%  103.521     13 Template:Cite_web\n  5.73%   64.518     16 Template:Unbulleted_list\n  5.68%   64.029      5 Template:Fix\n  5.18%   58.356      4 Template:Citation_needed\n  4.63%   52.217     11 Template:Cite_book\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:1195987-0!canonical and timestamp 20180909111350 and revision id 857016260\n -->\n</div>"},"langlinks":[{"lang":"ar","url":"https://ar.wikipedia.org/wiki/%D9%86%D8%A7%D9%84%D8%AA%D8%B1%D9%8A%D9%83%D8%B3%D9%88%D9%86","langname":"Arabic","autonym":"\u0627\u0644\u0639\u0631\u0628\u064a\u0629","*":"\u0646\u0627\u0644\u062a\u0631\u064a\u0643\u0633\u0648\u0646"},{"lang":"azb","url":"https://azb.wikipedia.org/wiki/%D9%86%D8%A7%D9%84%D8%AA%D8%B1%D9%88%DA%A9%D8%B3%D8%A7%D9%86","langname":"South Azerbaijani","autonym":"\u062a\u06c6\u0631\u06a9\u062c\u0647","*":"\u0646\u0627\u0644\u062a\u0631\u0648\u06a9\u0633\u0627\u0646"},{"lang":"bg","url":"https://bg.wikipedia.org/wiki/%D0%9D%D0%B0%D0%BB%D1%82%D1%80%D0%B5%D0%BA%D1%81%D0%BE%D0%BD","langname":"Bulgarian","autonym":"\u0431\u044a\u043b\u0433\u0430\u0440\u0441\u043a\u0438","*":"\u041d\u0430\u043b\u0442\u0440\u0435\u043a\u0441\u043e\u043d"},{"lang":"cs","url":"https://cs.wikipedia.org/wiki/Naltrexon","langname":"Czech","autonym":"\u010de\u0161tina","*":"Naltrexon"},{"lang":"cy","url":"https://cy.wikipedia.org/wiki/Naltrecson","langname":"Welsh","autonym":"Cymraeg","*":"Naltrecson"},{"lang":"de","url":"https://de.wikipedia.org/wiki/Naltrexon","langname":"German","autonym":"Deutsch","*":"Naltrexon"},{"lang":"es","url":"https://es.wikipedia.org/wiki/Naltrexona","langname":"Spanish","autonym":"espa\u00f1ol","*":"Naltrexona"},{"lang":"fa","url":"https://fa.wikipedia.org/wiki/%D9%86%D8%A7%D9%84%D8%AA%D8%B1%D9%88%DA%A9%D8%B3%D8%A7%D9%86","langname":"Persian","autonym":"\u0641\u0627\u0631\u0633\u06cc","*":"\u0646\u0627\u0644\u062a\u0631\u0648\u06a9\u0633\u0627\u0646"},{"lang":"fr","url":"https://fr.wikipedia.org/wiki/Naltrexone","langname":"French","autonym":"fran\u00e7ais","*":"Naltrexone"},{"lang":"ko","url":"https://ko.wikipedia.org/wiki/%EB%82%A0%ED%8A%B8%EB%A0%89%EC%86%90","langname":"Korean","autonym":"\ud55c\uad6d\uc5b4","*":"\ub0a0\ud2b8\ub809\uc190"},{"lang":"is","url":"https://is.wikipedia.org/wiki/Naltrex%C3%B3n","langname":"Icelandic","autonym":"\u00edslenska","*":"Naltrex\u00f3n"},{"lang":"it","url":"https://it.wikipedia.org/wiki/Naltrexone","langname":"Italian","autonym":"italiano","*":"Naltrexone"},{"lang":"he","url":"https://he.wikipedia.org/wiki/%D7%A0%D7%9C%D7%98%D7%A8%D7%A7%D7%A1%D7%95%D7%9F","langname":"Hebrew","autonym":"\u05e2\u05d1\u05e8\u05d9\u05ea","*":"\u05e0\u05dc\u05d8\u05e8\u05e7\u05e1\u05d5\u05df"},{"lang":"nl","url":"https://nl.wikipedia.org/wiki/Naltrexon","langname":"Dutch","autonym":"Nederlands","*":"Naltrexon"},{"lang":"no","url":"https://no.wikipedia.org/wiki/Naltrekson","langname":"Norwegian","autonym":"norsk","*":"Naltrekson"},{"lang":"or","url":"https://or.wikipedia.org/wiki/%E0%AC%A8%E0%AC%BE%E0%AC%B2%E0%AC%9F%E0%AD%8D%E0%AC%B0%E0%AD%87%E0%AC%95%E0%AD%8D%E0%AC%B8%E0%AD%8B%E0%AC%A8","langname":"Odia","autonym":"\u0b13\u0b21\u0b3c\u0b3f\u0b06","*":"\u0b28\u0b3e\u0b32\u0b1f\u0b4d\u0b30\u0b47\u0b15\u0b4d\u0b38\u0b4b\u0b28"},{"lang":"pl","url":"https://pl.wikipedia.org/wiki/Naltrekson","langname":"Polish","autonym":"polski","*":"Naltrekson"},{"lang":"pt","url":"https://pt.wikipedia.org/wiki/Naltrexona","langname":"Portuguese","autonym":"portugu\u00eas","*":"Naltrexona"},{"lang":"ru","url":"https://ru.wikipedia.org/wiki/%D0%9D%D0%B0%D0%BB%D1%82%D1%80%D0%B5%D0%BA%D1%81%D0%BE%D0%BD","langname":"Russian","autonym":"\u0440\u0443\u0441\u0441\u043a\u0438\u0439","*":"\u041d\u0430\u043b\u0442\u0440\u0435\u043a\u0441\u043e\u043d"},{"lang":"simple","url":"https://simple.wikipedia.org/wiki/Naltrexone","langname":"Simple English","autonym":"Simple English","*":"Naltrexone"},{"lang":"sr","url":"https://sr.wikipedia.org/wiki/Naltrekson","langname":"Serbian","autonym":"\u0441\u0440\u043f\u0441\u043a\u0438 / srpski","*":"Naltrekson"},{"lang":"sh","url":"https://sh.wikipedia.org/wiki/Naltrekson","langname":"Serbo-Croatian","autonym":"srpskohrvatski / \u0441\u0440\u043f\u0441\u043a\u043e\u0445\u0440\u0432\u0430\u0442\u0441\u043a\u0438","*":"Naltrekson"},{"lang":"fi","url":"https://fi.wikipedia.org/wiki/Naltreksoni","langname":"Finnish","autonym":"suomi","*":"Naltreksoni"},{"lang":"sv","url":"https://sv.wikipedia.org/wiki/Naltrexon","langname":"Swedish","autonym":"svenska","*":"Naltrexon"},{"lang":"uk","url":"https://uk.wikipedia.org/wiki/%D0%9D%D0%B0%D0%BB%D1%82%D1%80%D0%B5%D0%BA%D1%81%D0%BE%D0%BD","langname":"Ukrainian","autonym":"\u0443\u043a\u0440\u0430\u0457\u043d\u0441\u044c\u043a\u0430","*":"\u041d\u0430\u043b\u0442\u0440\u0435\u043a\u0441\u043e\u043d"}],"categories":[{"sortkey":"","hidden":"","*":"Webarchive_template_wayback_links"},{"sortkey":"","hidden":"","*":"Wikipedia_articles_needing_page_number_citations_from_January_2017"},{"sortkey":"","hidden":"","*":"CS1_French-language_sources_(fr)"},{"sortkey":"","hidden":"","*":"CS1_Polish-language_sources_(pl)"},{"sortkey":"M","hidden":"","*":"Template:drugs.com_link_with_non-standard_subpage"},{"sortkey":"*","hidden":"","*":"Drugs_with_non-standard_legal_status"},{"sortkey":"","hidden":"","*":"Articles_with_changed_EBI_identifier"},{"sortkey":"*","hidden":"","*":"ECHA_InfoCard_ID_from_Wikidata"},{"sortkey":"","hidden":"","*":"Drugboxes_which_contain_changes_to_verified_fields"},{"sortkey":"","hidden":"","*":"Drugboxes_which_contain_changes_to_watched_fields"},{"sortkey":"","hidden":"","*":"All_articles_with_unsourced_statements"},{"sortkey":"","hidden":"","*":"Articles_with_unsourced_statements_from_December_2009"},{"sortkey":"","hidden":"","*":"Articles_with_unsourced_statements_from_June_2017"},{"sortkey":"","*":"Alcohol_abuse"},{"sortkey":"","*":"Cyclopropanes"},{"sortkey":"","*":"Diols"},{"sortkey":"","*":"Ethers"},{"sortkey":"","*":"GABAA_receptor_negative_allosteric_modulators"},{"sortkey":"","*":"Kappa_antagonists"},{"sortkey":"","*":"Ketones"},{"sortkey":"","*":"Morphinans"},{"sortkey":"","*":"Phenols"},{"sortkey":"","*":"Opioid_antagonists"},{"sortkey":"","hidden":"","*":"RTT"}],"links":[{"ns":0,"*":"Naltrexone (data page)"},{"ns":0,"exists":"","*":"14-Methoxymetopon"},{"ns":0,"exists":"","*":"18-Methoxycoronaridine"},{"ns":0,"exists":"","*":"3-HO-PCP"},{"ns":0,"exists":"","*":"4',7-Dihydroxyflavone"},{"ns":0,"exists":"","*":"4-Caffeoyl-1,5-quinide"},{"ns":0,"exists":"","*":"5'-Guanidinonaltrindole"},{"ns":0,"exists":"","*":"6'-Guanidinonaltrindole"},{"ns":0,"exists":"","*":"6\u03b2-Naltrexol"},{"ns":0,"exists":"","*":"6\u03b2-Naltrexol-d4"},{"ns":0,"exists":"","*":"6\u03b2-naltrexol"},{"ns":0,"exists":"","*":"7-Hydroxymitragynine"},{"ns":0,"exists":"","*":"7-Spiroindanyloxymorphone"},{"ns":0,"exists":"","*":"8-Carboxamidocyclazocine"},{"ns":0,"exists":"","*":"AH-7921"},{"ns":0,"exists":"","*":"AM251"},{"ns":0,"exists":"","*":"AT-076"},{"ns":0,"exists":"","*":"ATC code N07"},{"ns":0,"exists":"","*":"Acamprosate"},{"ns":0,"exists":"","*":"Acetaldehyde dehydrogenase inhibitor"},{"ns":0,"exists":"","*":"Acetyldihydrocodeine"},{"ns":0,"exists":"","*":"Acetylfentanyl"},{"ns":0,"exists":"","*":"Acrylfentanyl"},{"ns":0,"exists":"","*":"Active metabolite"},{"ns":0,"exists":"","*":"Adrenergic agonist"},{"ns":0,"exists":"","*":"Adrenorphin"},{"ns":0,"exists":"","*":"Akuammicine"},{"ns":0,"exists":"","*":"Akuammine"},{"ns":0,"exists":"","*":"Alazocine"},{"ns":0,"exists":"","*":"Alcohol dependence"},{"ns":0,"exists":"","*":"Alcoholism"},{"ns":0,"exists":"","*":"Alfentanil"},{"ns":0,"exists":"","*":"Alkermes (company)"},{"ns":0,"exists":"","*":"Alvimopan"},{"ns":0,"exists":"","*":"Amastatin"},{"ns":0,"exists":"","*":"Amentoflavone"},{"ns":0,"exists":"","*":"American Society of Health-System Pharmacists"},{"ns":0,"exists":"","*":"Amidorphin"},{"ns":0,"exists":"","*":"Amitriptyline"},{"ns":0,"exists":"","*":"Amoxapine"},{"ns":0,"exists":"","*":"Anatomical Therapeutic Chemical Classification System"},{"ns":0,"exists":"","*":"Anileridine"},{"ns":0,"exists":"","*":"Anxiety"},{"ns":0,"exists":"","*":"Apigenin"},{"ns":0,"exists":"","*":"Apparicine"},{"ns":0,"exists":"","*":"Archives of General Psychiatry"},{"ns":0,"exists":"","*":"Asimadoline"},{"ns":0,"exists":"","*":"Axelopran"},{"ns":0,"exists":"","*":"BRL-52537"},{"ns":0,"exists":"","*":"BTRX-246040"},{"ns":0,"exists":"","*":"BU-48"},{"ns":0,"exists":"","*":"BU09059"},{"ns":0,"exists":"","*":"BW-373U86"},{"ns":0,"exists":"","*":"Baclofen"},{"ns":0,"exists":"","*":"Barbiturate"},{"ns":0,"exists":"","*":"Benzhydrocodone"},{"ns":0,"exists":"","*":"Benzodiazepine"},{"ns":0,"exists":"","*":"Benzodiazepine dependence"},{"ns":0,"exists":"","*":"Benzylmorphine"},{"ns":0,"exists":"","*":"Beta-Funaltrexamine"},{"ns":0,"exists":"","*":"Beta-endorphin"},{"ns":0,"exists":"","*":"Bevenopran"},{"ns":0,"exists":"","*":"Bezitramide"},{"ns":0,"exists":"","*":"Big dynorphin"},{"ns":0,"exists":"","*":"Binaltorphimine"},{"ns":0,"exists":"","*":"Binding affinity"},{"ns":0,"exists":"","*":"Bioavailability"},{"ns":0,"exists":"","*":"Biological half-life"},{"ns":0,"exists":"","*":"Biphalin"},{"ns":0,"exists":"","*":"Blood\u2013brain barrier"},{"ns":0,"exists":"","*":"Bremazocine"},{"ns":0,"exists":"","*":"British Approved Name"},{"ns":0,"exists":"","*":"Buprenorphine"},{"ns":0,"exists":"","*":"Buprenorphine/naloxone"},{"ns":0,"exists":"","*":"Buprenorphine/naltrexone"},{"ns":0,"exists":"","*":"Buprenorphine/samidorphan"},{"ns":0,"exists":"","*":"Bupropion"},{"ns":0,"exists":"","*":"Bupropion/naltrexone"},{"ns":0,"exists":"","*":"Butorphanol"},{"ns":0,"exists":"","*":"Butyrfentanyl"},{"ns":0,"exists":"","*":"CAS Registry Number"},{"ns":0,"exists":"","*":"CERC-501"},{"ns":0,"exists":"","*":"CR665"},{"ns":0,"exists":"","*":"Calcium carbimide"},{"ns":0,"exists":"","*":"Cancer"},{"ns":0,"exists":"","*":"Candoxatril"},{"ns":0,"exists":"","*":"Cannabidiol"},{"ns":0,"exists":"","*":"Carfentanil"},{"ns":0,"exists":"","*":"Casokefamide"},{"ns":0,"exists":"","*":"Catechin"},{"ns":0,"exists":"","*":"Catechin gallate"},{"ns":0,"exists":"","*":"Catnip"},{"ns":0,"exists":"","*":"Cebranopadol"},{"ns":0,"exists":"","*":"ChEBI"},{"ns":0,"exists":"","*":"ChEMBL"},{"ns":0,"exists":"","*":"ChemSpider"},{"ns":0,"exists":"","*":"Chemical formula"},{"ns":0,"exists":"","*":"Chemical synthesis"},{"ns":0,"exists":"","*":"Chlordiazepoxide"},{"ns":0,"exists":"","*":"Chloroxymorphamine"},{"ns":0,"exists":"","*":"Ciprefadol"},{"ns":0,"exists":"","*":"Clinical trial"},{"ns":0,"exists":"","*":"Clocinnamox"},{"ns":0,"exists":"","*":"Clonidine"},{"ns":0,"exists":"","*":"Codeine"},{"ns":0,"exists":"","*":"Competitive antagonist"},{"ns":0,"exists":"","*":"Compliance (medicine)"},{"ns":0,"exists":"","*":"Conjugation (biochemistry)"},{"ns":0,"exists":"","*":"Contingency management"},{"ns":0,"exists":"","*":"Coronaridine"},{"ns":0,"exists":"","*":"Cyclazocine"},{"ns":0,"exists":"","*":"Cyclorphan"},{"ns":0,"exists":"","*":"Cyprenorphine"},{"ns":0,"exists":"","*":"Cyprodime"},{"ns":0,"exists":"","*":"Cyproterone acetate"},{"ns":0,"exists":"","*":"Cytisine"},{"ns":0,"exists":"","*":"Cytochrophin-4"},{"ns":0,"exists":"","*":"Cytokine"},{"ns":0,"exists":"","*":"DADLE"},{"ns":0,"exists":"","*":"DAMGO"},{"ns":0,"exists":"","*":"DPDPE"},{"ns":0,"exists":"","*":"DPI-221"},{"ns":0,"exists":"","*":"DPI-3290"},{"ns":0,"exists":"","*":"Defined daily dose"},{"ns":0,"exists":"","*":"Deltorphin"},{"ns":0,"exists":"","*":"Deltorphin I"},{"ns":0,"exists":"","*":"Denominazione Comune Italiana"},{"ns":0,"exists":"","*":"Depersonalization"},{"ns":0,"exists":"","*":"Derealization"},{"ns":0,"exists":"","*":"Dermorphin"},{"ns":0,"exists":"","*":"Desipramine"},{"ns":0,"exists":"","*":"Desmethylclozapine"},{"ns":0,"exists":"","*":"Desmetramadol"},{"ns":0,"exists":"","*":"Desomorphine"},{"ns":0,"exists":"","*":"Dextromoramide"},{"ns":0,"exists":"","*":"Dextropropoxyphene"},{"ns":0,"exists":"","*":"Dezocine"},{"ns":0,"exists":"","*":"Diacetylnalorphine"},{"ns":0,"exists":"","*":"Diarrhea"},{"ns":0,"exists":"","*":"Diazepam"},{"ns":0,"exists":"","*":"Difelikefalin"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Dihydrocodeine"},{"ns":0,"exists":"","*":"Dihydroetorphine"},{"ns":0,"exists":"","*":"Dihydromorphine"},{"ns":0,"exists":"","*":"Dimenoxadol"},{"ns":0,"exists":"","*":"Dimethylaminopivalophenone"},{"ns":0,"exists":"","*":"Dinalbuphine sebacate"},{"ns":0,"exists":"","*":"Diphenoxylate"},{"ns":0,"exists":"","*":"Dipipanone"},{"ns":0,"exists":"","*":"Diprenorphine"},{"ns":0,"exists":"","*":"Dissociation (psychology)"},{"ns":0,"exists":"","*":"Disulfiram"},{"ns":0,"exists":"","*":"Dopaminergic"},{"ns":0,"exists":"","*":"DrugBank"},{"ns":0,"exists":"","*":"Drug metabolism"},{"ns":0,"exists":"","*":"Drug nomenclature"},{"ns":0,"exists":"","*":"Drugs.com"},{"ns":0,"exists":"","*":"DuPont"},{"ns":0,"exists":"","*":"Duration of action"},{"ns":0,"exists":"","*":"Dynorphin A"},{"ns":0,"exists":"","*":"Dynorphin B"},{"ns":0,"exists":"","*":"Dysphoria"},{"ns":0,"exists":"","*":"D\u00e9nomination Commune Fran\u00e7aise"},{"ns":0,"exists":"","*":"ECHA InfoCard"},{"ns":0,"exists":"","*":"Ecadotril"},{"ns":0,"exists":"","*":"Eluxadoline"},{"ns":0,"exists":"","*":"Embutramide"},{"ns":0,"exists":"","*":"Enadoline"},{"ns":0,"exists":"","*":"Endomorphin-1"},{"ns":0,"exists":"","*":"Endomorphin-2"},{"ns":0,"exists":"","*":"Endorphin"},{"ns":0,"exists":"","*":"Enkephalinase inhibitor"},{"ns":0,"exists":"","*":"Enzyme"},{"ns":0,"exists":"","*":"Epicatechin"},{"ns":0,"exists":"","*":"Epicatechin gallate"},{"ns":0,"exists":"","*":"Epigallocatechin"},{"ns":0,"exists":"","*":"Eptazocine"},{"ns":0,"exists":"","*":"Eseroline"},{"ns":0,"exists":"","*":"Ethylketazocine"},{"ns":0,"exists":"","*":"Ethylmorphine"},{"ns":0,"exists":"","*":"Etorphine"},{"ns":0,"exists":"","*":"Excretion"},{"ns":0,"exists":"","*":"Fedotozine"},{"ns":0,"exists":"","*":"Fentanyl"},{"ns":0,"exists":"","*":"Fibromyalgia"},{"ns":0,"exists":"","*":"Fluorophen"},{"ns":0,"exists":"","*":"Frakefamide"},{"ns":0,"exists":"","*":"Furanylfentanyl"},{"ns":0,"exists":"","*":"GR-89696"},{"ns":0,"exists":"","*":"Gastrointestinal"},{"ns":0,"exists":"","*":"Gemazocine"},{"ns":0,"exists":"","*":"Generic term"},{"ns":0,"exists":"","*":"Gliadorphin"},{"ns":0,"exists":"","*":"Glucuronide"},{"ns":0,"exists":"","*":"Gluten exorphin"},{"ns":0,"exists":"","*":"Guide to Pharmacology"},{"ns":0,"exists":"","*":"HIV"},{"ns":0,"exists":"","*":"HZ-2"},{"ns":0,"exists":"","*":"Headache"},{"ns":0,"exists":"","*":"Hemorphin"},{"ns":0,"exists":"","*":"Hemorphin-4"},{"ns":0,"exists":"","*":"Herkinorin"},{"ns":0,"exists":"","*":"Heroin"},{"ns":0,"exists":"","*":"Hodgkinsine"},{"ns":0,"exists":"","*":"Hydrocodone"},{"ns":0,"exists":"","*":"Hydrogen cyanamide"},{"ns":0,"exists":"","*":"Hydromorphinol"},{"ns":0,"exists":"","*":"Hydromorphone"},{"ns":0,"exists":"","*":"Hyperoside"},{"ns":0,"exists":"","*":"IBNtxA"},{"ns":0,"exists":"","*":"ICI-199,441"},{"ns":0,"exists":"","*":"ICI-204,448"},{"ns":0,"exists":"","*":"IUPAC nomenclature of chemistry"},{"ns":0,"exists":"","*":"Ibogaine"},{"ns":0,"exists":"","*":"Ibogamine"},{"ns":0,"exists":"","*":"Imipramine"},{"ns":0,"exists":"","*":"Inhibitor constant"},{"ns":0,"exists":"","*":"Injection (medicine)"},{"ns":0,"exists":"","*":"Institut de l'information scientifique et technique"},{"ns":0,"exists":"","*":"Interferon alpha"},{"ns":0,"exists":"","*":"International Chemical Identifier"},{"ns":0,"exists":"","*":"International Nonproprietary Name"},{"ns":0,"exists":"","*":"International Standard Book Number"},{"ns":0,"exists":"","*":"International Standard Serial Number"},{"ns":0,"exists":"","*":"Internet"},{"ns":0,"exists":"","*":"Intramuscular"},{"ns":0,"exists":"","*":"Intramuscular injection"},{"ns":0,"exists":"","*":"Isomethadone"},{"ns":0,"exists":"","*":"J-113397"},{"ns":0,"exists":"","*":"JDTic"},{"ns":0,"exists":"","*":"JSmol"},{"ns":0,"exists":"","*":"JTC-801"},{"ns":0,"exists":"","*":"KEGG"},{"ns":0,"exists":"","*":"Kava"},{"ns":0,"exists":"","*":"Kelatorphan"},{"ns":0,"exists":"","*":"Ketamine"},{"ns":0,"exists":"","*":"Ketazocine"},{"ns":0,"exists":"","*":"Ketobemidone"},{"ns":0,"exists":"","*":"Kleptomania"},{"ns":0,"exists":"","*":"Kyotorphin"},{"ns":0,"exists":"","*":"LPK-26"},{"ns":0,"exists":"","*":"LY-2459989"},{"ns":0,"exists":"","*":"LY-255582"},{"ns":0,"exists":"","*":"Laudanosine"},{"ns":0,"exists":"","*":"Lefetamine"},{"ns":0,"exists":"","*":"Leu-enkephalin"},{"ns":0,"exists":"","*":"Leumorphin"},{"ns":0,"exists":"","*":"Levacetylmethadol"},{"ns":0,"exists":"","*":"Levallorphan"},{"ns":0,"exists":"","*":"Levomethorphan"},{"ns":0,"exists":"","*":"Levorphanol"},{"ns":0,"exists":"","*":"List of opioids"},{"ns":0,"exists":"","*":"Liver"},{"ns":0,"exists":"","*":"Liver failure"},{"ns":0,"exists":"","*":"Lobeline"},{"ns":0,"exists":"","*":"Lofentanil"},{"ns":0,"exists":"","*":"Lofexidine"},{"ns":0,"exists":"","*":"Loperamide"},{"ns":0,"exists":"","*":"Lorazepam"},{"ns":0,"exists":"","*":"Low-dose naltrexone"},{"ns":0,"exists":"","*":"Lufuradom"},{"ns":0,"exists":"","*":"MCOPPB"},{"ns":0,"exists":"","*":"Matrine"},{"ns":0,"exists":"","*":"Mecamylamine"},{"ns":0,"exists":"","*":"Medical management"},{"ns":0,"exists":"","*":"Medication"},{"ns":0,"exists":"","*":"MedlinePlus"},{"ns":0,"exists":"","*":"Melting point"},{"ns":0,"exists":"","*":"Menthol"},{"ns":0,"exists":"","*":"Meptazinol"},{"ns":0,"exists":"","*":"Mesolimbic pathway"},{"ns":0,"exists":"","*":"Met-enkephalin"},{"ns":0,"exists":"","*":"Metabolism"},{"ns":0,"exists":"","*":"Metabolite"},{"ns":0,"exists":"","*":"Metadoxine"},{"ns":0,"exists":"","*":"Metazocine"},{"ns":0,"exists":"","*":"Methadone"},{"ns":0,"exists":"","*":"Methyl"},{"ns":0,"exists":"","*":"Methylcyclopropane"},{"ns":0,"exists":"","*":"Methylnaltrexone"},{"ns":0,"exists":"","*":"Metkefamide"},{"ns":0,"exists":"","*":"Metopon"},{"ns":0,"exists":"","*":"Mianserin"},{"ns":0,"exists":"","*":"Mirtazapine"},{"ns":0,"exists":"","*":"Mitragyna speciosa"},{"ns":0,"exists":"","*":"Mitragynine"},{"ns":0,"exists":"","*":"Mitragynine pseudoindoxyl"},{"ns":0,"exists":"","*":"Molar mass"},{"ns":0,"exists":"","*":"Morphiceptin"},{"ns":0,"exists":"","*":"Morphine"},{"ns":0,"exists":"","*":"Morphine/naltrexone"},{"ns":0,"exists":"","*":"Moxazocine"},{"ns":0,"exists":"","*":"Multiple sclerosis"},{"ns":0,"exists":"","*":"N-Ethylmaleimide"},{"ns":0,"exists":"","*":"N-Phenethyl-14-ethoxymetopon"},{"ns":0,"exists":"","*":"NFEPP"},{"ns":0,"exists":"","*":"NNC 63-0532"},{"ns":0,"exists":"","*":"Nalbuphine"},{"ns":0,"exists":"","*":"Naldemedine"},{"ns":0,"exists":"","*":"Nalfurafine"},{"ns":0,"exists":"","*":"Nalmefene"},{"ns":0,"exists":"","*":"Nalmexone"},{"ns":0,"exists":"","*":"Nalodeine"},{"ns":0,"exists":"","*":"Nalorphine"},{"ns":0,"exists":"","*":"Nalorphine dinicotinate"},{"ns":0,"exists":"","*":"Naloxazone"},{"ns":0,"exists":"","*":"Naloxegol"},{"ns":0,"exists":"","*":"Naloxol"},{"ns":0,"exists":"","*":"Naloxonazine"},{"ns":0,"exists":"","*":"Naloxone"},{"ns":0,"exists":"","*":"Naltalimide"},{"ns":0,"exists":"","*":"Naltriben"},{"ns":0,"exists":"","*":"Naltrindole"},{"ns":0,"exists":"","*":"Naringenin"},{"ns":0,"exists":"","*":"National Institute on Drug Abuse"},{"ns":0,"exists":"","*":"National Institutes of Health"},{"ns":0,"exists":"","*":"Nausea"},{"ns":0,"exists":"","*":"Neoendorphin"},{"ns":0,"exists":"","*":"Nepetalactone"},{"ns":0,"exists":"","*":"New York City"},{"ns":0,"exists":"","*":"Nicocodeine"},{"ns":0,"exists":"","*":"Nicodicodeine"},{"ns":0,"exists":"","*":"Nicomorphine"},{"ns":0,"exists":"","*":"Nicotine dependence"},{"ns":0,"exists":"","*":"Nociceptin"},{"ns":0,"exists":"","*":"Nociceptin receptor"},{"ns":0,"exists":"","*":"Norbinaltorphimine"},{"ns":0,"exists":"","*":"Norbuprenorphine"},{"ns":0,"exists":"","*":"Norbuprenorphine-3-glucuronide"},{"ns":0,"exists":"","*":"Noribogaine"},{"ns":0,"exists":"","*":"Norketamine"},{"ns":0,"exists":"","*":"Nortriptyline"},{"ns":0,"exists":"","*":"OPRM1"},{"ns":0,"exists":"","*":"Obesity"},{"ns":0,"exists":"","*":"Octreotide"},{"ns":0,"exists":"","*":"Off-label use"},{"ns":0,"exists":"","*":"Oliceridine"},{"ns":0,"exists":"","*":"One Little Pill (2014 film)"},{"ns":0,"exists":"","*":"Opioid"},{"ns":0,"exists":"","*":"Opioid antagonist"},{"ns":0,"exists":"","*":"Opioid dependence"},{"ns":0,"exists":"","*":"Opioid receptor"},{"ns":0,"exists":"","*":"Opioid use disorder"},{"ns":0,"exists":"","*":"Opioid withdrawal"},{"ns":0,"exists":"","*":"Opium"},{"ns":0,"exists":"","*":"Oral administration"},{"ns":0,"exists":"","*":"Oripavine"},{"ns":0,"exists":"","*":"Overdose"},{"ns":0,"exists":"","*":"Oxazepam"},{"ns":0,"exists":"","*":"Oxilorphan"},{"ns":0,"exists":"","*":"Oxycodone"},{"ns":0,"exists":"","*":"Oxymorphazone"},{"ns":0,"exists":"","*":"Oxymorphone"},{"ns":0,"exists":"","*":"Oxymorphone-3-methoxynaltrexonazine"},{"ns":0,"exists":"","*":"PF-4455242"},{"ns":0,"exists":"","*":"PZM21"},{"ns":0,"exists":"","*":"Papaver somniferum"},{"ns":0,"exists":"","*":"Patent"},{"ns":0,"exists":"","*":"Pawhuskin A"},{"ns":0,"exists":"","*":"Pentazocine"},{"ns":0,"exists":"","*":"Pericine"},{"ns":0,"exists":"","*":"Pethidine"},{"ns":0,"exists":"","*":"Pharmaceutical company"},{"ns":0,"exists":"","*":"Pharmacokinetics"},{"ns":0,"exists":"","*":"Phenazocine"},{"ns":0,"exists":"","*":"Phencyclidine"},{"ns":0,"exists":"","*":"Phenibut"},{"ns":0,"exists":"","*":"Phenobarbital"},{"ns":0,"exists":"","*":"Phenylalanine"},{"ns":0,"exists":"","*":"Picenadol"},{"ns":0,"exists":"","*":"Piminodine"},{"ns":0,"exists":"","*":"Piritramide"},{"ns":0,"exists":"","*":"Plasma protein binding"},{"ns":0,"exists":"","*":"Pornography addiction"},{"ns":0,"exists":"","*":"Potency (pharmacology)"},{"ns":0,"exists":"","*":"Pregnancy"},{"ns":0,"exists":"","*":"Pregnancy category"},{"ns":0,"exists":"","*":"Prescription drug"},{"ns":0,"exists":"","*":"Prodine"},{"ns":0,"exists":"","*":"Prodynorphin"},{"ns":0,"exists":"","*":"Proenkephalin"},{"ns":0,"exists":"","*":"Proglumide"},{"ns":0,"exists":"","*":"Proopiomelanocortin"},{"ns":0,"exists":"","*":"Propiram"},{"ns":0,"exists":"","*":"Proxorphan"},{"ns":0,"exists":"","*":"PubChem"},{"ns":0,"exists":"","*":"PubMed Central"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Quadazocine"},{"ns":0,"exists":"","*":"RB-101"},{"ns":0,"exists":"","*":"RB-120"},{"ns":0,"exists":"","*":"RB-3007"},{"ns":0,"exists":"","*":"RB-64"},{"ns":0,"exists":"","*":"RWJ-394674"},{"ns":0,"exists":"","*":"Racecadotril"},{"ns":0,"exists":"","*":"Racemethorphan"},{"ns":0,"exists":"","*":"Racemorphan"},{"ns":0,"exists":"","*":"Receptor modulator"},{"ns":0,"exists":"","*":"Regulation of therapeutic goods"},{"ns":0,"exists":"","*":"Remifentanil"},{"ns":0,"exists":"","*":"Rimonabant"},{"ns":0,"exists":"","*":"Ro64-6198"},{"ns":0,"exists":"","*":"Route of administration"},{"ns":0,"exists":"","*":"Rubiscolin"},{"ns":0,"exists":"","*":"SB-612111"},{"ns":0,"exists":"","*":"SC-17599"},{"ns":0,"exists":"","*":"SNC-80"},{"ns":0,"exists":"","*":"Salvia divinorum"},{"ns":0,"exists":"","*":"Salvinorin A"},{"ns":0,"exists":"","*":"Salvinorin B ethoxymethyl ether"},{"ns":0,"exists":"","*":"Salvinorin B methoxymethyl ether"},{"ns":0,"exists":"","*":"Samidorphan"},{"ns":0,"exists":"","*":"Selank"},{"ns":0,"exists":"","*":"Self-injury"},{"ns":0,"exists":"","*":"Semax"},{"ns":0,"exists":"","*":"Simplified molecular-input line-entry system"},{"ns":0,"exists":"","*":"Sinclair method"},{"ns":0,"exists":"","*":"Single-nucleotide polymorphism"},{"ns":0,"exists":"","*":"Sinomenine"},{"ns":0,"exists":"","*":"Smoking cessation"},{"ns":0,"exists":"","*":"SoRI-9409"},{"ns":0,"exists":"","*":"Spinorphin"},{"ns":0,"exists":"","*":"Spiradoline"},{"ns":0,"exists":"","*":"Standard for the Uniform Scheduling of Drugs and Poisons"},{"ns":0,"exists":"","*":"Subcutaneous implant"},{"ns":0,"exists":"","*":"Substance dependence"},{"ns":0,"exists":"","*":"Sufentanil"},{"ns":0,"exists":"","*":"TAN-67"},{"ns":0,"exists":"","*":"TRIMU 5"},{"ns":0,"exists":"","*":"Tabernanthine"},{"ns":0,"exists":"","*":"Tablet (pharmacy)"},{"ns":0,"exists":"","*":"Tapentadol"},{"ns":0,"exists":"","*":"Taxifolin"},{"ns":0,"exists":"","*":"Tertiary amine"},{"ns":0,"exists":"","*":"Tetrahydrocannabinol"},{"ns":0,"exists":"","*":"Tetrahydropapaveroline"},{"ns":0,"exists":"","*":"The New York Times"},{"ns":0,"exists":"","*":"Thebaine"},{"ns":0,"exists":"","*":"Thienorphine"},{"ns":0,"exists":"","*":"Thiobromadol"},{"ns":0,"exists":"","*":"Thiorphan"},{"ns":0,"exists":"","*":"Tianeptine"},{"ns":0,"exists":"","*":"Tifluadom"},{"ns":0,"exists":"","*":"Tilidine"},{"ns":0,"exists":"","*":"Tom Price (American politician)"},{"ns":0,"exists":"","*":"Tonazocine"},{"ns":0,"exists":"","*":"Topiramate"},{"ns":0,"exists":"","*":"Tramadol"},{"ns":0,"exists":"","*":"Trichotillomania"},{"ns":0,"exists":"","*":"Tricyclic antidepressant"},{"ns":0,"exists":"","*":"Trimebutine"},{"ns":0,"exists":"","*":"Trouble sleeping"},{"ns":0,"exists":"","*":"Tynorphin"},{"ns":0,"exists":"","*":"U-47700"},{"ns":0,"exists":"","*":"U-50,488"},{"ns":0,"exists":"","*":"U-69,593"},{"ns":0,"exists":"","*":"Ubenimex"},{"ns":0,"exists":"","*":"Unique Ingredient Identifier"},{"ns":0,"exists":"","*":"United States Adopted Name"},{"ns":0,"exists":"","*":"United States Pharmacopeia"},{"ns":0,"exists":"","*":"United States Secretary of Health and Human Services"},{"ns":0,"exists":"","*":"Urine"},{"ns":0,"exists":"","*":"Valorphin"},{"ns":0,"exists":"","*":"Varenicline"},{"ns":0,"exists":"","*":"Viminol"},{"ns":0,"exists":"","*":"Wayback Machine"},{"ns":0,"exists":"","*":"Xorphanol"},{"ns":0,"exists":"","*":"Zenazocine"},{"ns":0,"exists":"","*":"Zyklophin"},{"ns":0,"exists":"","*":"\u0391-Chlornaltrexamine"},{"ns":0,"exists":"","*":"\u0392-Casomorphin"},{"ns":0,"exists":"","*":"\u0392-Chlornaltrexamine"},{"ns":0,"exists":"","*":"\u0392-Endorphin"},{"ns":0,"exists":"","*":"\u0392-Lipotropin"},{"ns":0,"exists":"","*":"\u0394-Opioid receptor"},{"ns":0,"exists":"","*":"\u0394-opioid receptor"},{"ns":0,"exists":"","*":"\u039a-Opioid receptor"},{"ns":0,"exists":"","*":"\u039a-opioid receptor"},{"ns":0,"exists":"","*":"\u039c-Opioid receptor"},{"ns":0,"exists":"","*":"\u039c-opioid receptor"},{"ns":0,"*":"Dihydrodiol dehydrogenase"},{"ns":0,"*":"7-Acetoxymitragynine"},{"ns":0,"*":"\u03a8-Akuammigine"},{"ns":0,"*":"Alpha-Narcotine"},{"ns":0,"*":"Akuammidine"},{"ns":0,"*":"Bovine adrenal medullary peptide-12P"},{"ns":0,"*":"Bovine adrenal medullary peptide-18P"},{"ns":0,"*":"Bovine adrenal medullary peptide-22P"},{"ns":0,"*":"BU08070"},{"ns":0,"*":"Butorphan"},{"ns":0,"*":"Lexanopadol"},{"ns":0,"*":"Loxicodegol"},{"ns":0,"*":"Naloxone benzoylhydrazone"},{"ns":0,"*":"Neopine"},{"ns":0,"*":"NKTR-181"},{"ns":0,"*":"Oxymorphonazine"},{"ns":0,"*":"Oxymorphone phenylhydrazone"},{"ns":0,"*":"Oxymorphone p-nitrophenylhydrazone"},{"ns":0,"*":"PL-017"},{"ns":0,"*":"Salsolinol"},{"ns":0,"*":"TH-030418"},{"ns":0,"*":"TRV734"},{"ns":0,"*":"Tubotaiwine"},{"ns":0,"*":"BMS-986121"},{"ns":0,"*":"BMS-986122"},{"ns":0,"*":"3CS-nalmefene"},{"ns":0,"*":"4\u2032-Hydroxyflavanone"},{"ns":0,"*":"Alpha-Gliadin"},{"ns":0,"*":"CTAP"},{"ns":0,"*":"CTOP"},{"ns":0,"*":"Cyclofoxy"},{"ns":0,"*":"Ginsenoside R"},{"ns":0,"*":"LY-2196044"},{"ns":0,"*":"Methocinnamox"},{"ns":0,"*":"Methylsamidorphan chloride"},{"ns":0,"*":"Naltrexazone"},{"ns":0,"*":"Naltrexonazine"},{"ns":0,"*":"Dihydroakuuamine"},{"ns":0,"*":"ADL-5747"},{"ns":0,"*":"ADL-5859"},{"ns":0,"*":"AR-M100390"},{"ns":0,"*":"AZD2327"},{"ns":0,"*":"Deltorphin II"},{"ns":0,"*":"(D-Ser2, Leu5, Thr6)-Enkephalin"},{"ns":0,"*":"Fentanyl isothiocyanate"},{"ns":0,"*":"JNJ-20788560"},{"ns":0,"*":"KNT-127"},{"ns":0,"*":"SB-235863"},{"ns":0,"*":"SNC-162"},{"ns":0,"*":"TRV250"},{"ns":0,"*":"Naltrindole-5'-isothiocyanate"},{"ns":0,"*":"Alpha-Santolol"},{"ns":0,"*":"7-Benzylidenenaltrexone"},{"ns":0,"*":"ICI-154129"},{"ns":0,"*":"ICI-174864"},{"ns":0,"*":"Methylnaltrindole"},{"ns":0,"*":"N-Benzylnaltrindole"},{"ns":0,"*":"SDM25N"},{"ns":0,"*":"Akuuamicine"},{"ns":0,"*":"Allomatrine"},{"ns":0,"*":"Apadoline"},{"ns":0,"*":"Erinacine E"},{"ns":0,"*":"GR-103545"},{"ns":0,"*":"HS665"},{"ns":0,"*":"MB-1C-OH"},{"ns":0,"*":"MR-2034"},{"ns":0,"*":"N-MPPP"},{"ns":0,"*":"Niravoline"},{"ns":0,"*":"U-54,494A"},{"ns":0,"*":"5'-Acetamidinoethylnaltrindole"},{"ns":0,"*":"Arodyne"},{"ns":0,"*":"AZ-MTAB"},{"ns":0,"*":"DIPPA"},{"ns":0,"*":"LY-2444296"},{"ns":0,"*":"LY-2795050"},{"ns":0,"*":"MeJDTic"},{"ns":0,"*":"ML190"},{"ns":0,"*":"ML350"},{"ns":0,"*":"MR-2266"},{"ns":0,"*":"N-Fluoropropyl-JDTic"},{"ns":0,"*":"UPHIT"},{"ns":0,"*":"(Arg14,Lys15)Nociceptin"},{"ns":0,"*":"((pF)Phe4)Nociceptin(1-13)NH2"},{"ns":0,"*":"(Phe1\u03a8(CH2-NH)Gly2)Nociceptin(1-13)NH2"},{"ns":0,"*":"Ac-RYYRWK-NH2"},{"ns":0,"*":"Ac-RYYRIK-NH2"},{"ns":0,"*":"JNJ-19385899"},{"ns":0,"*":"MT-7716"},{"ns":0,"*":"Nociceptin (1-11)"},{"ns":0,"*":"Nociceptin (1-13)NH2"},{"ns":0,"*":"Ro65-6570"},{"ns":0,"*":"SCH-221510"},{"ns":0,"*":"SCH-486757"},{"ns":0,"*":"SR-8993"},{"ns":0,"*":"SR-16435"},{"ns":0,"*":"(Nphe1)Nociceptin(1-13)NH2"},{"ns":0,"*":"BAN-ORL-24"},{"ns":0,"*":"Nociceptin (1-7)"},{"ns":0,"*":"Nocistatin"},{"ns":0,"*":"SR-16430"},{"ns":0,"*":"Trap-101"},{"ns":0,"*":"UFP-101"},{"ns":0,"*":"BAM-20P"},{"ns":0,"*":"Deprolorphin"},{"ns":0,"*":"Met5-Enkephalin-Arg6,Phe7,Leu8"},{"ns":0,"*":"Met5-Enkephalin-Arg6,Phe7"},{"ns":0,"*":"Peptide B"},{"ns":0,"*":"Peptide E"},{"ns":0,"*":"Peptide F"},{"ns":0,"*":"Peptide I"},{"ns":0,"*":"Soymorphin"},{"ns":0,"*":"BL-2401"},{"ns":0,"*":"Dexecadotril"},{"ns":0,"*":"Opiorphan"},{"ns":0,"*":"Pronociceptin"},{"ns":14,"exists":"","*":"Category:Articles with unsourced statements from December 2009"},{"ns":14,"exists":"","*":"Category:Articles with unsourced statements from June 2017"},{"ns":14,"exists":"","*":"Category:Wikipedia articles needing page number citations from January 2017"},{"ns":10,"exists":"","*":"Template:Dependence treatment"},{"ns":10,"exists":"","*":"Template:Opioid receptor modulators"},{"ns":10,"exists":"","*":"Template:Receptor modulators"},{"ns":10,"exists":"","*":"Template:Signaling peptide/protein receptor modulators"},{"ns":4,"exists":"","*":"Wikipedia:Citation needed"},{"ns":4,"exists":"","*":"Wikipedia:Citing sources"},{"ns":4,"exists":"","*":"Wikipedia:WikiProject Chemicals/Chembox validation"},{"ns":11,"exists":"","*":"Template talk:Dependence treatment"},{"ns":11,"exists":"","*":"Template talk:Opioid receptor modulators"}],"templates":[{"ns":10,"exists":"","*":"Template:Distinguish"},{"ns":10,"exists":"","*":"Template:Drugbox"},{"ns":10,"exists":"","*":"Template:Infobox drug"},{"ns":10,"exists":"","*":"Template:Infobox"},{"ns":10,"exists":"","*":"Template:Infobox drug/title"},{"ns":10,"exists":"","*":"Template:Drugs.com"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":10,"exists":"","*":"Template:Infobox drug/licence"},{"ns":10,"exists":"","*":"Template:Infobox drug/pregnancy category"},{"ns":10,"exists":"","*":"Template:Abbr"},{"ns":10,"exists":"","*":"Template:Unbulleted list"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatATC"},{"ns":10,"exists":"","*":"Template:Infobox drug/legal status"},{"ns":10,"exists":"","*":"Template:Nowrap"},{"ns":10,"exists":"","*":"Template:Collapsible list"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatCASnumber"},{"ns":10,"exists":"","*":"Template:Cascite"},{"ns":10,"exists":"","*":"Template:Tick"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatPubChemCID"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatPubChemSID"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatIUPHARBPS"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatDrugBank"},{"ns":10,"exists":"","*":"Template:Drugbankcite"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatChemSpider"},{"ns":10,"exists":"","*":"Template:Chemspidercite"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatUNII"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatKEGG"},{"ns":10,"exists":"","*":"Template:Keggcite"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatChEBI"},{"ns":10,"exists":"","*":"Template:Ebicite"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatChEMBL"},{"ns":10,"exists":"","*":"Template:Cross"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatChemDBNIAID"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatPDBligand"},{"ns":10,"exists":"","*":"Template:EditAtWikidata"},{"ns":10,"exists":"","*":"Template:Infobox drug/chemical formula"},{"ns":10,"exists":"","*":"Template:Chembox Elements/molecular formula"},{"ns":10,"exists":"","*":"Template:Yesno"},{"ns":10,"exists":"","*":"Template:Chem molar mass"},{"ns":10,"exists":"","*":"Template:Chem molar mass/format"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatJmol"},{"ns":10,"exists":"","*":"Template:Convert"},{"ns":10,"exists":"","*":"Template:Stdinchicite"},{"ns":10,"exists":"","*":"Template:Nobold"},{"ns":10,"exists":"","*":"Template:Template other"},{"ns":10,"exists":"","*":"Template:Button"},{"ns":10,"exists":"","*":"Template:Border-radius"},{"ns":10,"exists":"","*":"Template:Linear-gradient"},{"ns":10,"exists":"","*":"Template:Fdacite"},{"ns":10,"exists":"","*":"Template:Infobox drug/maintenance categories"},{"ns":10,"exists":"","*":"Template:TOC limit"},{"ns":10,"exists":"","*":"Template:Abbrlink"},{"ns":10,"exists":"","*":"Template:Citation needed"},{"ns":10,"exists":"","*":"Template:Fix"},{"ns":10,"exists":"","*":"Template:Category handler"},{"ns":10,"exists":"","*":"Template:Fix/category"},{"ns":10,"exists":"","*":"Template:Delink"},{"ns":10,"exists":"","*":"Template:Main article"},{"ns":10,"exists":"","*":"Template:Main"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Column-width"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Cite book"},{"ns":10,"exists":"","*":"Template:Webarchive"},{"ns":10,"exists":"","*":"Template:ISBN"},{"ns":10,"exists":"","*":"Template:Catalog lookup link"},{"ns":10,"exists":"","*":"Template:Trim"},{"ns":10,"exists":"","*":"Template:Yesno-no"},{"ns":10,"exists":"","*":"Template:Error-small"},{"ns":10,"exists":"","*":"Template:Tl"},{"ns":10,"exists":"","*":"Template:Page needed"},{"ns":10,"exists":"","*":"Template:Cite news"},{"ns":10,"exists":"","*":"Template:INIST"},{"ns":10,"exists":"","*":"Template:Antiaddictives"},{"ns":10,"exists":"","*":"Template:Dependence treatment"},{"ns":10,"exists":"","*":"Template:Navbox"},{"ns":10,"exists":"","*":"Template:Opioid receptor modulators"},{"ns":10,"exists":"","*":"Template:Smaller"},{"ns":10,"exists":"","*":"Template:Resize"},{"ns":828,"exists":"","*":"Module:Distinguish"},{"ns":828,"exists":"","*":"Module:Hatnote"},{"ns":828,"exists":"","*":"Module:Hatnote list"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:TableTools"},{"ns":828,"exists":"","*":"Module:Infobox"},{"ns":828,"exists":"","*":"Module:Navbar"},{"ns":828,"exists":"","*":"Module:InfoboxImage"},{"ns":828,"exists":"","*":"Module:String"},{"ns":828,"exists":"","*":"Module:List"},{"ns":828,"exists":"","*":"Module:Collapsible list"},{"ns":828,"exists":"","*":"Module:EditAtWikidata"},{"ns":828,"exists":"","*":"Module:Convert"},{"ns":828,"exists":"","*":"Module:Convert/data"},{"ns":828,"exists":"","*":"Module:Convert/text"},{"ns":828,"exists":"","*":"Module:TemplatePar"},{"ns":828,"exists":"","*":"Module:ParameterCount"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Unsubst"},{"ns":828,"exists":"","*":"Module:Category handler"},{"ns":828,"exists":"","*":"Module:Category handler/data"},{"ns":828,"exists":"","*":"Module:Category handler/config"},{"ns":828,"exists":"","*":"Module:Category handler/shared"},{"ns":828,"exists":"","*":"Module:Category handler/blacklist"},{"ns":828,"exists":"","*":"Module:Namespace detect/data"},{"ns":828,"exists":"","*":"Module:Namespace detect/config"},{"ns":828,"exists":"","*":"Module:Delink"},{"ns":828,"exists":"","*":"Module:No globals"},{"ns":828,"exists":"","*":"Module:Main"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Webarchive"},{"ns":828,"exists":"","*":"Module:Webarchive/data"},{"ns":828,"exists":"","*":"Module:Check isxn"},{"ns":828,"exists":"","*":"Module:Error"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"},{"ns":828,"exists":"","*":"Module:Navbox"}],"images":["Lock-green.svg","Naltrexone_skeletal.svg","Naltrexone-3D-balls.png","Yes_check.svg","X_mark.svg","Blue_pencil.svg"],"externallinks":["https://www.drugs.com/monograph/naltrexone.html","https://web.archive.org/web/20171109134845/https://www.drugs.com/monograph/naltrexone.html","//doi.org/10.1002/phar.1958","//www.ncbi.nlm.nih.gov/pubmed/28543191","https://books.google.ca/books?id=qp-H3UruKvIC&pg=PT265","https://web.archive.org/web/20171205042100/https://books.google.ca/books?id=qp-H3UruKvIC&pg=PT265","http://www.whocc.no/atc_ddd_index/?code=N07BB04","https://web.archive.org/web/20160303220724/http://www.whocc.no/atc_ddd_index/?code=N07BB04","https://data.medicaid.gov/Drug-Pricing-and-Payment/NADAC-as-of-2017-11-29/pmhw-skdi","https://web.archive.org/web/20171203153928/https://data.medicaid.gov/Drug-Pricing-and-Payment/NADAC-as-of-2017-11-29/pmhw-skdi","//doi.org/10.1136/dtb.2017.11.0550","//www.ncbi.nlm.nih.gov/pubmed/29117992","//doi.org/10.1007/s40263-016-0373-0","//www.ncbi.nlm.nih.gov/pubmed/27401883","//doi.org/10.1002/14651858.CD001867.pub2","//www.ncbi.nlm.nih.gov/pubmed/21154349","//doi.org/10.1111/add.12875","//www.ncbi.nlm.nih.gov/pubmed/25664494","//doi.org/10.2174/138161210791516459","//www.ncbi.nlm.nih.gov/pubmed/20482515","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3970823","//doi.org/10.1111/j.1360-0443.2012.04054.x","//www.ncbi.nlm.nih.gov/pubmed/23075288","https://www.psychologytoday.com/blog/overcoming-addiction/201307/drink-your-way-sober-naltrexone","https://web.archive.org/web/20160917232955/https://www.psychologytoday.com/blog/overcoming-addiction/201307/drink-your-way-sober-naltrexone","//doi.org/10.1093/alcalc/36.1.2","//www.ncbi.nlm.nih.gov/pubmed/11139409","//doi.org/10.1007/s11920-017-0783-9","//www.ncbi.nlm.nih.gov/pubmed/28526967","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4920977","//doi.org/10.1016/j.chc.2016.03.002","//www.ncbi.nlm.nih.gov/pubmed/27338968","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4200530","//doi.org/10.1001/archpsyc.63.2.210","//www.ncbi.nlm.nih.gov/pubmed/16461865","//doi.org/10.1002/14651858.CD001333.pub4","//www.ncbi.nlm.nih.gov/pubmed/21491383","//doi.org/10.1111/j.1360-0443.2006.01369.x","//www.ncbi.nlm.nih.gov/pubmed/16548929","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4038652","//doi.org/10.1002/14651858.CD003086.pub3","//www.worldcat.org/issn/1469-493X","//www.ncbi.nlm.nih.gov/pubmed/23744347","https://books.google.com/books?id=wH86DwAAQBAJ&pg=PA88","http://www.medicalnewstoday.com/articles/41707.php","https://web.archive.org/web/20090105124047/http://www.medicalnewstoday.com/articles/41707.php","https://www.ebs.tga.gov.au/ebs/ANZTPAR/PublicWeb.nsf/cuMedicines?OpenView","https://web.archive.org/web/20090514095145/https://www.ebs.tga.gov.au/ebs/ANZTPAR/PublicWeb.nsf/cuMedicines?OpenView","https://www.ebs.tga.gov.au/servlet/xmlmillr6?dbid=ebs/PublicHTML/pdfStore.nsf&docid=12AA89E8C8E53B46CA257FA7004211EE&agid=(PrintDetailsPublic)&actionid=1","//doi.org/10.1001/archgenpsychiatry.2009.130","//www.ncbi.nlm.nih.gov/pubmed/19805701","https://archives.drugabuse.gov/pdf/monographs/download67.html","//www.ncbi.nlm.nih.gov/pubmed/3092099","https://web.archive.org/web/20170121150620/https://archives.drugabuse.gov/pdf/monographs/download67.html","http://molpharm.aspetjournals.org/content/45/2/330.short","//www.ncbi.nlm.nih.gov/pubmed/8114680","http://jpet.aspetjournals.org/content/274/3/1263.short","//www.ncbi.nlm.nih.gov/pubmed/7562497","https://web.archive.org/web/20170202020241/http://jpet.aspetjournals.org/content/274/3/1263.short","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4600601","//doi.org/10.1007/s40263-013-0096-4","//www.ncbi.nlm.nih.gov/pubmed/23881605","//doi.org/10.1016/S0024-3205(96)00597-8","//www.ncbi.nlm.nih.gov/pubmed/9000113","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2666924","//doi.org/10.1001/archpsyc.65.2.135","//www.ncbi.nlm.nih.gov/pubmed/18250251","http://www.snpedia.com/index.php/Rs1799971","https://web.archive.org/web/20111127185453/http://www.snpedia.com/index.php/Rs1799971","//doi.org/10.1111/j.1530-0277.2001.tb02356.x","//www.ncbi.nlm.nih.gov/pubmed/11584154","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3409877","//doi.org/10.1016/j.drugalcdep.2009.07.006","//www.ncbi.nlm.nih.gov/pubmed/19717248","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3249007","//doi.org/10.1111/j.1530-0277.2011.01633.x","//www.ncbi.nlm.nih.gov/pubmed/21895723","https://books.google.com/books?id=pEYrAAAAYAAJ&pg=PA265","https://books.google.com/books?id=hdMAnL5neAAC&pg=PA207","https://books.google.com/books?id=ft6IAgAAQBAJ&pg=PT112","https://books.google.com/books?id=9hOBAgAAQBAJ&pg=RA1-PA78","https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA851","https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA715","https://books.google.com/books?id=tsjrCAAAQBAJ&pg=PA189","https://www.drugs.com/international/naltrexone.html","https://web.archive.org/web/20171204114601/https://www.drugs.com/international/naltrexone.html","//doi.org/10.1038/sj.clpt.6100503","//www.ncbi.nlm.nih.gov/pubmed/18212797","https://psmag.com/social-justice/vivitrol-help-control-addictions-57261","https://web.archive.org/web/20170913135050/https://psmag.com/social-justice/vivitrol-help-control-addictions-57261","https://www.researchgate.net/profile/Evgeny_Krupitsky/publication/51086253_Krupitsky_E_Nunes_EV_Ling_W_Illeperuma_A_Gastfriend_DR_Silverman_BL_Injectable_extended-release_naltrexone_for_opioid_dependence_a_double-blind_placebo-controlled_multicentre_randomised_trial_Lancet_3/links/0deec521d0385a2aff000000/Krupitsky-E-Nunes-EV-Ling-W-Illeperuma-A-Gastfriend-DR-Silverman-BL-Injectable-extended-release-naltrexone-for-opioid-dependence-a-double-blind-placebo-controlled-multicentre-randomised-trial-L.pdf","//doi.org/10.1016/s0140-6736(11)60358-9","https://web.archive.org/web/20170912192327/https://www.researchgate.net/profile/Evgeny_Krupitsky/publication/51086253_Krupitsky_E_Nunes_EV_Ling_W_Illeperuma_A_Gastfriend_DR_Silverman_BL_Injectable_extended-release_naltrexone_for_opioid_dependence_a_double-blind_placebo-controlled_multicentre_randomised_trial_Lancet_3/links/0deec521d0385a2aff000000/Krupitsky-E-Nunes-EV-Ling-W-Illeperuma-A-Gastfriend-DR-Silverman-BL-Injectable-extended-release-naltrexone-for-opioid-dependence-a-double-blind-placebo-controlled-multicentre-randomised-trial-L.pdf","//doi.org/10.1016/S0140-6736(11)61333-0","//doi.org/10.1001/jamapsychiatry.2017.3206","//www.ncbi.nlm.nih.gov/pubmed/29049469","https://www.nytimes.com/2017/06/11/health/vivitrol-drug-opioid-addiction.html","https://web.archive.org/web/20170611133547/https://www.nytimes.com/2017/06/11/health/vivitrol-drug-opioid-addiction.html","https://www.documentcloud.org/documents/3723472-Tom-Price-Letter-Re-MAT.html","https://web.archive.org/web/20170625103407/http://www.documentcloud.org/documents/3723472-Tom-Price-Letter-Re-MAT.html","https://books.google.com/books?id=ONLyq-mVLuIC&pg=PA166","https://books.google.com/books?id=0i-FAwAAQBAJ&pg=PA489","//doi.org/10.1586/14737175.8.1.19","//www.ncbi.nlm.nih.gov/pubmed/18088198","http://www.sciencebasedmedicine.org/index.php/low-dose-naltrexone-bogus-or-cutting-edge-science/","https://web.archive.org/web/20110708043917/http://www.sciencebasedmedicine.org/index.php/low-dose-naltrexone-bogus-or-cutting-edge-science/","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2891387","//doi.org/10.1111/j.1526-4637.2009.00613.x","//www.ncbi.nlm.nih.gov/pubmed/19453963","https://web.archive.org/web/20111222063116/http://www.nationalmssociety.org/multimedia-library/momentum-magazine/back-issues/momentum-spring-09/index.aspx","http://www.nationalmssociety.org/multimedia-library/momentum-magazine/back-issues/momentum-spring-09/index.aspx","//doi.org/10.1007/BF02684958","http://www.mc.vanderbilt.edu/reporter/index.html?ID=461","https://web.archive.org/web/20090105011250/http://www.mc.vanderbilt.edu/reporter/index.html?ID=461","//doi.org/10.1016/j.biopsych.2008.11.022","//www.ncbi.nlm.nih.gov/pubmed/19217077","https://www.sciencedaily.com/releases/2009/04/090401101900.htm","http://ichgcp.net/clinical-trials-registry/NCT00326807","https://web.archive.org/web/20150626114447/http://ichgcp.net/clinical-trials-registry/NCT00326807","//doi.org/10.1016/S0006-3223(01)01079-4","//www.ncbi.nlm.nih.gov/pubmed/11377409","//doi.org/10.4065/83.2.226","//www.ncbi.nlm.nih.gov/pubmed/18241634","//doi.org/10.1016/s0013-7006(05)82400-5","//www.ncbi.nlm.nih.gov/pubmed/16142050","http://cat.inist.fr/?aModele=afficheN&cpsidt=16920336","http://www.psychiatriapsychoterapia.pl/?a=articles_show&id=459","//www.ncbi.nlm.nih.gov/pubmed/17068950","https://web.archive.org/web/20170202010519/http://www.psychiatriapsychoterapia.pl/?a=articles_show&id=459","https://www.wikidata.org/wiki/Q409587#P2566","https://medlineplus.gov/druginfo/meds/a685041.html","https://www.whocc.no/atc_ddd_index/?code=N07BB04","http://www.commonchemistry.org/ChemicalDetail.aspx?ref=16590-41-3","https://pubchem.ncbi.nlm.nih.gov/compound/5360515","http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1639","https://www.drugbank.ca/drugs/DB00704","http://www.chemspider.com/Chemical-Structure.4514524.html","https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=5S6W795CQM","http://www.kegg.jp/entry/D05113","https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:7465","https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL19019","https://echa.europa.eu/substance-information/-/substanceinfo/100.036.939","https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC4%5BC@@H%5D5Oc1c2c(ccc1O)C%5BC@H%5D3N(CC%5BC@%5D25%5BC@@%5D3(O)CC4)CC6CC6"],"sections":[{"toclevel":1,"level":"2","line":"Medical uses","number":"1","index":"1","fromtitle":"Naltrexone","byteoffset":6019,"anchor":"Medical_uses"},{"toclevel":2,"level":"3","line":"Alcoholism","number":"1.1","index":"2","fromtitle":"Naltrexone","byteoffset":6037,"anchor":"Alcoholism"},{"toclevel":2,"level":"3","line":"Opioid use","number":"1.2","index":"3","fromtitle":"Naltrexone","byteoffset":9422,"anchor":"Opioid_use"},{"toclevel":2,"level":"3","line":"Others","number":"1.3","index":"4","fromtitle":"Naltrexone","byteoffset":12482,"anchor":"Others"},{"toclevel":2,"level":"3","line":"Available forms","number":"1.4","index":"5","fromtitle":"Naltrexone","byteoffset":12951,"anchor":"Available_forms"},{"toclevel":1,"level":"2","line":"Contraindications","number":"2","index":"6","fromtitle":"Naltrexone","byteoffset":15216,"anchor":"Contraindications"},{"toclevel":1,"level":"2","line":"Side effects","number":"3","index":"7","fromtitle":"Naltrexone","byteoffset":15374,"anchor":"Side_effects"},{"toclevel":1,"level":"2","line":"Pharmacology","number":"4","index":"8","fromtitle":"Naltrexone","byteoffset":17624,"anchor":"Pharmacology"},{"toclevel":2,"level":"3","line":"Pharmacodynamics","number":"4.1","index":"9","fromtitle":"Naltrexone","byteoffset":17642,"anchor":"Pharmacodynamics"},{"toclevel":3,"level":"4","line":"Mechanism of action","number":"4.1.1","index":"10","fromtitle":"Naltrexone","byteoffset":19708,"anchor":"Mechanism_of_action"},{"toclevel":2,"level":"3","line":"Pharmacokinetics","number":"4.2","index":"11","fromtitle":"Naltrexone","byteoffset":20941,"anchor":"Pharmacokinetics"},{"toclevel":2,"level":"3","line":"Pharmacogenetics","number":"4.3","index":"12","fromtitle":"Naltrexone","byteoffset":21503,"anchor":"Pharmacogenetics"},{"toclevel":1,"level":"2","line":"Chemistry","number":"5","index":"13","fromtitle":"Naltrexone","byteoffset":26184,"anchor":"Chemistry"},{"toclevel":2,"level":"3","line":"Analogues","number":"5.1","index":"14","fromtitle":"Naltrexone","byteoffset":26459,"anchor":"Analogues"},{"toclevel":1,"level":"2","line":"History","number":"6","index":"15","fromtitle":"Naltrexone","byteoffset":26929,"anchor":"History"},{"toclevel":1,"level":"2","line":"Society and culture","number":"7","index":"16","fromtitle":"Naltrexone","byteoffset":29866,"anchor":"Society_and_culture"},{"toclevel":2,"level":"3","line":"Generic names","number":"7.1","index":"17","fromtitle":"Naltrexone","byteoffset":29891,"anchor":"Generic_names"},{"toclevel":2,"level":"3","line":"Brand names","number":"7.2","index":"18","fromtitle":"Naltrexone","byteoffset":30454,"anchor":"Brand_names"},{"toclevel":2,"level":"3","line":"Controversies","number":"7.3","index":"19","fromtitle":"Naltrexone","byteoffset":32435,"anchor":"Controversies"},{"toclevel":1,"level":"2","line":"Research","number":"8","index":"20","fromtitle":"Naltrexone","byteoffset":39419,"anchor":"Research"},{"toclevel":2,"level":"3","line":"Depersonalization","number":"8.1","index":"21","fromtitle":"Naltrexone","byteoffset":39433,"anchor":"Depersonalization"},{"toclevel":2,"level":"3","line":"Low-dose","number":"8.2","index":"22","fromtitle":"Naltrexone","byteoffset":41097,"anchor":"Low-dose"},{"toclevel":2,"level":"3","line":"Self-injury","number":"8.3","index":"23","fromtitle":"Naltrexone","byteoffset":43094,"anchor":"Self-injury"},{"toclevel":2,"level":"3","line":"Behavioral disorders","number":"8.4","index":"24","fromtitle":"Naltrexone","byteoffset":44253,"anchor":"Behavioral_disorders"},{"toclevel":2,"level":"3","line":"Interferon alpha","number":"8.5","index":"25","fromtitle":"Naltrexone","byteoffset":46228,"anchor":"Interferon_alpha"},{"toclevel":1,"level":"2","line":"See also","number":"9","index":"26","fromtitle":"Naltrexone","byteoffset":47582,"anchor":"See_also"},{"toclevel":1,"level":"2","line":"References","number":"10","index":"27","fromtitle":"Naltrexone","byteoffset":47827,"anchor":"References"}],"parsewarnings":[],"displaytitle":"Naltrexone","iwlinks":[],"properties":[{"name":"wikibase_item","*":"Q409587"}]}}